21390519	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer .	miR-195	metastasis	downregulate	negative	colorectal cancer	D001943
21562850	MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility .	MicroRNA-9	metastasis	upregulate	positive	colorectal cancer	D001943
21598109	Let-7 could inhibit cell proliferation and lower expressed in ESCC , and there was a correlation between let-7 lower expression and lymph node metastasis in ESCC patients .	Let-7|let-7	metastasis	inhibit	negative	ESCC	D009369
21633953	These results suggest that miR-30a targets Snai1 , inhibits invasion and metastasis , and is downregulated in NSCLC .	miR-30a	metastasis	inhibit	negative	NSCLC	D009369
21666718	Higher expression of miR-370 in GC tissues was associated with more advanced nodal metastasis and a higher clinical stage compared with controls .	miR-370	metastasis	control	neutral	GC	D061325
21672940	In HCC cell lines , stable overexpression of miR-124 was sufficient to inhibit cell motility and invasion in vitro , and suppress intrahepatic and pulmonary metastasis in vivo .	miR-124	metastasis	inhibit	negative	HCC|intrahepatic|pulmonary	D009369
21672940	These data highlight an important role for miR-124 in the regulation of invasion and metastasis in the molecular aetiology of HCC , and suggest a potential application of miR-124 in prognosis prediction and cancer treatment .	miR-124	metastasis	regulate	positive	HCC	D009369
21725369	In vivo , enforced miR-200b or miR-15b expression suppressed metastasis of TSCC xenografts established by CAL27-res cells .	miR-200b|miR-15b	metastasis	suppress	negative	TSCC	D009369
21813472	MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor .	MicroRNA-375	metastasis	inhibit	negative	oesophageal squamous cell carcinoma	D009369
21813472	The downregulation of miR-375 was frequently detected in primary ESCC , which was significantly correlated with advanced stage ( p=0.003 ) , distant metastasis ( p < 0.0001 ) , poor overall survival ( p=0.048 ) and disease-free survival ( p=0.0006 ) .	miR-375	metastasis	downregulate	negative	ESCC	D009369
21822301	Overexpression of miR-335 suppressed gastric cancer cell invasion and metastasis in vitro and in vivo , but has no significant effects on cell proliferation .	miR-335	metastasis	suppress	negative	gastric cancer cell	D061325
21822301	Furthermore , miR-335 might suppress gastric cancer invasion and metastasis by targeting Bcl-w and specificity protein 1 ( SP1 ) .	miR-335	metastasis	suppress	negative	gastric cancer	D061325
21888875	MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma .	MicroRNA-135a	metastasis	promote	positive	portal vein tumor	D009369
21984339	Taken together , these results demonstrate that let-7c , apart from its tumour growth suppression role , also functions as a tumour metastasis suppressor in colorectal cancer by directly destabilizing the mRNAs of MMP11 and PBX3 at least .	let-7c	metastasis	suppress	negative	colorectal cancer	D001943
22034498	Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells .	microRNA-335	metastasis	induce	positive	breast cancer	D001943
22052152	MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration , invasion and tumor angiogenesis .	MicroRNA-378	metastasis	promote	positive	non-small cell lung cancer	D009369
22052152	Our study showed evidences that miR-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration , invasion and tumor angiogenesis .	miR-378	metastasis	promote	positive	non-small cell lung cancer	D009369
22134529	microRNA-320a inhibits tumor invasion by targeting neuropilin ? 1 and is associated with liver metastasis in colorectal cancer .	microRNA-320a	metastasis	inhibit	negative	colorectal cancer	D001943
22160187	Suppression of miR-96 expression inhibits the invasion of HCC cells , suggesting that miR-96 may be a therapeutic target for inhibiting HCC invasion and metastasis .	miR-96	metastasis	suppress	negative	HCC	D009369
22179828	MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers .	MicroRNA-409	metastasis	suppress	negative	gastric cancers	D061325
22179828	In this study , miR-409-3p was found to be downregulated frequently in human GCs , and its expression was significantly associated with tumor-node-metastasis ( TNM ) stage and lymph node metastasis .	miR-409	metastasis	downregulate	negative	tumor-node-metastasis 	D009369
22179828	Taken together , these results demonstrate that miR-409 suppresses GC cell invasion and metastasis by directly targeting RDX and that patients with downregulated miR-409-3p are prone to lymph node metastasis .	miR-409	metastasis	suppress	negative	GC 	D061325
22179829	We report that elevated microRNA-133b ( miR-133b ) acts as an oncogene in human cervical carcinoma to promote tumorigenesis and metastasis .	microRNA-133b|miR-133b	metastasis	promote	positive	human cervical carcinoma	D001943
22179829	Mouse experiments revealed that upregulation of miR-133b in cervical carcinoma cells strongly promotes both in vivo tumorigenesis and independent metastasis to the mouse lung .	miR-133b	metastasis	upregulate	positive	cervical carcinoma	D001943
22189055	The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis .	miR-610|miR610	metastasis	regulate	positive	gastric cancer	D061325
22231446	Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster , methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer .	mir-200b	metastasis	control	neutral	breast cancer	D001943
22234174	We conclude that miR-375 represents a potential prognostic marker of poor outcome and metastasis in HNSCC and that it may function by suppressing the tumor 's invasive properties .	miR-375	metastasis	suppress	negative	HNSCC	D006258
22234835	MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma .	MicroRNA-7	metastasis	inhibit	negative	hepatocellular carcinoma	D009369
22234835	Here , we demonstrate that miR-7 inhibits HCC cell growth and metastasis in vitro and in vivo .	miR-7	metastasis	inhibit	negative	HCC	D009369
22234835	These findings indicate that miR-7 functions as a tumor suppressor and plays a substantial role in inhibiting the tumorigenesis and reversing the metastasis of HCC through the PI3K/Akt/mTOR-signaling pathway in vitro and in vivo .	miR-7	metastasis	inhibit	negative	HCC	D009369
22240480	CRC cells overexpressing miR-28 developed tumors more slowly in mice compared with control cells , but miR-28 promoted tumor metastasis in mice .	miR-28	metastasis	control	neutral	CRC	D001943
22267008	microRNA-21 expression was upregulated in gastric carcinoma tissues and was significantly associated with the degree of differentiation of tumour tissues , local invasion and lymph node metastasis .	microRNA-21	metastasis	upregulate	positive	local invasion 	D009362
22289355	Together , our results provide the initial evidence for a mechanism by which miR-31 , an important determinant of the invasion metastasis cascade , is regulated in breast cancer .	miR-31	metastasis	regulate	positive	breast cancer	D001943
22311119	miR-200b regulates ZEB2 expression and thus controls metastasis in gastric cancer .	miR-200b	metastasis	regulate	positive	gastric cancer	D061325
22322863	Mechanistically , we demonstrated that the oncogenic properties of miR-182 in ovarian cancer were mediated in part by its impaired repair of DNA double-strand breaks and negative regulation of breast cancer 1 ( BRCA1 ) and metastasis suppressor 1 ( MTSS1 ) expression as well as its positive regulation of the oncogene high-mobility group AT-hook 2 ( HMGA2 ) .	miR-182	metastasis	mediate	neutral	ovarian cancer|breast cancer 1	D009369
22370644	This study 's aim was to clarify the roles of miR-145 in gastric carcinomas and its underlying molecular mechanism in regulating tumor metastasis .	miR-145	metastasis	regulate	positive	tumor metastasis	D009369
22370644	We suggest that miR-145 suppresses tumor metastasis by inhibiting N-cadherin protein translation , and then indirectly downregulates its downstream effector MMP9 .	miR-145	metastasis	suppress	negative	tumor metastasis	D009369
22373578	We propose that , in a subset of colon cancer , upregulation of miR-493 during carcinogenesis prevents liver metastasis via the induction of cell death of metastasized cells .	miR-493	metastasis	upregulate	positive	colon cancer	D001943
22402125	miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling .	miRNA-29b	metastasis	suppress	negative	prostate cancer	D001943
22407237	It is known that miRNA-107 ( miR-107 ) promotes cancer invasion and metastasis .	miRNA-107|miR-107	metastasis	promote	positive	promotes cancer	D009369
22407310	Taken together , our study demonstrated that miR-200c inhibits metastatic ability by targeting ZEB1 in colon cancer cells SW480/620 and suggested that modulation of miR-200c could serve as therapeutic tool for inhibiting metastasis in colorectal cancer .	miR-200c	metastasis	inhibit	negative	colon cancer|colorectal cancer	D001943
22426647	microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis .	microRNA-155	metastasis	downregulate	negative	gastric cancer	D061325
22426647	Taken together , these data suggest that miR-155 may function as a tumor suppressor to regulate gastric cancer cell metastasis by targeting SMAD2 , and its downregulation in gastric cancer cells may be partly ascribed to DNA methylation .	miR-155	metastasis	regulate	positive	gastric cancer	D061325
22438992	Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .	let-7c|miR-100|miR-125b|miR-143|miR-145|miR-199a	metastasis	downregulate	negative	 SCCC	D009369
22450326	Moreover , we demonstrated that the up-regulation of miR-25 was significantly correlated with the status of lymph node metastasis and TNM ( Tumor , Node and Metastasis ) stage .	miR-25	metastasis|Metastasis	upregulate	positive	 TNM	D009369
22455847	MiR-23a expression promotes colon carcinoma cell growth , invasion and metastasis through inhibition of MTSS gene .	MiR-23a	metastasis	promote	positive	colon carcinoma cell	D009369
22457788	MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo .	MicroRNA-34a	metastasis	inhibit	negative	osteosarcoma cells	D009362
22457788	Over-expression of miR-34a partially inhibited proliferation , migration and invasion of osteosarcoma cells in vitro , as well as the tumor growth and pulmonary metastasis of osteosarcoma cells in vivo .	miR-34a	metastasis	inhibit	negative	osteosarcoma cells	D009362
22469510	Meanwhile , the overexpression of miR-26a in the A549 human lung cancer cell line dramatically inhibited cell proliferation , blocked G1/S phase transition , induced apoptosis , and inhibited cell metastasis and invasion in ? vitro .	miR-26a	metastasis	inhibit	negative	lung cancer	D061325
22472569	MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells .	MicroRNA-145	metastasis	inhibit	negative	osteosarcoma cells	D063646
22472569	Therefore , it can be concluded that miR-145 can inhibit invasion and metastasis of osteosarcoma cells .	miR-145	metastasis	inhibit	negative	osteosarcoma cells	D063646
22476851	In conclusion , these findings suggest a role for miR-30a in inhibiting breast tumor invasiveness and metastasis .	miR-30a	metastasis	inhibit	negative	breast tumor	D001943
22477528	Vaccination with the viable B16F10/ESAT-6-GPI-IL-21 vaccine resulted in an increase of IFN-帠 level and the CD8 ( + ) CTL cytotoxicity , a decrease in TGF-?] generation and increase in the expression of miR-200c that serves as melanoma suppressor by directly targeting zinc-finger E-box binding homeobox 1 to inhibit epithelial-mesenchymal transition and block tumor metastasis .	miR-200c	metastasis	inhibit	negative	epithelial-mesenchymal transition|block tumor	D009369
22488243	The miR-1258 regulates the expression level of HPSE to influence the morbidity and metastasis of NSCLC .	miR-1258	metastasis	regulate	positive	NSCLC	D009369
22489664	In aggregate , these data suggest that miR-151-5p upregulation may suppress metastasis in primary breast tumors .	miR-151	metastasis	upregulate	positive	primary breast tumors	D001943
22528944	These results suggest that miR-10b may positively regulate the invasion and metastasis of HCC through targeting CADM1 .	miR-10b	metastasis	regulate	positive	HCC	D009369
22540680	Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist .	miR-214	metastasis	downregulate	negative	intrahepatic cholangiocarcinoma	D009362
22540680	Inhibition of miR-214 levels by its inhibitor promoted metastasis of human intrahepatic cholangiocarcinoma cell .	miR-214	metastasis	inhibit	negative	intrahepatic cholangiocarcinoma	D009362
22540680	These results suggest an important role for miR-214 in regulating metastasis of intrahepatic cholangiocarcinoma , and potential application of miR-214 in intrahepatic cholangiocarcinoma therapy .	miR-214	metastasis	regulate	positive	intrahepatic cholangiocarcinoma	D009362
22544933	Knockdown of miR-494 significantly reversed the activity of MDSCs and inhibited the tumor growth and metastasis of 4T1 murine breast cancer in vivo .	miR-494	metastasis	inhibit	negative	breast cancer	D001943
22547075	Our data support a critical role of DNA damage-induced NF-庥B activation in promoting cancer metastasis following genotoxic treatment , and NF-庥B-dependent miR-21 induction may contribute to both therapeutic resistance and metastasis in breast cancer .	miR-21	metastasis	activate	positive	breast cancer	D001943
22564723	microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion , metastasis , and angiogenesis of neuroblastoma cells .	microRNA-9	metastasis	inhibit	negative	neuroblastoma	D009369
22564723	These data indicate that miR-9 suppresses MMP-14 expression via the binding site in the 3'-UTR , thus inhibiting the invasion , metastasis , and angiogenesis of neuroblastoma .	miR-9	metastasis	suppress	negative	neuroblastoma	D009369
22580051	MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor .	MiR-139	metastasis	inhibit	negative	colorectal cancer	D001943
22580051	In this study , we describe the down-regulation and function of miR-139 in colorectal cancer ( CRC ) metastasis .	miR-139	metastasis	downregulate	negative	colorectal cancer ( CRC )	D001943
22580051	Re-expression of miR-139 did not inhibit CRC cell growth but suppresses CRC cell metastasis and invasion in vitro and in vivo .	miR-139	metastasis	inhibit	negative	CRC cell	D001943
22580051	MiR-139 might suppress CRC cells invasion and metastasis by targeting type I insulin-like growth factor receptor ( IGF-IR ) .	MiR-139	metastasis	suppress	negative	CRC cells	D001943
22580051	Targeting miR-139 may provide a strategy for blocking CRC metastasis .	miR-139	metastasis	block	negative	CRC	D001943
22593189	miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4 .	miR-103/107	metastasis	promote	positive	colorectal cancer	D001943
22593189	In mouse models of CRC , miR-103/107 overexpression potentiated local invasion and liver metastasis effects , which were suppressed by reexpression of DAPK or KLF4 .	miR-103/107	metastasis	suppress	negative	CRC	D001943
22593189	Our findings therefore indicate that miR-103/107-mediated repression of DAPK and KLF4 promotes metastasis in CRC , and this regulatory circuit may contribute in part to hypoxia-stimulated tumor metastasis .	miR-103/107	metastasis	promote	positive	CRC	D001943
22614005	In vivo metastasis assays also demonstrated that overexpression of miR-7 markedly inhibited GC metastasis .	miR-7	metastasis	inhibit	negative	GC	D061325
22614005	Targeting this novel miR-7/IGF1R/Snail axis would be helpful as a therapeutic approach to block GC metastasis .	miR-7/IGF	metastasis	block	negative	GC	D061325
22664743	We propose that IRS-1 suppresses metastasis of head and neck cancer possibly through miR-9 .	miR-9	metastasis	suppress	negative	head and neck cancer	D006258
22666537	EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours .	miR-21	metastasis	induction	positive	Trp53-deficient tumours	D009369
22677169	Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK .	miR-625	metastasis	downregulate	negative	gastric cancer	D061325
22677169	Here , we report that expression of miR-625 is significantly down-regulated and negatively correlated with lymph node metastasis in gastric cancer .	miR-625	metastasis	downregulate	negative	gastric cancer	D061325
22677169	miR-625 significantly inhibits invasion and metastasis of gastric cancer cells both in vitro and in vivo .	miR-625	metastasis	inhibit	negative	gastric cancer cells	D061325
22677902	miR-21 , miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer .	miR-21|miR-17|miR-19a	metastasis	induce	positive	colon cancer	D001943
22677902	Here , we demonstrate that the miR-21 , miR-17 and miR-19a expressions induced by PRL-3 are involved in the proliferation and metastasis of colon cancer .	miR-21|miR-17|miR-19a	metastasis	induce	positive	colon cancer	D001943
22678116	The enhanced abundance of microRNA-21 ( miR-21 ) in breast cancer cells contributes to the growth and metastasis .	microRNA-21|miR-21	metastasis	enhance	positive	breast cancer cells	D001943
22681717	MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma .	MicroRNA-182	metastasis	downregulate	negative	hepatocellular carcinoma	D009369
22681717	miR-182 could promote metastasis of HCC and inhibit the expression of MTSS1 .	miR-182	metastasis	promote	positive	HCC	D009369
22684455	miR-23a , a critical regulator of " migR " ation and metastasis in colorectal cancer .	miR-23a	metastasis	regulate	positive	colorectal cancer	D001943
22693547	MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells .	MicroRNA-125b	metastasis	induce	positive	breast cancer cells	D001943
22711166	Taken together , our results provide evidence that miR-146a suppresses gastric cancer cell invasion and metastasis in ? vitro and in ? vivo , which may be in part due to the downregulation of L1CAM .	miR-146a	metastasis	suppress	negative	gastric cancer	D061325
22711166	miR-146a may have the therapeutic potential to suppress gastric cancer metastasis .	miR-146a	metastasis	suppress	negative	gastric cancer	D061325
22745231	We have performed experiments to test predictions from this miRNA-regulatory network to demonstrate that miRNAs of the miR-29 family ( miR-29a , miR-29b , and miR-29c ) regulate specific genes associated with tissue invasion and metastasis in lung adenocarcinoma .	miR-29|miR-29a|miR-29b|miR-29c	metastasis	regulate	positive	lung adenocarcinoma	D009369
22768249	Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF .	MiR-125a	metastasis	inhibit	negative	hepatocellular carcinoma	D009369
22768249	Ectopic expression of miR-125a was used to test the influences of miR-125a on proliferation and metastasis of HCC cells in vitro and in vivo .	miR-125a	metastasis	influence	neutral	HCC cells	D009369
22768249	MiR-125a inhibits the proliferation and metastasis of HCC by targeting MMP11 and VEGF-A .	MiR-125a	metastasis	inhibit	negative	HCC	D009369
22795796	MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .	MiR-200|miR-200a|miR-200b|miR-200c|miR-141|miR-429|miR-200b	metastasis	regulate	positive	epithelial-mesenchymal transition ( EMT )	D009369
22799367	Metastasis was associated with mir-21 expression in serum ( P < 0.05 ) , ESCC patients with metastasis having 8.4-fold higher serum miR-21 concentrations than healthy controls .	mir-21|miR-21	Metastasis|metastasis	control	neutral	ESCC	D009369
22800791	The levels of miR-195 in the breast cancer with histological high grade , tumor size of T3-4 , lymph nodal involvement or vessel invasion were significantly down-regulated , compared with those of patients with histological low grade ( Z = -2.271 , P = 0.023 ) , tumor size of T1-2 ( Z = -2.687 , P = 0.007 ) , no lymph node metastasis ( Z = -1.967 , P = 0.049 ) and vessel invasion ( Z = -2.432 , P = 0.015 ) .	miR-195	metastasis	downregulate	negative	breast cancer	D001943
22809510	MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells .	MicroRNA-224	metastasis	control	neutral	human breast cancer cells	D001943
22809510	Promotion of metastasis in response to miR-224 downregulation was associated with derepression of the stroma-associated RKIP target genes , CXCR4 , MMP1 , and OPN , which are involved in breast tumor metastasis to the bone .	miR-224	metastasis	promote	positive	breast tumor	D001943
22809510	Taken together , our data indicate that miR-224 play an important role in metastasis of human breast cancer cells to the bone by directly suppressing the RKIP tumor suppressor .	miR-224	metastasis	suppress	negative	human breast cancer cells	D001943
22825752	MicroRNAs ( miRNAs ) have been implicated in the regulation of various biological and pathological processes in cancer , however , the special role of miR-9 in uveal melanoma metastasis is largely unknown .	miR-9	metastasis	regulate	positive	uveal melanoma	D009369
22850877	Ectopic expression of miR-34a decreased tumor cell invasion and metastasis , inhibited the formation of promigratory cytoskeletal structures , suppressed activation of the RHO GTPase family , and regulated a gene expression signature enriched in cytoskeletal functions and predictive of outcome in human lung adenocarcinomas .	miR-34a	metastasis	inhibit	negative	 human lung adenocarcinomas	D001943
22851079	miR-183 is down-regulated in stage II ( GC , and associated with the differentiation , metastasis , and prognosis. Ezrin is a potential regulatory protein of miR-183 .	miR-183	metastasis	downregulate	negative	GC	D061325
22853714	MiR-7 transfection into ovarian cancer cells induces changes in cell adhesion and other developmental networks previously associated with epithelial-mesenchymal transitions ( EMT ) and other processes linked with metastasis .	MiR-7	metastasis	induce	positive	ovarian cancer	D009369
22859270	MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis .	MiR-196a	metastasis	regulate	positive	esophageal squamous cell carcinoma	D063646
22867052	These findings suggest that decreased expression of miR-98 and miR-214 might promote metastasis of human ESCC by inducing accumulation of EZH2 protein .	miR-98|miR-214	metastasis	promote	positive	ESCC	D009369
22876288	MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression .	MicroRNA-7	metastasis	inhibit	negative	breast cancer cells	D001943
22885155	MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN .	MiR-26a	metastasis	enhance	positive	lung cancer	D061325
22885155	In the present study , we investigated the effect of miR-26a on metastasis potential of lung cancer cells .	miR-26a	metastasis	effect	neutral	lung cancer	D061325
22885155	Our study demonstrated that miR-26a enhanced lung cancer cell metastasis potential via modulation of metastasis-related gene expression , and activation of AKT pathway by PTEN suppression , suggesting that miR-26a might be a potential therapeutic candidate in patients with metastatic lung cancer .	miR-26a	metastasis	enhance	positive	lung cancer cell|lung cancer	D009369
22907300	These results indicate that over-expression of miR-129 could inhibit breast cancer motility and migration , and the down-regulation of miR-129 may participate in the breast cancer migration and metastasis .	miR-129	metastasis	inhibit	negative	breast cancer	D001943
22922800	miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells .	miR-183	metastasis	inhibit	negative	osteosarcoma	D009362
22922800	This suggests that miR-183 may possibly play a tumor suppressor role in the metastasis of osteosarcoma by downregulating Ezrin expression levels .	miR-183	metastasis	downregulate	negative	osteosarcoma	D009362
22948942	A previous study showed that miR-143 and miR-145 play an important role in regulating bone metastasis of prostate cancer ( PCa ) , but the exact mechanism of regulation of bone metastasis of PCa is not fully understood .	miR-143|miR-145	metastasis	regulate	positive	prostate cancer|Pca	D001943
22948942	In this study , we found that overexpression of miR-143 and miR-145 inhibited the cell viability and colony formation of PC-3 cells from PCa bone metastasis .	miR-143|miR-145	metastasis	inhibit	negative	PCa 	D001943
22948942	Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .	miR-143|miR-145|miR-143|miR-145	metastasis	inhibit	negative	CSC|Pca	D001943
22949171	MicroRNA-146a suppresses metastatic activity in brain metastasis .	MicroRNA-146a	metastasis	suppress	negative	brain metastasis	D009362
22949650	Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer .	microRNA-205	metastasis	enhance	positive	prostate cancer	D001943
22952217	In this study , we focus on matrix-derived influences on epithelial morphogenesis of a metastatic cell line ( 344SQ ) that harbors mutations in Kras and p53 ( trp53 ) and is prone to a microRNA-200 ( miR-200 ) -dependent epithelial-mesenchymal transition ( EMT ) and metastasis .	microRNA-200|miR-200	metastasis	influence	neutral	epithelial-mesenchymal transition ( EMT )	D009369
22956424	MicroRNA-21 ( miR-21 ) expression promotes growth , metastasis , and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN .	MicroRNA-21|miR-21	metastasis	promote	positive	lung cancer cells|PTEN	D009369
22958893	In this study , we demonstrated that miR-518b was down-regulated in esophageal squamous cell carcinoma ( ESCC ) tissues and correlated with metastasis and survival .	miR-518b	metastasis	downregulate	negative	esophageal squamous cell carcinoma ( ESCC )	D009369
22982443	In addition , miR-200c overexpression significantly inhibited melanoma xenograft growth and metastasis in vivo , and this correlated with diminished expression of BMI-1 and reduced levels of E-cadherin in these tumors .	miR-200c	metastasis	inhibit	negative	melanoma 	D012878
22986525	Here , we report that miRNAs encoded by miR-106b-25 are upregulated in both primary tumors and distant metastasis .	miR-106b	metastasis	upregulate	positive	primary tumors	D009369
23001043	MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1 .	MicroRNA-34	metastasis	suppress	negative	breast cancer	D001943
23001043	Here , we describe the regulation and function of miR-34a and miR-34c ( miR-34a/c ) in breast cancer metastasis .	miR-34a|miR-34c|miR-34a/c	metastasis	regulate	positive	breast cancer metastasis	D001943
23001043	Overexpression of miR-34a/c could inhibit breast cancer cell migration and invasion in vitro and distal pulmonary metastasis in vivo .	miR-34a/c	metastasis	inhibit	negative	breast cancer cell|pulmonary metastasis	D001943
23001043	Our results demonstrate that miR-34a/c functions as a metastasis suppressor to regulate breast cancer migration and invasion through targeting Fra-1 oncogene and suggest a therapeutic application of miR-34 in breast cancer .	miR-34a/c|miR-34	metastasis	regulate	positive	breast cancer	D001943
23001723	Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma .	microRNA-139	metastasis	downregulate	negative	human hepatocellular carcinoma	D009369
23001723	Derepression of c-Fos caused by miR-139 down-regulation contributes to the metastasis of HCC .	miR-139	metastasis	downregulate	negative	HCC	D009369
23013135	Analysis of the regulation of ZEB1 by miR-150 could provide new insights into preventing metastasis and also suggests novel targeted therapeutic strategies in ESCC .	miR-150	metastasis	regulate	positive	ESCC	D009369
23017832	MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro .	MiR-135a	metastasis	promote	positive	colorectal cancer	D001943
23053883	Upregulated expression of miR-451 induced apoptosis and suppressed cell proliferation , invasion and metastasis in the esophageal carcinoma cell line EC9706 .	miR-451	metastasis	upregulate	positive	esophageal carcinoma	D009369
23056431	MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer .	MicroRNA-1280	metastasis	inhibit	negative	bladder cancer	D061325
23070684	miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway .	miR-143	metastasis	inhibit	negative	pancreatic cancer	D009369
23072640	Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .	miR-9*|miR-183|miR-375	metastasis	react	neutral	primary tumour |MTC	D009369
23107361	Let-7i was significantly down-regulated in most tumor tissues ( 78/86 : 91 % ) compared with paired NATs ( P < 0.001 ) , and low levels of let-7i were significantly correlated with local invasion , lymphatic metastasis , and poor pathologic tumor response .	Let-7i|let-7i	metastasis	downregulate	negative	lymphatic metastasis	D009362
23108995	Results of qRT-PCR in clinical samples showed that downregulated miR-26a expression is related to tumorigenesis and metastasis of EA .	miR-26a	metastasis	downregulate	negative	EA	D009369
23111103	In this study , we found that miR-429 expression was up-regulated in human colorectal cancer ( CRC ) tissues , and the high miR-429 expression was significantly associated with tumor size , lymph node metastasis and poor prognosis .	miR-429	metastasis	upregulate	positive	human colorectal cancer ( CRC ) 	D001943
23134218	MicroRNAs are closely linked to tumor metastasis and let-7a may play a role in inhibiting the proliferation , invasion , and metastasis of lung cancer .	let-7a	metastasis	inhibit	negative	lung cancer	D009362
23142282	MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma .	MiR-29c	metastasis	suppress	negative	nasopharyngeal carcinoma	D009362
23142282	Wound healing , Transwell migration and lung metastasis assays demonstrated that ectopic expression of miR-29c inhibited NPC cell migration and invasion in vitro and suppressed the formation of lung metastases in vivo .	miR-29c	metastasis	inhibit	negative	NPC	D009369
23142282	The newly identified miR-29c/TIAM1 pathway further elucidates the molecular mechanisms regulating invasion and metastasis in NPC , and may provide novel prognostic and treatment strategies for NPC patients .	miR-29c/TIAM	metastasis	regulate	positive	NPC	D009369
23151088	MiR-100 was significantly downregulated in NSCLC tissues , and low miR-100 expression was found to be closely correlated with higher clinical stage , advanced tumor classification and lymph node metastasis of patients .	MiR-100|miR-100	metastasis	downregulate	negative	advanced tumor 	D009369
23188671	Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer .	miR-153	metastasis	downregulate	negative	human epithelial cancer	D009369
23201162	MicroRNA-137 , an HMGA1 target , suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2 .	MicroRNA-137	metastasis	suppress	negative	colorectal cancer	D009369
23222716	MicroRNA-145 inhibits the growth , invasion , metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha .	MicroRNA-145	metastasis	inhibit	negative	neuroblastoma	D009369
23222811	Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma .	MiR-200	metastasis	activate	positive	hepatocellular carcinoma	D009369
23233482	miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion , metastasis , and angiogenesis of gastric cancer cells .	miRNA-145	metastasis	suppress	negative	gastric cancer	D061325
23233482	These results show that miR-145 suppresses Ets1 expression via the binding site in the 3'-UTR , thus inhibiting the invasion , metastasis , and angiogenesis of gastric cancer cells .	miR-145	metastasis	suppress	negative	gastric cancer	D061325
23241956	TGF-?] upregulates miR-181a expression to promote breast cancer metastasis .	miR-181a	metastasis	upregulate	positive	breast cancer metastasis	D001943
23246488	Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin .	miR-363	metastasis	affect	neutral	head and neck cancer	D006258
23246488	In this study , we have first confirmed that miR-363 is down-regulated in HNSCC tissues with lymph node metastasis and cell lines with highly invasive capacity .	miR-363	metastasis	downregulate	negative	HNSCC|ymph node metastasis	D006258
23246488	Furthermore , we provided evidence to demonstrate that PDPN dysregulation caused by down-regulation of miR-363 contributes to HNSCC invasion and metastasis .	miR-363	metastasis	downregulate	negative	HNSCC	D006258
23250910	MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer .	MiR-124	metastasis	regulate	positive	breast cancer	D001943
23250910	Also , lentivirus-delivered miR-124 endows MDA-MB-231 cells with the ability to suppress cell colony formation in vitro and pulmonary metastasis in vivo .	miR-124	metastasis	suppress	negative	pulmonary metastasis	D009362
23270926	In addition , the cancerous metastatic nude mouse model established on the basis of primary bladder cancer cell lines suggested that miR-100/mTOR regulated cell motility and was associated with tumor metastasis .	miR-100/mTOR	metastasis	regulate	positive	bladder cancer	D061325
23272133	Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway .	MicroRNA-21	metastasis	inhibit	negative	prostate cancer	D001943
23274497	In human epithelial cancers , the microRNA ( miRNA ) mir-30d is amplified with high frequency and serves as a critical oncomir by regulating metastasis , apoptosis , proliferation , and differentiation .	mir-30d	metastasis	regulate	positive	human epithelial cancers	D009369
23275153	Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer .	miR-137	metastasis	induce	positive	colorectal cancer	D009369
23275153	Taken together , these results demonstrated that overexpression of PXN induced by suppression of miR-137 promotes tumor progression and metastasis and could serve as an independent prognostic indicator in CRC patients .	miR-137	metastasis	induce	positive	CRC	D001943
23291181	The functions of miR-9 in some cancers are recently implicated in regulating proliferation , epithelial-mesenchymal transition ( EMT ) , invasion and metastasis , apoptosis , and tumor angiogenesis , etc. miR-9 is commonly down-regulated in nasopharyngeal carcinoma ( NPC ) , but the exact roles of miR-9 dysregulation in the pathogenesis of NPC remains unclear .	miR-9	metastasis	regulate	positive	epithelial-mesenchymal transition ( EMT )|nasopharyngeal carcinoma ( NPC )	D009369
23292869	Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis .	miR-34a	metastasis	downregulate	negative	breast tumors	D001943
23295946	Furthermore , transurethral injections of synthetic miR-582 molecule suppressed tumor growth and metastasis in an animal model of bladder cancer .	miR-582	metastasis	suppress	negative	bladder cancer	D061325
23300597	However , there was no effect of miR-23b/-27b on cell proliferation suggesting that these miRs function as metastasis ( but not growth ) suppressors in prostate cancer .	miR-23b/	metastasis	effect	neutral	prostate cancer	D001943
23301089	MISH results also showed that miR-375 was frequently downregulated in ESCCs , which was significantly associated with advanced clinical stage ( p = 0.003 ) tumor metastasis ( p = 0.04 ) and poor outcome ( p = 0.04 ) of ESCC .	miR-375	metastasis	downregulate	negative	ESCCs 	D009369
23302487	Up-regulated miR-155 level was observed in breast cancer with lymph node metastasis , pT3+4 , advanced TNM stage , HER-2 positive and with vascular invasion ( Z = -6.320 to -2.041 , P = 0.000 to 0.041 ) .	miR-155	metastasis	upregulate	positive	breast cancer 	D001943
23305226	MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3 .	MicroRNA-34b	metastasis	inhibit	negative	pancreatic cancer	D009369
23305226	In human specimens , we found that miR-34b was down-regulated in pancreatic cancer tissues and low level of miR-34b expression was positively correlated with tumor-node-metastasis ( TNM ) stage , lymph-node metastasis and overall survival .	miR-34b	metastasis	downregulate	negative	tumor-node-metastasis ( TNM ) stage|lymph-node metastasis	D009369
23314380	miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44 .	miR-34a	metastasis	inhibit	negative	osteosarcoma	D009362
23314380	These data suggest that miR-34a plays a tumor suppressor role in the metastasis of osteosarcoma cells by repressing the expression of CD44 .	miR-34a	metastasis	repress	negative	osteosarcoma	D009362
23321667	MicroRNA-374a activates Wnt/?] -catenin signaling to promote breast cancer metastasis .	MicroRNA-374a	metastasis	activate	positive	breast cancer metastasis	D001943
23321667	In breast cancer cell lines , ectopic overexpression of miR-374a promoted EMT and metastasis both in vitro and in vivo .	miR-374a	metastasis	promote	positive	breast cancer cell lines|EMT 	D001943
23321675	Here , we report that miR-148a is repressed by hepatitis B virus ( HBV ) X protein ( HBx ) to promote cancer growth and metastasis in a mouse model of hepatocellular carcinoma ( HCC ) .	miR-148a	metastasis	repress	negative	hepatocellular carcinoma ( HCC )	D009369
23321675	In cultured cells and a mouse xenograft model , miR-148a reduced the growth , epithelial-to-mesenchymal transition , invasion , and metastasis of HBx-expressing hepatocarcinoma cells through inhibition of HPIP-mediated mTOR signaling .	miR-148a	metastasis	inhibit	negative	HPIP	D019337
23340296	MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer .	MicroRNA-200a	metastasis	promote	positive	human breast cancer	D001943
23340296	This study aimed to test the hypothesis that miR-200a promotes metastasis through increased anoikis resistance in breast cancer .	miR-200a	metastasis	promote	positive	breast cancer	D001943
23354167	Here , we show that GATA3 promotes differentiation , suppresses metastasis and alters the tumour microenvironment in breast cancer by inducing microRNA-29b ( miR-29b ) expression .	microRNA-29b|miR-29b	metastasis	promote	positive	breast cancer	D001943
23354167	Accordingly , miR-29b is enriched in luminal breast cancers and loss of miR-29b , even in GATA3-expressing cells , increases metastasis and promotes a mesenchymal phenotype .	miR-29b	metastasis	promote	positive	luminal breast cancers	D001943
23354167	The discovery that a GATA3-miR-29b axis regulates the tumour microenvironment and inhibits metastasis opens up possibilities for therapeutic intervention in breast cancer .	miR-29b	metastasis	regulate	positive	breast cancer	D001943
23355420	Although we had identified that microRNA ( miR ) -145 could repress bone metastasis of PCa via regulating epithelial-mesenchymal transition ( EMT ) in previous study , it is still unknown how miR-145 regulated EMT .	miR-145	metastasis	repress	negative	Pca|EMT	D001943
23364795	In breast cancer cell systems , miR-31 has been shown to inhibit cell migration , invasion , and metastasis .	miR-31	metastasis	inhibit	negative	breast cancer cell	D001943
23372348	miR-193b suppressed the invasion and metastasis of GC cells in vivo and in vitro , and down-regulated urokinase-type plasminogen activator ( uPA ) protein in GC cells .	miR-193b	metastasis	suppress	negative	GC	D061325
23372348	Among the altered miRNAs , TGF-?] 1 induced the down-regulation of miR-193b , which inhibited cell invasion and metastasis in vivo and in vitro , and down-regulated uPA protein in GC cells .	miR-193b	metastasis	induce	positive	GC	D061325
23373996	Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo .	microRNA-7	metastasis	regulate	positive	malignant gliomas	D009369
23378255	Our study revealed that down-regulation of miR-126 plays an important role in HCC metastasis , and suggest a potential application of miR-126 in prognosis prediction and HCC treatment .	miR-126	metastasis	downregulate	negative	HCC	D009369
23383271	microRNA-9 suppresses the proliferation , invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1 .	microRNA-9	metastasis	suppress	negative	gastric cancer cells	D061325
23383271	Over-expression of miR-9 suppressed the proliferation , invasion , and metastasis of SGC-7901 and AGS cells in vitro and in vivo .	miR-9	metastasis	suppress	negative	AGS	D009369
23383271	These data indicate that miR-9 suppresses the expression of cyclin D1 and Ets1 via the binding sites in their 3'-UTR , thus inhibiting the proliferation , invasion and metastasis of gastric cancer .	miR-9	metastasis	suppress	negative	gastric cancer	D061325
23383988	Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression .	microRNA-143	metastasis	upregulate	positive	prostate cancer cells	D001943
23383988	Moreover , the down-regulation of miR-143 suppressed prostate cancer cells migration and invasion in vitro and systemically inhibited metastasis in vivo .	miR-143	metastasis	downregulate	negative	prostate cancer cells	D001943
23383988	These data demonstrate for the first time that miR-143 was up-regulated during the differentiation of prostate cancer stem cells and promoted prostate cancer metastasis by repressing FNDC3B expression .	miR-143	metastasis	upregulate	positive	prostate cancer	D001943
23384942	miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4 .	miR-7	metastasis	suppress	negative	breast cancer	D001943
23389731	MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1帢 .	MicroRNA-138	metastasis	suppress	negative	ovarian cancer	D009369
23389731	An orthotopic xenograft mouse model further demonstrated that the expression of miRNA-138 inhibited ovarian cancer metastasis to other organs .	miRNA-138	metastasis	inhibit	negative	ovarian cancer	D009369
23389731	Our study demonstrates the role and clinical relevance of miR-138 in ovarian cancer cell invasion and metastasis , providing a potential therapeutic strategy for suppression of ovarian cancer metastasis by targeting SOX4 and HIF-1帢 pathways .	miR-138	metastasis	suppress	negative	ovarian cancer	D009369
23389848	MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway .	MicroRNA-26a	metastasis	suppress	negative	hepatocellular carcinoma	D009369
23389848	In this study , we investigated the roles of miR-26a in tumor growth and metastasis of HCC and found that miR-26a was frequently down-regulated in HCC tissues .	miR-26a	metastasis	downregulate	negative	HCC	D009369
23389848	Down-regulation of miR-26a correlated with HCC recurrence and metastasis .	miR-26a	metastasis	downregulate	negative	HCC	D009369
23389848	Importantly , miR-26a suppressed in vivo tumor growth and metastasis in nude mice models bearing human HCC .	miR-26a	metastasis	suppress	negative	HCC	D009369
23389848	miR-26a could suppress tumor growth and metastasis of HCC through IL-6-Stat3 signaling and is a novel prognostic marker and therapeutic target for HCC .	miR-26a	metastasis	suppress	negative	HCC	D009369
23396050	miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis .	miR-126|miR-126*	metastasis	repress	negative	breast cancer metastasis	D001943
23396050	We report here that miR-126/miR-126 ( * ) , a microRNA pair derived from a single precursor , independently suppress the sequential recruitment of mesenchymal stem cells and inflammatory monocytes into the tumour stroma to inhibit lung metastasis by breast tumour cells in a mouse xenograft model .	miR-126/miR	metastasis	suppress	negative	breast tumour	D001943
23396050	These findings determine how this microRNA pair alters the composition of the primary tumour microenvironment to favour breast cancer metastasis , and demonstrate a correlation between miR-126/126 ( * ) downregulation and poor metastasis-free survival of breast cancer patients .	miR-126/126	metastasis	downregulate	negative	breast cancer metastasis|breast cancer	D001943
23401231	MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor ?] receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma .	MicroRNA-140	metastasis	suppress	negative	hepatocellular carcinoma	D009369
23401231	We also found that miR-140-5p suppressed HCC cell proliferation and HCC metastasis .	miR-140	metastasis	suppress	negative	HCC	D009369
23401231	Silencing TGFBR1 and FGF9 by small interfering RNA ( siRNA ) resembled the phenotype resulting from ectopic miR-140-5p expression , while overexpression of TGFBR1 and FGF9 attenuated the effect of miR-140-5p on HCC growth and metastasis .	miR-140	metastasis	effect	neutral	HCC	D009369
23404342	MiR-145 , a direct target of p53 , represses bone metastasis of PCa and is involved in regulating EMT and cancer cell stemness .	MiR-145	metastasis	repress	negative	Pca|EMT	D001943
23404342	These results suggest that loss of WT-p53 may promote the bone metastasis of PCa at least partially through repressing miR-145 to elevate EMT and stemness of cancer cells .	miR-145	metastasis	promote	positive	Pca|EMT	D001943
23417858	Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis .	microRNA-21	metastasis	regulate	positive	cholangiocarcinoma	D063646
23417858	These results indicated that miR-21 plays a role in the carcinogenesis and metastasis of O. viverrini-associated CCA by suppressing the function of PDCD4 .	miR-21	metastasis	suppress	negative	CCA|PDCD4 	D063646
23425975	These results suggested that miR-125b could be used for the development of new molecular markers and therapeutic approaches to inhibit bladder cancer metastasis .	miR-125b	metastasis	inhibit	negative	bladder cancer	D061325
23430441	In addition , miR-210 upregulation more frequently occurred in osteosarcoma tissues with large tumor size ( P = 0.02 ) , poor response to preoperative chemotherapy ( P = 0.008 ) , and positive metastasis ( P = 0.01 ) .	miR-210	metastasis	upregulate	positive	osteosarcoma	D009362
23438830	Taken together , our findings reveal that oncogenic miR-27a plays an important role in ovarian cancer cell growth and metastasis , and genistein , as nontoxic inactivators of miRNA , can block ovarian cancer cell growth and migration , offering novel insights into the mechanisms of genistein therapeutic actions .	miR-27a	metastasis	block	negative	ovarian cancer	D009369
23440286	miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9 .	miRNA-22	metastasis	suppress	negative	colon cancer cell|lymphoma invasion	D001943
23441132	Taken together , these data support the involvement of EMT and mesenchymal-to-epithelial transition ( MET ) in the metastasis cascade and show that miR-200 is downregulated in the initial stages of stromal invasion but is restored at metastatic sites .	miR-200	metastasis	downregulate	negative	MET	D009369
23442323	The Rac-controlled regulator of invasion and metastasis , T-cell lymphoma invasion and metastasis 1 ( TIAM1 ) , was identified as a miR-21 target additionally downregulated by T ( 3 ) .	miR-21	metastasis	regulate	positive	lymphoma invasion	D009369
23447578	Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b .	miR-290	metastasis	suppress	negative	breast cancer	D001943
23448381	Focusing on miR-181a , they uncovered an intricate pathway regulating breast cancer metastasis that sheds new insight into metastasis regulation that may prove useful in clinical settings .	miR-181a	metastasis	regulate	positive	breast cancer metastasis	D001943
23458685	We have found that miR-33a , which is downregulated in lung cancer cells , directly targets PTHrP ( parathyroid hormone-related protein ) , a potent stimulator of osteoclastic bone resorption , leading to decreased osteolytic bone metastasis .	miR-33a	metastasis	downregulate	negative	lung cancer|bone metastasis	D009369
23468064	MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF , VAV2 , and CDC42 .	MicroRNA-195	metastasis	suppress	negative	hepatocellular carcinoma	D009369
23468064	Based on mouse models , we found that the induced expression of miR-195 dramatically reduced microvessel densities in xenograft tumors and repressed both intrahepatic and pulmonary metastasis .	miR-195	metastasis	induce	positive	pulmonary metastasis	D009362
23468064	Additionally , miR-195 down-regulation led to increases in VAV2 and CDC42 expression , which stimulated VAV2/Rac1/CDC42 signaling and lamellipodia formation and thereby facilitated the metastasis of HCC cells .	miR-195	metastasis	downregulate	negative	HCC	D009369
23474644	The expression of miR-182 was found up-regulated in colorectal cancer tissues compared with adjacent noncancerous tissues ( p < 0.001 ) , and its up-regulation was significantly correlated with large tumor size ( p = 0.016 ) , positive regional lymph node metastasis ( p = 0.008 ) , and advanced tumor-node-metastasis stage ( p = 0.020 ) .	miR-182	metastasis	upregulate	positive	colorectal cancer |advanced tumor-node-metastasis stage	D001943|D009369
23474751	Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis .	microRNA-182	metastasis	suppress	negative	breast cancer metastasis	D001943
23474751	We further demonstrated that miR-182 directly targets MIM ( Missing in Metastasis ) , which suppresses metastasis by inhibiting ras homolog family member A ( RhoA ) activity and stress fiber formation in breast cancer cells .	miR-182	Metastasis|metastasis	suppress	negative	breast cancer cells	D001943
23474751	Hence , our data delineates the molecular pathway by which miR-182 promotes breast cancer invasion and metastasis , and may have important implication for the treatment of metastatic cancers .	miR-182	metastasis	promote	positive	breast cancer	D001943
23474761	Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer .	miR-486	metastasis	downregulate	negative	lung cancer	D009369
23474761	Forced expression of miR-486-5p inhibited NSCLC cell migration and invasion in vitro and metastasis in mice by inhibiting cell proliferation .	miR-486	metastasis	inhibit	negative	NSCLC 	D009369
23479198	miR-214 not only can promote NPC cell proliferation and invasion abilities in vitro , but also can accelerate tumor formation and lung metastasis in a mouse xenograft model .	miR-214	metastasis	promote	positive	NPC	D010181
23483935	Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process .	miR-106b	metastasis	promote	positive	hepatocellular carcinoma	D009369
23483935	In vivo functional studies also showed that over-expression of miR-106b promoted HCC metastasis .	miR-106b	metastasis	promote	positive	HCC	D009369
23483935	Our results suggested that miR-106b expression contributed to HCC metastasis by activating the EMT process promoting cell migration in vitro and metastasis in vivo .	miR-106b	metastasis	activate	positive	HCC	D009369
23486085	The aim of this study was to determine the regulation and function of miR-30a in colorectal carcinoma ( CRC ) metastasis .	miR-30a	metastasis	regulate	positive	colorectal carcinoma ( CRC )	D001943
23486085	Overexpression of miR-30a suppressed CRC cell migration and invasion in vitro and liver metastasis in vivo , whereas miR-30a deletion dramatically promoted cell migration and invasion .	miR-30a	metastasis	suppress	negative	CRC	D001943
23486085	miR-30a may be a potential therapeutic target to block CRC metastasis .	miR-30a	metastasis	block	negative	CRC	D001943
23487440	Senescence-associated microRNA , miR-22 , suppresses tumor growth and metastasis in vivo in a murine breast cancer model , and exosomal senescence-associated microRNA may affect the tumor microenvironment .	miR-22	metastasis	suppress	negative	breast cancer	D001943
23522567	Upregulation of ALDH1 ( p ? = ? 0.019 ) and miR-503 ( p ? = ? 0.033 ) correlated with high clinical stage , and upregulation of miR-27a was related with distant metastasis ( p ? = ? 0.046 ) in patients with ovarian cancer .	miR-503|miR-27a	metastasis	upregulate	positive	ovarian cancer	D009369
23552699	miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma .	miR-200b	metastasis	block	negative	hepatocellular carcinoma	D009369
23583431	Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD .	microRNA-212	metastasis	downregulate	negative	colorectal tumor	D001943
23583431	Overexpression of miR-212 inhibited CRC cell migration and invasion in vitro and formation of intrahepatic and pulmonary metastasis in vivo .	miR-212	metastasis	inhibit	negative	CRC|pulmonary metastasis	D001943
23584484	miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27 ( kip1 ) .	miR-194	metastasis	suppress	negative	lung cancer	D009369
23584484	Here , we show that overexpression of miR-194 in lung cancer cell lines , results in suppressing metastasis of lung cancer cells , while inhibiting its expression through 'miRNA sponge ' promotes the cancer cells to metastasize .	miR-194	metastasis	suppress	negative	lung cancer cell	D009369
23599767	miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2 .	miR-26a	metastasis	inhibit	negative	nasopharyngeal cancer	D009369
23599767	Additionally , we used a murine model to investigate the role of miR-26a in NPC metastasis and results showed that miR-26a overexpression suppresses the metastatic behavior of NPC cells in vivo .	miR-26a	metastasis	suppress	negative	NPC	D010181
23609190	The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .	miR-2861|miR-451|miR-193b|miR-1202|let-7i|miR-542|miR-664*|miR-564	metastasis	upregulate	positive	LN metastasis	D009362
23609190	Upregulated expression of miR-2861 and miR-451 in PTC with LN metastasis represents a unique miRNA signature associated with the prognosis and progression of PTC .	miR-2861|miR-451	metastasis	upregulate	positive	PTC|LN metastasis	D009362
23611780	Taken together , our data indicate that miR-106b-25 cluster may play an important role in the metastasis of human non-small cell lung cancer cells by directly suppressing the ?] -TRCP2 gene expression with a consequent increase in the expression of Snail .	miR-106b	metastasis	suppress	negative	lung cancer	D009369
23615712	Here , we showed miR-126 expression was much lower in HCT116 , SW620 and HT-29 colon cancer cells with highly metastatic potential and miR-126 downregulation was more frequent in colorectal cancers with metastasis .	miR-126	metastasis	downregulate	negative	HCT116|SW620|HT-29 colon cancer cells|colorectal cancers	D001943
23617628	Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth , vascularization , and metastasis .	miR-378	metastasis	affect	neutral	non-small cell lung carcinoma	D009369
23621247	MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis .	MicroRNA-21	metastasis	regulate	positive	cholangiocarcinoma	D009369
23621247	Influence on cholangiocarcinoma cell line invasion and metastasis was analyzed with microRNA-21 transfected cells .	microRNA-21	metastasis	influence	neutral	cholangiocarcinoma	D009369
23637748	miR-219-2-3p is potentially involved in gastric cancer progression and metastasis by regulating ERK1/2-related signal pathways , which may provide a novel therapeutic strategy for treatment of gastric cancer .	miR-219	metastasis	regulate	positive	gastric cancer	D061325
23644125	miR-143 plays a role in regulating the invasiveness and metastasis of NPC , and overexpression of miR-143 causes a significant reduction of the adhesion ability of the highly metastatic NPC cell line 5-8F .	miR-143	metastasis	regulate	positive	NPC	D010181
23647548	These findings suggest that TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration , and provide further insight into the non-apoptotic function of TRAIL in the prevention of metastasis as a therapy for breast cancer .	miR-146a	metastasis	suppress	negative	breast cancer	D001943
23649631	c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2 .	miR-23a/24	metastasis	promote	positive	mammary carcinoma	D009369
23649631	Forced expression of the miR-23a/24-2/27a cluster promoted mammary carcinoma cell migration , invasion , and hepatic metastasis , through targeting Sprouty2 ( SPRY2 ) and consequent activation of p44/42 MAPK .	miR-23a/24	metastasis	promote	positive	mammary carcinoma	D009369
23665284	MiR-20a triggers metastasis of gallbladder carcinoma .	MiR-20a	metastasis	trigger	positive	gallbladder carcinoma	D009369
23665284	Among them , the upregulation of pro-metastatic miR-20a was closely associated with local invasion , distant metastasis , and poor prognosis of 67 followed-up GBC patients , clinically .	miR-20a	metastasis	upregulate	positive	GBC	D001943
23665284	The ectopic expression of miR-20a could induce epithelial-mesenchymal transition and enhance metastasis of GBC cells in vitro and in vivo , by directly targeting the 3 ' UTR of Smad7 , and subsequently promoting nuclear translocation of ?] -catenin .	miR-20a	metastasis	induce	positive	GBC	D001943
23667173	Silencing ALCAM in miR-214-overexpressing melanoma cells reduced cell migration and invasion without affecting growth or anoikis in vitro , and it also impaired extravasation and metastasis formation in vivo .	miR-214	metastasis	affect	neutral	melanoma	D012878
23667256	The ZEB1 transcription factor is best known as an inducer of epithelial-mesenchymal transitions ( EMT ) in cancer metastasis , acting through transcriptional repression of CDH1 ( encoding E-cadherin ) and the EMT-suppressing microRNA-200s ( miR-200s ) .	microRNA-200s|miR-200s	metastasis	induce	positive	EMT	D009369
23670799	We found that miR-148a is significantly downregulated in non-small cell lung cancer ( NSCLC ) compared to adjacent non-cancerous lung tissues , and the downregulated miR-148a was significantly associated with lymph-node metastasis .	miR-148a	metastasis	downregulate	negative	non-small cell lung cancer ( NSCLC )|lymph-node metastasis	D009369
23672416	Ours is the first report that demonstrates significant up-regulation of miRNA-21 and miRNA-214 in tumor cells from ascites of patients with EOC compared to omental metastasis .	miRNA-21|miRNA-214	metastasis	upregulate	positive	EOC	D009369
23690767	In addition , enhanced expression of miRNA-221 and miRNA-222 was found in patients with cervical lymph node metastasis and advanced TNM stage .	miRNA-221|miRNA-222	metastasis	enhance	positive	cervical  advanced TNM stage	D009369
23691483	Regulation of GNAI1 by miR-320a/c/d indicates new therapeutic avenues for targeting HCC metastasis .	miR-320a/c	metastasis	regulate	positive	HCC	D009369
23695671	MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1 .	MicroRNA-135b	metastasis	promote	positive	lung cancer	D009369
23696794	MiR-339-5p regulates the growth , colony formation and metastasis of colorectal cancer cells by targeting PRL-1 .	MiR-339	metastasis	regulate	positive	colorectal cancer cells	D001943
23696794	In conclusion , our results demonstrate that miR-339-5p functions as a tumor suppressor and plays a role in inhibiting growth and metastasis of CRC cells through targeting PRL-1 and regulating p-ERK1/2 .These findings suggest that miR-339-5p may be useful as a new potential therapeutic target for CRC .	miR-339	metastasis	inhibit	negative	CRC	D001943
23708087	The microRNA ? 200 ( miR-200 ) family is a powerful regulator of the epithelial-mesenchymal transition ( EMT ) process , which is essential in tumor metastasis .	miR-200	metastasis	regulate	positive	epithelial-mesenchymal transition ( EMT )	D009369
23708087	Nevertheless , miR-200 family target genes that promote metastasis in non-small cell lung cancer ( NSCLC ) remain largely unknown .	miR-200	metastasis	promote	positive	non-small cell lung cancer ( NSCLC )	D009369
23708087	Here , we sought to investigate whether the microRNA-200 family regulates our previously identified NSCLC prognostic marker genes associated with metastasis , as potential molecular targets .	microRNA-200	metastasis	regulate	positive	NSCLC	D009369
23708087	These results provide new insights into miR-200 regulation in lung cancer metastasis and consequent clinical outcome , and may provide a potential basis for innovative therapeutic approaches for the treatment of this deadly disease .	miR-200	metastasis	regulate	positive	lung cancer	D009369
23718732	However , the role of miR-125b and MTA1 in the regulation of NSCLC metastasis remains unclear .	miR-125b	metastasis	regulate	positive	NSCLC	D009369
23725129	Aberrant expression of miR-20a was correlated with lymph node metastasis ( LNM ) , histological grade and tumor diameter , but down-regulated miR-203 was correlated with LNM only .	miR-20a|miR-203	metastasis	downregulate	negative	lymph node metastasis ( LNM )	D009369
23725476	Our results suggest that miR-491 is involved in metastasis of HCC by blocking EMT and decreasing MMP-9 levels , which may provide a new clue for preventing tumour metastasis of HCC .	miR-491	metastasis	block	negative	HCC|EMT	D009369
23728999	Overexpression of miR-370 inhibited growth and metastasis of HCC cells in vivo .	miR-370	metastasis	inhibit	negative	HCC	D009369
23732700	These results indicated that miR-143 may be suitable for the development of novel molecular markers and therapeutic approaches to inhibit metastasis in prostate cancer .	miR-143	metastasis	inhibit	negative	prostate cancer	D001943
23754305	The aim of the present study was to investigate the possible roles of miR-200c in regulating metastasis and to identify its target genes in renal cell carcinoma ( RCC ) .	miR-200c	metastasis	regulate	positive	renal cell carcinoma ( RCC )	D001943
23766411	miR-22 is downregulated in HCC and its expression is associated with the differentiation , metastasis and prognosis of the carcinoma .	miR-22	metastasis	downregulate	negative	HCC	D009369
23768087	These data demonstrate that miR-204 plays an important role in regulating metastasis of gastric cancer , which is involved in post-transcriptional repression of SIRT1 .	miR-204	metastasis	regulate	positive	gastric cancer	D061325
23768087	These data demonstrate that miR-204 plays an important role in regulating metastasis of gastric cancer , which is involved in post-transcriptional repression of SIRT1 .	miR-204	metastasis	regulate	positive	gastric cancer	D061325
23770133	Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2 , suppressing maspin and promoting colorectal tumor growth and metastasis in mice .	miR-224|miR-221	metastasis	suppress	negative	colorectal tumor	D061325
23806264	miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis .	miR-335|miR-363	metastasis	regulate	positive	neuroblastoma tumorigenesis	D063646
23816858	Our findings highlight an important role of miR-124 in the regulation of invasion and metastasis by breast cancer cells and suggest a potential application for miR-124 in breast cancer treatment .	miR-124	metastasis	regulate	positive	breast cancer	D001943
23824713	miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene .	miR-134	metastasis	induce	positive	head and neck carcinoma	D006258
23824713	Ectopic miR-134 expression significantly enhanced in vitro oncogenic phenotypes and the orthotopic growth and metastasis of HNSCC cells .	miR-134	metastasis	enhance	positive	HNSCC	D006258
23826258	Down-regulated miR-30a in ccRCC was associated with tumor hematogenous metastasis through increasing microvessel density by targeting angiogenesis-specific DLL4 .	miR-30a	metastasis	downregulate	negative	ccRCC	D009369
23830207	Here we find miR-22 triggers epithelial-mesenchymal transition ( EMT ) , enhances invasiveness and promotes metastasis in ? mouse xenografts .	miR-22	metastasis	trigger	positive	epithelial-mesenchymal transition ( EMT )	D009369
23831570	MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene .	MicroRNA-19a	metastasis	inhibit	negative	breast cancer	D001943
23842108	MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition .	MicroRNA-200c	metastasis	inhibit	negative	ovarian cancer	D001943
23842108	The goal of this study was to investigate the effect of miRNA-200c overexpression on the EMT , tumorigenicity and metastasis of epithelial ovarian cancer ( EOC ) CSCs .	miRNA-200c	metastasis	effect	neutral	epithelial ovarian cancer ( EOC )|CSCs	D009369
23842108	Importantly , the miR-200c overexpression significantly inhibited the CD117+CD44+CSCs xenograft growth and lung metastasis in vivo in nude mice by inhibition of the EMT .	miR-200c	metastasis	inhibit	negative	EMT	D009369
23843100	By understanding the function and molecular mechanism of miRNA-148a in NSCLC , miRNA-148a may have therapeutic potential to suppress lung cancer metastasis .	miRNA-148a	metastasis	suppress	negative	lung cancer	D009369
23847439	Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity .	miR30	metastasis	suppress	negative	melanoma	D012878
23851508	In addition , miR-21 downregulation induced by MMP-8 increases the levels of tumor suppressors such as programmed cell death 4 , which may also contribute to the decrease in tumor formation and metastasis of breast cancer cells overexpressing this metalloproteinase .	miR-21	metastasis	downregulate	negative	breast cancer	D001943
23851509	MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin .	MicroRNA-30a	metastasis	suppress	negative	breast tumor	D001943
23851509	Ectopic expression of miR-30a in breast cancer cell lines resulted in the suppression of cell growth and metastasis in vitro .	miR-30a	metastasis	suppress	negative	breast cancer	D001943
23851509	Taken together , our findings indicated miR-30a inhibits breast cancer proliferation and metastasis by directly targeting MTDH , and miR-30a can serve as a prognostic marker for breast cancer .	miR-30a	metastasis	inhibit	negative	breast cancer	D001943
23861214	Our results suggest that miR-625 may serve as an efficient clinical biomarker and a therapeutic tool for the inhibition of metastasis in CRC .	miR-625	metastasis	inhibit	negative	CRC	D001943
23861222	The results suggest that miR-148a inhibits the metastasis of HCCs by blocking EMT and CSCs-like properties through effects on the Wnt signaling pathway .	miR-148a	metastasis	inhibit	negative	HCCs|EMT|CSCs	D009369
23872151	MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1 .	MicroRNA-340	metastasis	suppress	negative	osteosarcoma tumor	D009362
23873106	microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition .	microRNA-148a	metastasis	suppress	negative	gastric cancer	D061325
23873106	miR-148a overexpression inhibited metastasis of gastric cancer cells .	miR-148a	metastasis	inhibit	negative	gastric cancer	D061325
23873106	MiR-148a suppresses gastric cancer metastasis and EMT , likely via SMAD2 .	MiR-148a	metastasis	suppress	negative	gastric cancer|EMT	D061325
23874105	In addition , miR-145 downregulation more frequently occurred in osteosarcoma specimens with advanced clinical stage ( P = 0.003 ) and positive distant metastasis ( P = 0.008 ) .	miR-145	metastasis	downregulate	negative	osteosarcoma	D009362
23874105	For the first time , the current data offer convincing evidence that the down-regulation of miR-145 may be associated with tumor aggressiveness and tumor metastasis of osteosarcoma , and that this miRNA may be an independent prognostic marker for osteosarcoma patients .	miR-145	metastasis	downregulate	negative	osteosarcoma	D009362
23886177	We found that miR-206 was down-regulated in the osteosarcoma cell line MG63 and primary tumor samples , and decreased miR-206 expression was significantly associated with advanced clinical stage , T classification , metastasis and poor histological differentiation .	miR-206	metastasis	downregulate	negative	osteosarcoma cell	D009362
23888967	ZEB1 , ZEB2 and SLUG , miR-200s are currently recognized as master regulators of EMT , thereby suppressing cancer invasion and metastasis .	miR-200s	metastasis	recognize	neutral	EMT	D009369
23894315	miR-21 regulates the processes of invasion and metastasis by downregulating multiple tumor/metastatic suppressor genes including PTEN ( phosphatase and tensin homolog ) .	miR-21	metastasis	regulate	positive	PTEN	D009369
23904792	In vitro experiments showed us that miR-143 could significantly suppress the migration and invasion of NSCLC cell lines while it had no effects on the growth of NSCLC cell lines , and in vivo metastasis assay showed the same results .	miR-143	metastasis	suppress	negative	NSCLC	D009369
23911747	MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway .	MicroRNA-181a	metastasis	suppress	negative	adenoid cystic carcinoma	D009369
23912452	Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells .	miR-17	metastasis	repress	negative	hepatoma cells	D009369
23924028	Overall , such findings suggest miR-205 as a brake against PCa metastasis by blocking both the afferent and efferent arms of the circuit between tumor cells and associated fibroblasts , thus interrupting the pro-oxidant and pro-inflammatory circuitries engaged by reactive stroma .	miR-205	metastasis	block	negative	PCa	D001943
23928793	The brain microenvironment negatively regulates miRNA-768-3p to promote K-ras expression and lung cancer metastasis .	miRNA-768	metastasis	regulate	positive	lung cancer	D009369
23936390	miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin ?] 1 and matrix metalloproteinase2 ( MMP2 ) .	miRNA-29c	metastasis	suppress	negative	lung cancer	D009369
23936390	Therefore , we hypothesized that miR-29c suppresses lung cancer cell adhesion to extracellular matrix ( ECM ) and metastasis by targeting integrin ?] 1 and MMP2 .	miR-29c	metastasis	suppress	negative	lung cancer|extracellular matrix ( ECM )	D009369
23936390	Nude mice with xenograft models of lung cancer cells confirmed that miR-29c inhibited lung cancer metastasis in vivo , including bone and liver metastasis .	miR-29c	metastasis	inhibit	negative	lung cancer	D009369
23936390	Taken together , our results demonstrate that miR-29c serves as a tumor metastasis suppressor , which suppresses lung cancer cell adhesion to ECM and metastasis by directly inhibiting integrin ?] 1 and MMP2 expression and by further reducing MMP2 enzyme activity .	miR-29c	metastasis	suppress	negative	lung cancer	D009369
23936642	Genetic heterogeneity of breast cancer metastasis may be related to miR-21 regulation of TIMP-3 in translation .	miR-21	metastasis	regulate	positive	breast cancer	D001943
23936642	The aim of this study is to determine whether microRNA-21 ( miR-21 ) , a specific microRNA implicated in multiple aspects of carcinogenesis , promoted breast cancer metastasis by regulating the tissue inhibitor of metalloproteinase 3 ( TIMP-3 ) gene .	microRNA-21|miR-21	metastasis	promote	positive	breast cancer	D001943
23936642	Our data suggest that miR-21 could promote metastasis in breast cancer via the regulation of TIMP3 translation , and there was consistency between miR-21 of serum and miR-21 in tissue .	miR-21	metastasis	promote	positive	breast cancer	D001943
23955085	MiR-155-mediated loss of C/EBP?] shifts the TGF-?] response from growth inhibition to epithelial-mesenchymal transition , invasion and metastasis in breast cancer .	MiR-155	metastasis	inhibit	negative	breast cancer	D001943
23955085	The results identify miR-155-mediated loss of C/EBP?] as a mechanism , which promotes breast cancer progression by shifting the TGF-?] response from growth inhibition to EMT , invasion and metastasis .	miR-155	metastasis	promote	positive	breast cancer|EMT	D001943
23959088	Further study found that re-expression of miR-199a in testicular cancer cells ( NT2 ) led to suppression of cell growth , cancer migration , invasion and metastasis .	miR-199a	metastasis	suppress	negative	testicular cancer	D009369
23962428	Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis .	microRNA-214	metastasis	downregulate	negative	hepatocellular carcinoma	D009369
23968734	miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway .	miR-133a	metastasis	repress	negative	colorectal cancer	D001943
23975506	In this study , we found that the expression of miR-335 in osteosarcoma tissues and cell lines was much lower than that in normal control , respectively , and the downregulated miR-335 was significantly associated with lymph-node metastasis .	miR-335	metastasis	control	neutral	osteosarcoma|lymph-node metastasis	D009362
23981581	However , the effect of specific let-7 member on metastasis of NSCLC remains undefined .	let-7	metastasis	effect	neutral	NSCLC	D009369
23982143	Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis .	miR-146a/b	metastasis	regulate	positive	gastric cancer	D061325
23982143	The newly identified miR-146a/b/UHRF1 axis provides insight into the GC metastasis process , and targeting this novel axis represents a therapeutic approach to blocking GC metastasis .	miR-146a/b	metastasis	block	negative	GC	D061325
23985560	Here we report that microRNA-9 ( miR-9 ) regulates the expression of the Metastasis Associated Lung Adenocarcinoma Transcript 1 ( MALAT-1 ) , one of the most abundant and conserved long non-coding RNAs .	microRNA-9|miR-9	Metastasis	regulate	positive	Lung Adenocarcinoma	D001943
23986650	Microenvironmental cues , including transforming growth factor-?] , can direct EMT tumor metastasis , such as by regulating miR-200 expression .	miR-200	metastasis	regulate	positive	EMT	D009369
23991015	MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis .	MicroRNA-21	metastasis	promote	positive	pancreatic ductal adenocarcinoma tumor	D009369
23991105	Finally , in colorectal carcinoma samples , upregulation of PAR2 and downregulation of miR-34a were significantly correlated with grade and lymphomatic metastasis .	miR-34a	metastasis	upregulate	positive	colorectal carcinoma	D009369
23999427	We show that microRNA-9 ( miR-9 ) contributed to SP expansion and metastasis , and miR-9 inhibition reduced the number of SP cells and metastasis .	microRNA-9|miR-9|miR-9	metastasis	inhibit	negative	SP	D009369
24013226	MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling .	MicroRNA-148a	metastasis	suppress	negative	hepatoma cells	D009369
24013226	An in vitro transwell assay and an in vivo orthotopic liver xenograft model showed that the restoration of miR-148a expression significantly repressed the migration and pulmonary metastasis of hepatoma cells .	miR-148a	metastasis	repress	negative	hepatoma cells	D009369
24013226	These data suggest that miR-148a may suppress EMT and cancer metastasis .	miR-148a	metastasis	suppress	negative	EMT	D009369
24013226	Taken together , miR-148a may negatively regulate Met/Snail signaling and therefore inhibit the EMT and metastasis of hepatoma cells .	miR-148a	metastasis	regulate	positive	EMT|hepatoma cells	D009369
24015269	miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer .	miR-26a	metastasis	suppress	negative	gastric cancer	D061325
24015269	In this study , we found that miR-26a was strongly downregulated in gastric cancer ( GC ) tissues and cell lines , and its expression levels were associated with lymph node metastasis and clinical stage , as well as overall survival and replase-free survival of GC .	miR-26a	metastasis	downregulate	negative	gastric cancer ( GC ) 	D061325
24015269	We also found that ectopic expression of miR-26a inhibited GC cell proliferation and GC metastasis in vitro and in vivo .	miR-26a	metastasis	inhibit	negative	GC	D061325
24019037	MiR-9 expression in non-small cell lung cancer tissues was significantly higher than that in adjacent normal tissues ( p = 0.001 ) , and its up-regulation was significantly correlated to advanced tumor-node-metastasis ( TNM ) stage ( p < 0.001 ) , tumor size ( p = 0.013 ) , and lymph node metastasis ( p = 0.001 ) .	MiR-9	metastasis	upregulate	positive	non-small cell lung cancer|tumor-node-metastasis ( TNM ) 	D009369
24026105	By functional assay , we found that the expression of miR-145 can regulate the ability of proliferation of A549 and SPC-A1 cells in ? vitro , but is not related to lymph node metastasis , migration and invasion .	miR-145	metastasis	regulate	positive	lymph node metastasis	D009369
24026406	The expression of miR-92a was significantly up-regulated in the tissues of CRC patients with lymph node metastasis .	miR-92a	metastasis	upregulate	positive	CRC 	D001943
24037528	MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways .	MiR-200	metastasis	repress	negative	breast cancer metastasis	D001943
24037528	Recent studies have indicated that the miR-200 family may exert their effects at distinct stages in the metastatic process , with an overall effect of enhancing metastasis in a syngeneic mouse breast cancer model .	miR-200	metastasis	effect	neutral	breast cancer	D001943
24037528	These findings highlight the context-dependent effects of miR-200 in breast cancer metastasis and demonstrate the existence of a moesin-dependent pathway , distinct from the ZEB1-E-cadherin axis , through which miR-200 can regulate tumour cell plasticity and metastasis .	miR-200	metastasis	regulate	positive	breast cancer	D001943
24039995	miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor .	miR-140	metastasis	suppress	negative	non-small cell lung cancer	D009369
24048714	Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .	miR-223|miR-19|miR-100|miR-19|miR-519b|miR-133a	metastasis	downregulate	negative	 FIGO staging	D016609
24053448	We investigate on the molecular mechanism by which miR-182 could regulate thrombospondin-1 ( TSP-1 ) expression , a protein downregulated in CRC and inversely correlated with tumor vascularity and metastasis .	miR-182	metastasis	regulate	positive	CRC	D001943
24053448	miR-182 , over-expressed in colorectal cancer ( CRC ) , has like predictive target thrombospondin-1 ( TSP-1 ) , a protein inversely correlated with tumor vascularity and metastasis that results downregulated in different types of cancer including CRC .	miR-182	metastasis	downregulate	negative	colorectal cancer ( CRC )	D001943
24056962	miR-26a was broadly reduced in multiple cancers , and overexpression of miR-26a significantly suppressed tumor growth and metastasis both in vitro and in vivo , including melanoma , prostate and liver cancers .	miR-26a	metastasis	suppress	negative	melanoma|prostate|liver cancers	D012878
24064224	Importantly , downregulation of miR-200b significantly correlated with shortened survival ( P = 0.025 ) , lymph node metastasis ( P = 0.002 ) and advanced clinical stage ( P = 0.020 ) in ESCC patients .	miR-200b	metastasis	downregulate	negative	 ESCC	D009369
24067373	Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .	miR200|miR200b|miR200a|miR429|miR200c|miR141	metastasis	activate	positive	epithelial-mesenchymal transition ( EMT )	D009369
24072701	We also found that expression of miRNA-200b is down-regulated in human breast cancer during lymph node metastasis , which has a significant negative correlation with Pin1 expression .	miRNA-200b	metastasis	downregulate	negative	human breast cancer 	D001943
24084898	miR-205 promotes the growth , metastasis and chemoresistance of NSCLC cells by targeting PTEN .	miR-205	metastasis	promote	positive	NSCLC|PTEN	D009369
24085799	Collectively , our data indicate that miR-720 is frequently decreased in breast cancer and manifests antimetastatic activity by downregulating TWIST1 , presenting a novel mechanism of miRNA-mediated regulation of tumor metastasis .	miR-720	metastasis	downregulate	negative	breast cancer	D001943
24086551	The miR-200b~200a~429 gene cluster is a key regulator of EMT and cancer metastasis , however the transcription-based mechanisms controlling its expression during this process are not well understood .	miR-200b	metastasis	regulate	positive	EMT	D009369
24113455	Collectively , miR-122 depletion facilitates cystogenesis and hepatocarcinogenesis in mice on DEN challenge by up-regulating several genes involved in proliferation , growth factor signaling , neovascularization , and metastasis .	miR-122	metastasis	upregulate	positive	DEN|hepatocarcinogenesis	D009369
24129185	miRNA-205 affects infiltration and metastasis of breast cancer .	miRNA-205	metastasis	affect	neutral	breast cancer	D001943
24135722	Epithelial-to-mesenchymal transition ( EMT ) is considered a critical step in the progression and metastasis of HCC and is regulated by the microRNA-200 ( miR-200 ) family .	microRNA-200|miR-200	metastasis	regulate	positive	Epithelial-to-mesenchymal transition ( EMT )|HCC	D009369
24137412	Increasing evidence has shown that miR-199a is important in regulating the tumor metastasis of ovarian cancer , although the precise biological function of miR-199a is unclear at present .	miR-199a	metastasis	regulate	positive	ovarian cancer	D001943
24149370	In conclusion , miR-21 is a key player in oncogenic EMT , its overexpression is controlled by the cooperation of genetic and epigenetic alterations , and its levels , along with ITG?] 4 and PDCD4 expression , could be exploited as a prognostic tool for CRC metastasis .	miR-21	metastasis	control	neutral	EMT|CRC	D001943
24154848	In the present study , we found that miR-27a was downregulated in esophageal carcinoma cell lines and ESCC specimens with lymph node metastasis .	miR-27a	metastasis	downregulate	negative	esophageal carcinoma cell|ESCC 	D009369
24155205	MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231 .	MicroRNA-127	metastasis	downregulate	negative	breast cancer	D001943
24155205	Collectively , our results suggested a novel mechanism that Tudor-SN promoted metastasis and proliferation of breast cancer cells via downregulating the miR-127 expression .	miR-127	metastasis	promote	positive	breast cancer	D001943
24164962	MicroRNA expression profiling showed miR-106b to be markedly downregulated during BC bone metastasis .	miR-106b	metastasis	downregulate	negative	BC	D001943
24164962	These results suggest that MMP2 upregulation plays an important role in BC bone metastasis through ERK pathways , and miR-106b directly regulates MMP2 expression .	miR-106b	metastasis	upregulate	positive	BC	D001943
24164962	The miR-106b/MMP2/ERK pathway may be a promising therapeutic target for inhibiting BC bone metastasis .	miR-106b/MMP	metastasis	inhibit	negative	BC	D001943
24169343	Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis .	miR-200b/c	metastasis	inhibit	negative	cholangiocarcinoma	D009369
24171926	Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2 .	miR-138	metastasis	downregulate	negative	colorectal cancer	D001943
24171926	We also identified that down-regulation of miR-138 was associated with lymph node metastasis , distant metastasis , and always predicted poor prognosis .	miR-138	metastasis	downregulate	negative	 lymph node metastasis	D009369
24171926	These data highlight a pivotal role for miR-138 in the regulation of CRC metastasis by targeting TWIST2 , and suggest a potential application of miR-138 in prognosis prediction and CRC treatment .	miR-138	metastasis	regulate	positive	CRC	D001943
24173237	MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer .	MiR-205	metastasis	downregulate	negative	 prostate cancer	D001943
24173237	Nevertheless , down-regulation of miR-205 in primary PCa was not correlated to the synchronous presence of metastasis and failed to predict the outcome for HRPCa patients .	miR-205	metastasis	downregulate	negative	Pca|HRPCa	D001943
24193225	Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model .	miR-424|miR-200	metastasis	regulate	positive	prostate cancer	D001943
24213572	MicroRNA-192 suppresses liver metastasis of colon cancer .	MicroRNA-192	metastasis	suppress	negative	colon cancer	D001943
24250228	Multivariate analysis further revealed that pathologic T stage ( P=0.02 ) , lymph node metastasis ( P=0.008 ) , and miR-335 expression ( P=0.006 ) maintained independent prognostic influence on overall survival .	miR-335	metastasis	influence	neutral	lymph node metastasis	D009369
24263102	MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells .	MiRNA-296	metastasis	promote	positive	prostate cancer	D001943
24263102	Above results suggest that this newly identified miR-296-3p-ICAM-1 axis has a pivotal role in mediating PCa metastasis by possible enhancing survival of NK cell-resistant CTC .	miR-296	metastasis	mediate	neutral	PCa	D001943
24269686	MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK .	MicroRNA-221	metastasis	promote	positive	colorectal cancer|RECK	D001943
24269686	We provide insight into the behavior of miR-221 in colorectal cancer ( CRC ) metastasis by showing that miR-221 is significantly upregulated in metastatic CRC cell lines and tissues .	miR-221	metastasis	upregulate	positive	colorectal cancer ( CRC )	D001943
24277750	The expression of microRNA-338-3p was significantly down-regulated in colorectal carcinoma tissues in comparison with those in the adjacent non-tumorous tissues , and the value was negatively related to advanced tumor , node , metastasis stage and local invasion .	microRNA-338	metastasis	downregulate	negative	colorectal carcinoma	D001943
24279510	Meantime , overexpression of miR-124 dramatically inhibits the motility of ovarian cancer cells in vitro and substantially suppresses the protein expression of SphK1 , reported as an invasion and metastasis-related gene in human cancers , whose expression is markedly increased in both ovarian cancer cell lines and clinical samples , particularly in two highly metastasis cells , SKOV3-ip and HO8910pm as well as metastatic ovarian tumor tissues .	miR-124	metastasis	inhibit	negative	ovarian cancer	D001943
24280681	miR-204 was frequently downregulated in human ICC , and the low-level expression of miR-204 was significantly associated with lymph node metastasis .	miR-204	metastasis	downregulate	negative	ICC 	D009369
24281002	MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4 .	MicroRNA-29a	metastasis	promote	positive	colorectal cancer	D001943
24281002	Increased expression of miR-29a promoted CRC metastasis by regulating MMP2/E-cad through direct targeting KLF4 , which highlights the potential of the miR-29a inhibitor as a novel agent against CRC metastasis .	miR-29a	metastasis	promote	positive	CRC	D001943
24283384	Downregulation of miR-148a was significantly correlated with an advanced clinical stage , lymph node metastasis , and poor clinical outcome .	miR-148a	metastasis	downregulate	negative	lymph node metastasis	D009369
24284362	Our data on target genes regulated by the tumor-suppressive miR-143/145 cluster provide new insights into the potential mechanisms of PCa oncogenesis and metastasis .	miR-143/145	metastasis	regulate	positive	PCa	D001943
24285725	p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer .	miR-15a/16	metastasis	regulate	positive	colorectal cancer	D001943
24286315	MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN .	MiR-221	metastasis	promote	positive	breast cancers	D001943
24286315	Here , we found that the oncogenic miRNA , miR-221 , inhibited apoptosis , induced trastuzumab resistance and promoted metastasis of HER2-positive breast cancers .	miR-221	metastasis	inhibit	negative	breast cancers	D001943
24286315	These findings indicate that miR-221 may promote trastuzumab resistance and metastasis of HER2-positive breast cancers by targeting PTEN , suggesting its role as a potential biomarker for progression and poor prognosis , and as a novel target for trastuzumab-combined treatment of breast cancers .	miR-221	metastasis	promote	positive	breast cancers	D001943
24290372	MicroRNA-30a-3p inhibits tumor proliferation , invasiveness and metastasis and is downregulated in hepatocellular carcinoma .	MicroRNA-30a	metastasis	inhibit	negative	hepatocellular carcinoma	D009369
24292682	Furthermore , miR-106b mediates TGF-?] effects on tumor growth and metastasis in breast cancer xenografts .	miR-106b	metastasis	mediate	neutral	breast cancer	D001943
24315818	Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/?] -catenin signaling .	microRNA-301a	metastasis	upregulate	positive	breast cancer	D001943
24315818	Gain-of-function and loss-of-function studies showed that ectopic overexpression of miR-301a promoted breast cancer cell migration , invasion and metastasis both in vitro and in vivo .	miR-301a	metastasis	promote	positive	breast cancer	D001943
24315818	Notably , Wnt/?] -catenin signaling was hyperactivated in metastatic breast cancer cells that express miR-301a , and mediated miR-301a-induced invasion and metastasis .	miR-301a	metastasis	mediate	neutral	metastatic breast cancer	D001943
24315818	These results demonstrate that miR-301a maintains constitutively activated Wnt/?] -catenin signaling by directly targeting PTEN , which promotes breast cancer invasion and metastasis .	miR-301a	metastasis	activate	positive	breast cancer	D001943
24318902	MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells .	MiR-139	metastasis	inhibit	negative	squamous carcinoma	D001943
24318902	Taken together , we conclude that miR-139 targets CXCR4 and inhibits proliferation and metastasis of LSCC .	miR-139	metastasis	inhibit	negative	LSCC	D009369
24333181	In vivo assays of metastasis in an orthotopically implanted model demonstrated that miR-223 effectively inhibited HCC metastasis .	miR-223	metastasis	inhibit	negative	HCC	D009369
24333181	Downregulation of miR-223 in HCC is associated with the epigenetic regulation by highly expressed sulfatide and involved in tumor metastasis .	miR-223	metastasis	downregulate	negative	HCC	D009369
24335959	GIT1 overexpression was sufficient to rescue miR-491-5p-mediated inhibition of migration/invasion and lung metastasis .	miR-491	metastasis	inhibit	negative	lung metastasis	D009362
24335959	Conversely , GIT1 silencing phenocopied the ability of miR-491-5p to inhibit migration/invasion and metastasis of OSCC cells .	miR-491	metastasis	inhibit	negative	OSCC	D009369
24343340	MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer .	MicroRNA-135b	metastasis	regulate	positive	colorectal cancer	D001943
24349438	Given that Lin28 induced the EMT via let-7a and promoted breast cancer metastasis , Lin28 may be a therapeutic target for the eradication of breast cancer metastasis .	let-7a	metastasis	induce	positive	EMT|breast cancer metastasis	D001943
24352663	miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer .	miR-185	metastasis	suppress	negative	gastric cancer	D061325
24352663	We further found that upregulation of miR-185 inhibited the proliferation and metastasis of gastric cancer cells in vitro and in vivo .	miR-185	metastasis	upregulate	positive	gastric cancer	D061325
24375248	MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis .	MicroRNA-497	metastasis	inhibit	negative	colorectal cancer	D001943
24375248	The study aims to investigate the effect of microRNA-497 ( miR-497 ) expression and bufalin treatment in regulating colorectal cancer invasion and metastasis .	microRNA-497|miR-497	metastasis	effect	neutral	colorectal cancer	D001943
24375248	The effect of both bufalin treatment and miR-497 overexpression on colorectal cancer metastasis was measured using an animal tumor model together with in vivo imaging .	miR-497	metastasis	effect	neutral	colorectal cancer	D001943
24375248	This study revealed that bufalin inhibited angiogenesis and regulated miR-497 expression and that bufalin and miR-497 acted in synergy to inhibit colorectal cancer metastasis , resulting in improved quality of life in a nude mouse model .	miR-497	metastasis	inhibit	negative	colorectal cancer	D001943
24382668	miR-224 downregulation was frequently found in PCa tissues with metastasis , higher PSA level and clinical stage , whereas TRIB1 upregulation was significantly associated with metastasis .	miR-224	metastasis	downregulate	negative	PCa	D001943
24385540	MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6 , in advanced cutaneous T-cell lymphoma .	MicroRNA-150	metastasis	inhibit	negative	CCR6	D009369
24385540	From these findings , we conclude that , in the presence of continuous CCR6 upregulation accompanied by miR-150 downregulation , IL-22 activation leads to continuous CCL20-CCR6 interaction in CTCL cells and , in turn , autocrine metastasis to distal organs .	miR-150	metastasis	upregulate	positive	CCR6	D009369
24386467	Our results illustrated that the up-regulation of miR-31 played an important role in CRC cell proliferation , invasion , and metastasis in vitro and in vivo through direct repressing SATB2 , suggesting a potential application of miR-31 in prognosis prediction and therapeutic application in CRC .	miR-31	metastasis	upregulate	positive	CRC	D001943
24391862	miR-200b inhibits prostate cancer EMT , growth and metastasis .	miR-200b	metastasis	inhibit	negative	prostate cancer|EMT	D001943
24398981	In addition , the combined miR-340 downregulation and ROCK1 upregulation ( miR-340-low/ROCK1-high ) occurred more frequently in osteosarcoma tissues with positive metastasis ( p < 0.001 ) and poor response to pre-operative chemotherapy ( p = 0.002 ) .	miR-340	metastasis	downregulate	negative	osteosarcoma	D009362
24405610	Here , we investigate to define the mechanism of miR-503 regulating metastasis in HCC .	miR-503	metastasis	regulate	positive	HCC	D009369
24405610	Meanwhile , a metastatic human HCC cell BALB/c nude mice model was used to investigate whether miR-503 regulates metastasis of HCC in ? vivo .	miR-503	metastasis	regulate	positive	HCC	D009369
24405610	Furthermore , luciferase activity of reporter gene , 3- ( 4 , 5-Dimethylthiazol-2-yl ) -2 , 5-diphenyltetrazolium bromide ( MTT ) , fluorescence-activated cell sorting analysis ( FACS ) , and invasion assay were carried out to characterize the mechanism of miR-503 regulating metastasis in HCC .	miR-503	metastasis	regulate	positive	HCC	D009369
24405610	We also showed that overexpression of miR-503 resulted in inhibition of proliferation and metastasis of HCC in ? vivo .	miR-503	metastasis	inhibit	negative	HCC	D009369
24405610	Our results suggest an important role of miR-503 in inhibiting metastasis of HCC through deregulating ARHGEF19 .	miR-503	metastasis	inhibit	negative	HCC	D009369
24410957	Overall , results indicate that miR-99a functions as a tumor metastasis suppressor in OSCC cells and mutually regulates IGF1R expression in a reciprocal regulation .	miR-99a	metastasis	regulate	positive	OSCC	D009369
24434435	TMPRSS4 regulates levels of integrin 帢5 in NSCLC through miR-205 activity to promote metastasis .	miR-205	metastasis	regulate	positive	NSCLC	D009369
24438167	miR-302b was significantly down-regulated and correlated with tumor differentiation and lymph node metastasis in ESCC .	miR-302b	metastasis	downregulate	negative	 ESCC	D009369
24440352	MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer .	MicroRNA-106a	metastasis	regulate	positive	gastric cancer	D061325
24440352	Here , we report that miR-106a is frequently up-regulated in gastric cancer tissues and positively correlates with metastasis .	miR-106a	metastasis	upregulate	positive	gastric cancer	D061325
24443799	Overexpression of miR-133b markedly inhibited metastasis of gastric cancer cells in vitro and in vivo .	miR-133b	metastasis	inhibit	negative	gastric cancer	D061325
24445397	TGF-?] upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1 .	miR-182	metastasis	upregulate	positive	gallbladder cancer	D009369
24445397	miR-182 is an important mediator of GBC metastasis , thus offering a new target for the development of therapeutic agents against GBC .	miR-182	metastasis	mediate	neutral	GBC	D001943
24448820	Our data suggest that miR-340 in bone marrow may play an important role in regulating the metastasis cascade of colorectal cancer .	miR-340	metastasis	regulate	positive	colorectal cancer	D001943
24452597	In addition , downregulation of miR-26a more frequently occurred in osteosarcoma specimens with adverse clinical stage and with the presence of distant metastasis .	miR-26a	metastasis	downregulate	negative	osteosarcoma	D009362
24452597	Thus , for the first time , we provide convincing evidence that downregulation of miR-26a is associated with tumor aggressiveness and tumor metastasis , and miR-26a inhibits cell migration and invasion by targeting the EZH2 gene in osteosarcoma .	miR-26a	metastasis	downregulate	negative	osteosarcoma	D009362
24460329	Enhanced invasion and metastasis , increased miR-21 expression , decreased PTEN , elevated pAKT level were demonstrated in gemcitabine-resistant HPAC and PANC-1 cells .	miR-21	metastasis	enhance	positive	HPAC|PANC-1 cells	D009369
24462867	miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression .	miR-17	metastasis	suppress	negative	osteosarcoma	D009362
24465504	These patients showed a significantly more advanced stage ( TNM stage ? IB , 35.0 % vs. 12.8 % , p ? = ? 0.045 ) and higher rate of LN metastasis ( 30.0 % vs. 5.1 % , p ? = ? 0.014 ) than those with up-regulation of miRNA-135a expression .	miRNA-135a	metastasis	upregulate	positive	LN metastasis	D009362
24465504	In a multivariate analysis , down-regulation of miRNA-135a was an independent risk factor for LN metastasis ( adjusted odds ratio , 8.04 ; 95 % confidence interval , 1.08-59.81 ; p ? = ? 0.042 ) .	miRNA-135a	metastasis	downregulate	negative	LN metastasis	D009362
24469061	MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway .	MicroRNA-193a	metastasis	suppress	negative	non-small-cell lung cancer	D009369
24469061	In this study , by comparing the miRNA expression profiles of SPC-A-1sci ( high metastatic ) and SPC-A-1 ( weakly metastatic ) cells , we demonstrated that the downregulation and function of miR-193a-3p and miR-193a-5p in NSCLC metastasis and the expression of these miRNAs was suppressed in NSCLC compared with corresponding non-tumorous tissues .	miR-193a	metastasis	downregulate	negative	NSCLC	D009369
24469061	Furthermore , functional assays showed that the overexpression of miR-193a-3p/5p inhibited NSCLC cell migration , invasion and epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .	miR-193a	metastasis	inhibit	negative	NSCLC|EMT	D009369
24484937	miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2 .	miR181b	metastasis	induce	positive	breast cancer	D001943
24484937	Importantly , over-expression of miR181b in metastatic breast cancer cells inhibits metastasis formation in ? vivo in immunodeficient mice .	miR181b	metastasis	inhibit	negative	breast cancer cells	D001943
24498348	Further investigation revealed that miR-134 suppressed the invasion and metastasis of HCC cells in vitro and in vivo , and integrin beta 1 ( ITGB1 ) was a direct and functional target gene of miR-134 .	miR-134	metastasis	suppress	negative	HCC	D009369
24517413	Furthermore , dysregulation of miR-9 is associated with MCT metastasis potentially through the induction of an invasive phenotype , identifying a potentially novel pathway for therapeutic intervention .	miR-9	metastasis	induction	positive	MCT	D016609
24517947	Down-regulated miR-143 expression was associated with both the tumor size and lymph node metastasis in patients with cervical cancer ( Z = -2.628 , P = 0.009 and Z = -2.127 , P = 0.033 respectively ) .	miR-143	metastasis	downregulate	negative	cervical cancer	D009369
24520301	MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1 .	MicroRNA-23a	metastasis	promote	positive	neuroblastoma cell	D009369
24520301	These findings provide evidence that miR-23a is key in promoting NB cell migration and invasion through targeting CDH1 , and suggest that exogenous miR-23a may have therapeutic value in treating NB metastasis .	miR-23a	metastasis	promote	positive	NB	D009369
24520312	In conclusion , aberrant expression of clustered miRNAs was identified by deep sequencing , and downregulation of miR-195/497 contributed to BC progression and metastasis .	miR-195/497	metastasis	downregulate	negative	BC	D001943
24533778	MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells .	miR-493	metastasis	mediate	neutral	colon cancer	D001943
24533778	We previously showed that IGF1R is a target gene of miR-493 , and that the inhibition of IGF1R partly explains how miR-493 suppresses liver metastasis .	miR-493	metastasis	inhibit	negative	 liver metastasis	D009362
24533778	Thus , MKK7 is a major functional target of miR-493 , and its suppression thwarts liver metastasis of colon cancer cells .	miR-493	metastasis	suppress	negative	colon cancer	D001943
24552534	miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis .	miR-372	metastasis	downregulate	negative	hepatocellular carcinoma	D009369
24573236	Taken together , our results indicate that miR-1236-3p regulates ovarian cancer metastasis by directly targeting ZEB1 , and it may play an important role in the diagnosis and treatment of ovarian cancer .	miR-1236	metastasis	regulate	positive	ovarian cancer	D001943
24573354	In vivo metastasis assay was performed to validate if miR-10b can promote BC cell line metastasis in vivo .	miR-10b	metastasis	promote	positive	BC	D001943
24573354	In vivo metastasis assay demonstrated that overexpression of miR-10b markedly promoted BC metastasis .	miR-10b	metastasis	promote	positive	BC	D001943
24573354	Furthermore , we found that E-cadherin and MMP14 may be the downstream factors of KLF4 and HOXD10 in the suppression of BC metastasis by miR-10b .	miR-10b	metastasis	suppress	negative	BC	D001943
24573354	Targeting these novel strategies , inhibition of miR-10b/KLF4/E-cadherin axis and miR-10b/HOXD10/MMP14 axis may be helpful as a therapeutic approach to block BC cell metastasis .	miR-10b/KLF|miR-10b/HOXD	metastasis	inhibit	negative	BC	D001943
24573489	miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression .	miR-7	metastasis	inhibit	negative	gastric cancer	D061325
24573597	However , as a tumor promoter , miR-29 mediates epithelial-mesenchymal transition ( EMT ) and promotes metastasis in breast cancer and colon cancer .	miR-29	metastasis	mediate	neutral	breast cancer|colon cancer	D001943
24593661	In the present study , we show that miR-30b is an important regulator in human CRC migration and invasion , which are vital steps in CRC liver metastasis .	miR-30b	metastasis	regulate	positive	CRC	D001943
24594999	TAp63 suppress metastasis via miR-133b in colon cancer cells .	miR-133b	metastasis	suppress	negative	colon cancer cell	D001943
24594999	In this study , we demonstrate that TAp63 suppresses metastasis in colon cancer cells through microRNA-133b .	microRNA-133b	metastasis	suppress	negative	colon cancer cell	D001943
24594999	TAp63 and microRNA-133b were able to suppress the metastasis of colon cancer .	microRNA-133b	metastasis	suppress	negative	colon cancer	D001943
24604208	miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion .	miR-208	metastasis	promote	positive	pancreatic cancer cell	D001943
24604208	miR-208 induces epithelial to mesenchymal transition of pancreatic cancer cell line BxPC3 by activating AKT/GSK-3?] /snail signaling pathway and thereby promotes cell metastasis and invasion .	miR-208	metastasis	induce	positive	pancreatic cancer cell	D001943
24606633	Moreover , miR-93 resulted in the attenuation of Smad-dependent TGF-?] signaling and the activation of PI3K/Akt pathway by suppressing TGF?] R2 , further promoting NPC cell uncontrolled growth , invasion , metastasis and EMT-like process .	miR-93	metastasis	activate	positive	NPC	D010181
24608434	MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis .	MicroRNA-149	metastasis	suppress	negative	breast cancer metastasis	D001943
24608434	We conclude that miR-149 suppresses breast cancer cell migration/invasion and metastasis by targeting GIT1 , suggesting potential applications of the miR-149-GIT1 pathway in clinical diagnosis and therapeutics .	miR-149	metastasis	suppress	negative	breast cancer cell	D001943
24613926	Mir-204 inhibited EBV positive C666-1 cell invasion and metastasis partly through targeting cdc42 .	Mir-204	metastasis	inhibit	negative	C666-1	D009369
24614175	Stepwise downregulation of microRNA-214 expression was observed among nontumourous gastric mucosa , nonmetastasis gastric cancer tissues , and metastasis gastric cancer tissues .	microRNA-214	metastasis	downregulate	negative	gastric mucosa|gastric cancer	D061325
24615544	MiR-200c suppresses TGF-?] signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer .	MiR-200c	metastasis	suppress	negative	breast cancer	D001943
24615544	Therefore , our study unraveled nested regulatory circuits of miR-200c/ZEB1 and miR-200c/ZNF217/TGF-?] /ZEB1 in synergistically promoting trastuzumab resistance and metastasis of breast cancer cells .	miR-200c/ZEB|miR-200c/ZNF	metastasis	promote	positive	breast cancer cells	D001943
24616020	Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression .	microRNA-214	metastasis	regulate	positive	colorectal cancer|liver metastasis	D001943
24616020	Ectopic expression of miR-214 suppressed proliferation , migration , and invasion in vitro , tumor growth and liver metastasis in an in vivo xenograft mouse model , whereas miR-214 knockdown promoted proliferation , migration , and invasion in CRC cell lines .	miR-214	metastasis	suppress	negative	CRC	D001943
24616020	Down-regulation of miR-214 expression was correlated with increased FGFR1 expression levels , which may contribute to increased CRC liver metastasis .	miR-214	metastasis	downregulate	negative	CRC|liver metastasis	D001943
24625224	Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis .	miR200c	metastasis	regulate	positive	melanoma	D012878
24625224	These results indicate that the tumor vaccine B16F10/GPI-IL-21 in combination with miR200c overexpression or ZEB1 knockdown effectively inhibited melanoma growth and metastasis a murine model .	miR200c	metastasis	inhibit	negative	melanoma	D012878
24632577	Herein , we report that miR-210 is frequently up-regulated in colorectal cancer tissues , with high miR-210 expression significantly correlating with large tumor size , lymph node metastasis , advanced clinical stage and poor prognosis .	miR-210	metastasis	upregulate	positive	colorectal cancer	D001943
24632577	Furthermore , miR-210 can be induced by hypoxia and mediates the hypoxia-induced metastasis of colorectal cancer cells .	miR-210	metastasis	induce	positive	colorectal cancer cells	D001943
24641415	MiR-202 and miR-9 are potential key factors affecting the metastasis of OS and CALD1 and STX1A may be possible targets beneficial for the treatment of metastatic OS .	MiR-202|miR-9	metastasis	affect	neutral	OS	D009369
24642471	IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis .	miR-34a	metastasis	promote	positive	epithelial-to-mesenchymal transition ( EMT )	D009369
24642471	Members of the miR-34 family are induced by the tumor suppressor p53 and are known to inhibit epithelial-to-mesenchymal transition ( EMT ) and therefore presumably suppress the early phases of metastasis .	miR-34	metastasis	induce	positive	epithelial-to-mesenchymal transition ( EMT )	D009369
24642628	MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1 .	MicroRNA-145	metastasis	inhibit	negative	colorectal cancer	D001943
24642628	Stable overexpression of miR-145 suppressed tumour growth and pulmonary metastasis in vivo .	miR-145	metastasis	suppress	negative	pulmonary metastasis	D001943
24644030	This study was to confirm that miR-494-3p might be a potentially post-transcriptional regulator of CXCR4 and over-expression of miR-494 might suppress prostate cancer progression and metastasis .	miR-494	metastasis	regulate	positive	prostate cancer	D001943
24647573	miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression .	miR-141	metastasis	regulate	positive	renal cell carcinoma	D001943
24649145	miR-9s methylation which induces expression silencing is common in NSCLC cases without lymph nodal metastasis , suggesting that miR-9s are oncogenically involved in NSCLC carcinogenesis through the promotion of tumor metastasis .	miR-9s	metastasis	induce	positive	NSCLC|lymph nodal metastasis	D009369
24658157	Regulation of colorectal carcinoma stemness , growth , and metastasis by an miR-200c-Sox2-negative feedback loop mechanism .	miR-200c	metastasis	regulate	positive	colorectal carcinoma	D009369
24658157	To elucidate a novel mechanism of miR-200c in the regulation of stemness , growth , and metastasis in colorectal carcinoma ( CRC ) .	miR-200c	metastasis	regulate	positive	colorectal carcinoma ( CRC )	D001943
24658157	Our findings indicate that miR-200c regulates Sox2 expression through a feedback loop and is associated with CRC stemness , growth , and metastasis .	miR-200c	metastasis	regulate	positive	CRC	D001943
24658854	EZH2 ( enhancer of zeste homolog 2 ) , which has been shown to be an important transcription factor involved in the proliferation and metastasis of tumor cells , was here confirmed to be a direct target gene of miR-124 .	miR-124	metastasis	enhance	positive	EZH2	D009369
24662829	Introduction of let-7i to mutant p53 cells significantly inhibited migration , invasion and metastasis by repressing a network of oncogenes including E2F5 , LIN28B , MYC and NRAS .	let-7i	metastasis	inhibit	negative	MYC|NRAS	D007938
24668416	Here , we showed that miR-99a and -99b ( miR-99a/b ) were down-regulated in human cervical cancer patient tissues and were negatively related with lymphatic metastasis .	miR-99a|miR-99a/b	metastasis	downregulate	negative	cervical cancer|lymphatic metastasis	D009369
24675462	In conclusion , miR-17-92 cluster members miR-19a/b facilitated gastric cancer cell migration , invasion and metastasis through targeting the antagonist of c-Myc -- MXD1 , implicating a novel mechanism for the malignant phenotypes of gastric cancer .	miR-17|miR-19a/b	metastasis	antagonize	negative	gastric cancer	D061325
24681249	miR-19 in the context of the miR-17~92 cluster at medium levels promoted tumor metastasis through induction of Wnt/?] -catenin-mediated epithelial-mesenchymal transition by targeting to the tumor-suppressor gene , PTEN .	miR-19|miR-17	metastasis	promote	positive	PTEN	D009369
24681249	However , higher levels of the miR-17~92 cluster switched from PTEN to oncogenes , including Ctnnb1 ( ?] -catenin ) via miR-18a , which resulted in inhibition of tumor growth and metastasis .	miR-17|miR-18a	metastasis	inhibit	negative	PTEN	D009369
24682933	However , how miR-200c regulates the apoptosis , survival , invasion , metastasis , and tumor growth in colon cancer cells remains to be fully elucidated .	miR-200c	metastasis	regulate	positive	colon cancer cells	D001943
24682933	In conclusion , miR-200c functions as an oncogene in colon cancer cells through regulating tumor cell apoptosis , survival , invasion , and metastasis as well as xenograft tumor growth through inhibition of PTEN expression and p53 phosphorylation .	miR-200c	metastasis	regulate	positive	colon cancer cells|PTEN	D001943
24704424	AKT2 was confirmed to be a direct target of miR-612 , through which the epithelial-mesenchymal transition ( EMT ) and metastasis of HCC were inhibited .	miR-612	metastasis	inhibit	negative	epithelial-mesenchymal transition ( EMT )|HCC	D009369
24706848	Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis .	microRNA-199a	metastasis	regulate	positive	ovarian cancer	D001943
24710410	miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM .	miR-483	metastasis	promote	positive	lung adenocarcinoma	D001943
24710933	miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1 .	miR-200c	metastasis	inhibit	negative	breast cancer cells	D001943
24710933	This study further examined the role of miR-200c in the invasion and metastasis of breast cancer that goes beyond the regulation on ZEB1 and ZEB2 expression .	miR-200c	metastasis	regulate	positive	breast cancer	D001943
24710934	Moreover , cervical cancer HeLa cells overexpressing miR-215 ( HeLa-miR-215 ) were constructed and subcutaneously injected into the nude mice to examine the effect of miR-215 on tumor growth and metastasis in vivo .	miR-215	metastasis	effect	neutral	cervical cancer	D009369
24715690	Silencing of miR-133a with locked nucleic acid ( LNA ) reduced cell invasion of this cell population , and systemic administration of LNA along with chemotherapy suppressed lung metastasis and prolonged the survival of osteosarcoma-bearing mice .	miR-133a	metastasis	suppress	negative	lung metastasis|osteosarcoma	D009362
24722426	Consequently , our study suggests that miRNA 17 family ( including miR-17 , 20a , 20b ) can act as TGF?] R2 suppressor for reversing cisplatin-resistant and suppressing metastasis in NSCLC .	miR-17	metastasis	suppress	negative	NSCLC	D009369
24729530	The microRNA-200c ( miR-200c ) , which is frequently lowly expressed in triple negative breast cancers ( TNBCs ) , inhibits metastasis by inducing the mesenchymal to epithelial transition ( MET ) .	microRNA-200c|miR-200c	metastasis	inhibit	negative	triple negative breast cancers ( TNBCs )|epithelial transition ( MET )	D009369
24736504	MicroRNA-338 inhibits growth , invasion and metastasis of gastric cancer by targeting NRP1 expression .	MicroRNA-338	metastasis	inhibit	negative	gastric cancer	D061325
24754877	The miRNA-200 family , which is frequently expressed at low levels in triple negative breast cancers , inhibits metastasis by blocking the epithelial-mesenchymal transition .	miRNA-200	metastasis	inhibit	negative	triple negative breast cancers	D009369
24755295	MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1 .	MicroRNA-181a	metastasis	promote	positive	colorectal cancer	D001943
24755295	Stable transfection of CRC cell lines with miR-181a promoted cell motility and invasion , as well as tumor growth and liver metastasis , while silencing its expression resulted in reduced migration and invasion .	miR-181a	metastasis	promote	positive	CRC|liver metastasis	D001943
24774218	Down regulation of miR-143 is related with tumor size , lymph node metastasis and HPV16 infection in cervical squamous cancer .	miR-143	metastasis	regulate	positive	 HPV16|cervical squamous cancer	D009362
24774218	Down-regulated miR-143 expression was associated with tumor size , lymph node metastasis and HPV16 infection in cervical cancer patients .	miR-143	metastasis	downregulate	negative	 HPV16|cervical cancer	D009369
24774218	Down-regulated miR-143 is related with tumor size , lymph node metastasis and HPV16 infection in cervical SCC , but miR-143 does not participate in the Taxol sensitivity response .	miR-143	metastasis	downregulate	negative	cervical SCC	D009369
24781864	miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3 .	miR-145	metastasis	suppress	negative	thyroid cancer	D009369
24791940	Loss of miR-200s has been shown to enhance cancer aggressiveness and metastasis , whereas replacement of miR-200 miRNAs has been shown to inhibit cell growth in several types of tumors , including lung cancer .	miR-200s|miR-200	metastasis	enhance	positive	lung cancer	D009369
24802328	MiR-34c inhibits osteosarcoma metastasis and chemoresistance .	MiR-34c	metastasis	inhibit	negative	osteosarcoma	D009362
24802328	Taken together , our data indicate that miR-34c suppresses OS metastasis and chemoresistance by targeting Notch1 and LEF1 .	miR-34c	metastasis	suppress	negative	OS	D009369
24802328	Restoring miR-34c may have important implications for the development of strategies for inhibiting metastasis and overcoming OS cell resistance to chemotherapy .	miR-34c	metastasis	inhibit	negative	OS	D009369
24805183	However , it is unknown whether and how miR-100 and AGO2 regulates metastasis of prostate cancer .	miR-100	metastasis	regulate	positive	prostate cancer	D001943
24805183	Taken together , our findings indicate that loss of miR-100 promotes the metastatic ability of prostate cancer cells at least partially by upregulating AGO2 expression through modulating migration , invasion , EMT and stemness of cancer cells , and suggest that miR-100/AGO2 may play an important role in regulating the metastasis of prostate cancer and is a potential target of prevention and therapy .	miR-100|miR-100/AGO	metastasis	promote	positive	prostate cancer	D001943
24810210	Honokiol suppresses renal cancer cells ' metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling .	miR-141/ZEB	metastasis	suppress	negative	renal cancer	D009369
24812123	MicroRNA-30a promotes invasiveness and metastasis in ? vitro and in ? vivo through epithelial-mesenchymal transition and results in poor survival of nasopharyngeal carcinoma patients .	MicroRNA-30a	metastasis	promote	positive	nasopharyngeal carcinoma	D009369
24812123	Although microRNA-30a ( miR-30a ) has been shown to regulate cancer metastasis , the molecular mechanism has not yet been clearly elucidated in nasopharyngeal carcinoma ( NPC ) .	microRNA-30a|miR-30a	metastasis	regulate	positive	nasopharyngeal carcinoma ( NPC )	D010181
24812123	In conclusion , miR-30a could play an important role in regulating NPC metastasis and potentially provide useful guidelines for individualized therapy .	miR-30a	metastasis	regulate	positive	NPC	D010181
24816687	MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer .	MicroRNA-7	metastasis	inhibit	negative	PCa	D001943
24816687	In this study , we found that miR-7 expression was significantly downregulated in highly metastatic epithelial ovarian cancer ( EOC ) cell lines and metastatic tissues , whereas the expression of , EGFR correlated positively with metastasis in both EOC patients and cell lines .	miR-7	metastasis	downregulate	negative	EGFR|epithelial ovarian cancer	D001943
24816687	Taken together , our results suggested that miR-7 inhibited tumor metastasis and reversed EMT through AKT and ERK1/2 pathway inactivation by reducing EGFR expression in EOC cell lines .	miR-7	metastasis	inhibit	negative	epithelial ovarian cancer ( EOC )|EGFR	D009369
24822185	For example , deficiencies of enzymes including Dicer and Drosha that are required for miRNA biogenesis may be adverse prognostic factors ; miRNAs such as miR-214 and miR-31 , which are involved in drug resistance , and the miR-200 family , which is implicated in metastasis , may serve as biomarkers ; and transfection of downregulated miRNAs and inhibition of upregulated miRNAs may be effective for treatment of ovarian cancer .	miR-214|miR-31|miR-200	metastasis	downregulate	negative	ovarian cancer	D001943
24823634	In this issue of Cancer Cell , Yuan and colleagues discover a novel TGF-?] -induced lncRNA , lncRNA-ATB , which stimulates EMT through sequestering miR-200s and facilitates colonization by stabilizing IL-11 mRNA , thus promoting both early and late steps of cancer metastasis .	miR-200s	metastasis	stimulate	positive	EMT	D009369
24825302	MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase .	MicroRNA-331	metastasis	promote	positive	hepatocellular carcinoma	D009369
24825302	We provided both in vivo and in vitro evidence demonstrating that miR-331-3p promoted proliferation and metastasis of HCC cells .	miR-331	metastasis	promote	positive	HCC	D009369
24825302	Finally , inhibition of miR-331-3p through a jetPEI-mediated delivery of anti-miR-331-3p vector resulted in marked inhibition of proliferation and metastasis of HCC in xenograft mice .	miR-331	metastasis	inhibit	negative	HCC	D009369
24825302	miR-331-3p promotes proliferation and EMT-mediated metastasis of HCC through suppression of PHLPP-mediated dephosphorylation of AKT .	miR-331	metastasis	promote	positive	HCC	D009369
24825857	MicroRNA-182 ( miR182 ) overexpression contributes to aggressive ovarian cancer , largely by its negative regulation of multiple tumor suppressor genes involved in tumor growth , invasion , metastasis , and DNA instability .	MicroRNA-182|miR182	metastasis	regulate	positive	ovarian cancer	D001943
24829139	MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2 .	MicroRNA-335	metastasis	inhibit	negative	colorectal cancer	D001943
24829139	Furthermore , enhancing the expression of miR-335 inhibited CRC cell migration and invasion in vitro and lung and liver metastasis in vivo , while silencing its expression resulted in increased migration and invasion .	miR-335	metastasis	enhance	positive	CRC	D001943
24829139	In conclusion , our results demonstrate that miR-335 functions as a tumor suppressor and play a role in inhibiting metastasis of CRC cells through targeting ZEB2 .	miR-335	metastasis	inhibit	negative	CRC	D001943
24837198	MicroRNA-34A inhibits the growth , invasion and metastasis of gastric cancer by targeting PDGFR and MET expression .	MicroRNA-34A	metastasis	inhibit	negative	gastric cancer	D061325
24837198	Meanwhile , we found that miR-34a was down-regulated in gastric cancer tissues and was associated with metastasis .	miR-34a	metastasis	downregulate	negative	gastric cancer	D061325
24837198	In conclusion , miR-34a may act as a potential tumour suppressor in gastric cancer and is associated with the mechanisms of gastric cancer metastasis ; miR-34a can inhibit gastric cancer tumourigenesis by targeting PDGFR and MET through the PI3K ( phosphoinositide 3-kinase ) /Akt pathway .	miR-34a	metastasis	inhibit	negative	gastric cancer|MET	D061325
24838609	Deregulation of this circuitry by mutational and epigenetic alterations in the p53/miR-34a axis promotes colorectal cancer ( CRC ) progression and metastasis formation .	miR-34a	metastasis	promote	positive	colorectal cancer ( CRC )	D001943
24845571	MiR-888 regulates side population properties and cancer metastasis in breast cancer cells .	MiR-888	metastasis	regulate	positive	breast cancer cells	D001943
24845571	miR-888 was found in our previous study to be up-regulated in SP cells and predicted to target E-Cadherin directly , indicating a potential role in maintaining SP properties and regulating the epithelial-mesenchymal transition ( EMT ) and cancer metastasis .	miR-888	metastasis	upregulate	positive	SP|epithelial-mesenchymal transition ( EMT )	D009369
24845571	In conclusion , miR-888 maintains SP properties and regulates EMT and metastasis in MCF-7 cells , potentially by targeting E-Cadherin expression .	miR-888	metastasis	regulate	positive	SP|EMT	D009369
24846313	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .	miR-206|miR-3923|miR-181a|miR-92a|miR-421|miR-339|miR-3196|miR-29b|miR-542|miR-200a|miR-564|miR-451|miR-30c|miR-200b|miR-191|miR-142|miR-185	metastasis	downregulate	negative	LN metastasis|LN	D009362
24855559	MicroRNA-206 suppresses gastric cancer cell growth and metastasis .	MicroRNA-206	metastasis	suppress	negative	gastric cancer	D061325
24855559	Down-regulation of miR-206 was particularly significant in tumors with lymphatic metastasis , local invasion , and advanced TNM staging .	miR-206	metastasis	downregulate	negative	lymphatic metastasis|TNM staging	D009369
24855559	Taken together , our results indicate that miR-206 is a tumor suppressor of gastric cancer acting at steps that regulate metastasis .	miR-206	metastasis	regulate	positive	gastric cancer	D061325
24858688	Our results indicate that down-regulation of miR-497 in ovarian cancer may facilitate tumor metastasis .	miR-497	metastasis	downregulate	negative	ovarian cancer	D001943
24859837	Systemically delivered miR-335 inhibited pancreatic cancer metastasis and extended animal survival .	miR-335	metastasis	inhibit	negative	pancreatic cancer	D001943
24866238	Taken together , our results suggest that miR-429 plays an important role in promoting the proliferation and metastasis of NSCLC cells and is a potential target for NSCLC therapy .	miR-429	metastasis	promote	positive	NSCLC	D009369
24866595	miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells .	miRNA-34a	metastasis	suppress	negative	renal carcinoma	D009369
24866595	Ectopic over expression of miR-34a restrained cell growth , tube formation and migration/invasion , and significantly suppressed the growth of renal carcinoma xenografts and metastasis in ? nude mice .	miR-34a	metastasis	suppress	negative	renal carcinoma	D009369
24866595	Our findings indicate that miR-34a targets CD44 in renal cancer cells and suppresses renal cancer cell growth , tube formation and metastasis in ? vitro and in ? vivo .	miR-34a	metastasis	suppress	negative	renal carcinoma	D009369
24874051	MiR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R .	MiR-195	metastasis	inhibit	negative	NSCLC	D009369
24884732	microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis .	microRNA-182	metastasis	promote	positive	colorectal cancer	D001943
24884732	Our results illustrated that the up-regulation of miR-182 played a pivotal role in CRC tumorigenesis and metastasis , which suggesting a potential implication of miR-182 in the molecular therapy for CRC .	miR-182	metastasis	upregulate	positive	CRC	D001943
24885626	miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer .	miR-300	metastasis	inhibit	negative	human epithelial cancer	D009369
24885626	MiR-300 may negatively regulate EMT by direct targeting Twist and therefore inhibit cancer cell invasion and metastasis , which implicates miR-300 as an attractive candidate for cancer therapy .	MiR-300|miR-300	metastasis	regulate	positive	EMT	D009369
24885920	miR-139-5p plays a pivotal role in colon cancer through inhibiting cell proliferation , metastasis , and promoting apoptosis and cell cycle arrest by targeting oncogenic NOTCH1 .	miR-139	metastasis	inhibit	negative	colon cancer	D001943
24894676	MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells .	MiR-186	metastasis	suppress	negative	NSCLC	D009369
24898736	Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis .	miR-29a	metastasis	downregulate	negative	neuroblastoma	D009369
24898736	Irrespective of the amplification status of MYCN , which is known to be associated with metastasis , pre-CNS primaries , and CNS metastases had significantly lower miR-29a expression than non-CNS primary tumors .	miR-29a	metastasis	amplify	positive	MYCN|CNS	D009369
24898736	These findings raised the hypothesis that miR-29a could be a biomarker for neuroblastoma CNS metastasis , and its downregulation may play a pivotal role in CNS progression .	miR-29a	metastasis	downregulate	negative	neuroblastoma|CNS	D009369
24902663	MicroRNA-21 ( miR-21 ) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation , proliferation , and metastasis in renal cell carcinoma .	MicroRNA-21|miR-21	metastasis	downregulate	negative	renal cell carcinoma	D001943
24903381	Taken together , these evidences suggest that miR-145 serves as a tumor suppressor which downregulates LCICs ' cancer stem cell properties and EMT process by targeting Oct4 , leading to the inhibition of tumor growth and metastasis .	miR-145	metastasis	downregulate	negative	EMT	D009369
24906624	In addition , miR-22 overexpression suppressed breast cancer cell invasion , metastasis , and proliferation by targeting CD147 in vitro and in vivo .	miR-22	metastasis	suppress	negative	breast cancer	D001943
24906624	Furthermore , we found that miR-22 was significantly downregulated in breast cancer tissues and that its expression was inversely correlated with the tumor-node-metastasis stage and lymphatic metastasis in patients .	miR-22	metastasis	downregulate	negative	breast cancer tissues|tumor-node-metastasis stage|lymphatic metastasis	D001943|D009369
24912422	MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression .	MicroRNA-17	metastasis	promote	positive	colorectal cancer	D001943
24913034	Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis .	miR-30b	metastasis	regulate	positive	gastric cancer	D061325
24914372	miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2 .	miR-132	metastasis	inhibit	negative	colorectal cancer	D001943
24914372	Down-regulation of miR-132 was associated with tumor size ( P = 0.016 ) , distant metastasis ( P = 0.002 ) , and TNM stage ( P = 0.020 ) in CRC patients .	miR-132	metastasis	downregulate	negative	CRC	D001943
24917697	Furthermore , we provided evidence to demonstrate that up-regulation of miR-639 contributes breast cancer invasion and metastasis .	miR-639	metastasis	upregulate	positive	breast cancer	D001943
24920070	H19 promotes pancreatic cancer metastasis by derepressing let-7 's suppression on its target HMGA2-mediated EMT .	let-7	metastasis	promote	positive	pancreatic cancer|EMT	D009369
24925028	MicroRNA-200b targets protein kinase C帢 and suppresses triple-negative breast cancer metastasis .	MicroRNA-200b	metastasis	suppress	negative	triple-negative breast cancer	D009369
24925028	The microRNA-200 ( miR-200 ) family is found to inhibit or promote breast cancer metastasis ; however , the underlying mechanism is not well understood .	microRNA-200|miR-200	metastasis	inhibit	negative	breast cancer metastasis	D001943
24925028	This study was performed to investigate the effect and mechanism of miR-200b on TNBC metastasis and identify targets for developing more efficient treatment for TNBC .	miR-200b	metastasis	effect	neutral	TNBC	D009369
24925028	Ectopically expressing a single member ( miR-200b ) of the miR-200 family drastically reduces TNBC cell migration and inhibits tumor metastasis in an orthotopic mouse mammary xenograft tumor model .	miR-200b|miR-200	metastasis	inhibit	negative	TNBC	D009369
24925028	In contrast , forced expression of PKC帢 impairs the inhibitory effect of miR-200b on cell migration and tumor metastasis .	miR-200b	metastasis	effect	neutral	PKC	D010181
24925028	These results show that loss of miR-200b expression plays a crucial role in TNBC aggressiveness and that miR-200b suppresses TNBC cell migration and tumor metastasis by targeting PKC帢 .	miR-200b	metastasis	suppress	negative	TNBC|PKC	D009369
24933454	MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer .	MicroRNA-196a/	metastasis	promote	positive	gastric cancer	D061325
24933454	Together , miR-196a/-196b inhibitory oligonucleotides or overexpression of the radixin may thus have therapeutic potential in suppressing GC metastasis .	miR-196a/	metastasis	suppress	negative	GC	D061325
24936152	Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis .	miR-574	metastasis	regulate	positive	colorectal cancer|liver metastasis	D001943
24939570	Endothelial progenitors promote hepatocarcinoma intrahepatic metastasis through monocyte chemotactic protein-1 induction of microRNA-21 .	microRNA-21	metastasis	promote	positive	hepatocarcinoma	D009362
24944639	Therefore , the results demonstrated that miR-203 exhibited an inhibitory effect on MM cell migration via directly targeting versican , thus , may become an effective inhibitor for MM metastasis .	miR-203	metastasis	effect	neutral	MM	D012878
24944666	Marked downregulation of miR-133a was observed in the OVCAR-3 cell line and primary tumor samples , and it was found that reduced miR-133a expression significantly correlated with advanced clinical stages , poor histological differentiation and lymph node metastasis .	miR-133a	metastasis	downregulate	negative	lymph node metastasis	D009369
24954667	We identified SNAI1 as a direct target of miR-30a and demonstrated miR-30a as a novel regulator of EMT by targeting SNAI1 , indicating its potential therapeutic value for reducing invasion and metastasis of HCC .	miR-30a	metastasis	regulate	positive	EMT|HCC	D009369
24955153	miR-18a downregulates DICER1 and promotes proliferation and metastasis of nasopharyngeal carcinoma .	miR-18a	metastasis	downregulate	negative	nasopharyngeal carcinoma	D009369
24955153	In situ hybridization revealed that miR-18a was more highly expressed in nasopharyngeal carcinoma tissues than in control tissues ( P < 0.05 ) , and the overexpression correlated with clinical stage and lymph node metastasis ( P < 0.05 ) , but not with age and gender ( P > 0.05 ) .	miR-18a	metastasis	control	neutral	nasopharyngeal carcinoma 	D009369
24955153	These findings suggest that miR-18a expression can promote proliferation and metastasis of nasopharyngeal carcinoma cells and that these activities may occur through its regulation of DICER1 .	miR-18a	metastasis	promote	positive	nasopharyngeal carcinoma	D009369
24958806	The effects of miR216a on NSCLC cell growth and metastasis were examined both in vitro and in vivo by overexpressing or inhibiting miR216a .	miR216a	metastasis	inhibit	negative	NSCLC	D009369
24958806	Our data also show that overexpression of miR216a suppresses NSCLC cell growth and metastasis , and enhances cisplatin-induced cell growth inhibition and apoptosis .	miR216a	metastasis	suppress	negative	NSCLC	D009369
24958806	In contrast , inhibition of miR216a stimulates NSCLC cell growth and metastasis , and suppresses cisplatin-induced cell growth inhibition and apoptosis .	miR216a	metastasis	inhibit	negative	NSCLC	D009369
24962996	Serum miR-9 was significantly upregulated in patients with osteosarcoma ( n ? = ? 118 ) compared with healthy control subjects ( n ? = ? 60 ) ; its upregulation was significantly associated with advanced tumour-node-metastasis stage , larger tumour size and presence of distant metastasis .	miR-9	metastasis	upregulate	positive	osteosarcoma|tumour-node-metastasis	D009362
24963047	miR-409-3p/-5p promotes tumorigenesis , epithelial-to-mesenchymal transition , and bone metastasis of human prostate cancer .	miR-409	metastasis	promote	positive	human prostate cancer	D001943
24963047	Intracardiac inoculation ( to mimic systemic dissemination ) of miR-409-5p inhibitor-treated bone metastatic ARCaPM prostate cancer cells in mice led to decreased bone metastasis and increased survival compared with control vehicle-treated cells .	miR-409	metastasis	control	neutral	prostate cancer cells	D001943
24966325	The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin .	microRNA-23b/27b	metastasis	promote	positive	breast cancer	D001943
24970808	FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2 .	microRNA-137	metastasis	suppress	negative	hepatocellular carcinoma	D009369
24970808	In vivo studies confirm that FoxD3-regulated miR-137 inhibited HCC growth and metastasis via targeting AKT2 .	miR-137	metastasis	inhibit	negative	HCC	D009369
24970812	The miR-34 family also affected tumorsphere ultra-structure and inhibited the xenografted tumor growth as well as lung metastasis of SC-M1 cells through YY1 .	miR-34	metastasis	affect	neutral	lung metastasis	D009362
24972966	Next , by lentivirus-mediated gain-of-function studies , it was showed that stable miR-26a inhibited cell proliferation , metastasis , and epithelial mesenchymal transition and induced G1 phase arrest in prostate cancer .	miR-26a	metastasis	inhibit	negative	prostate cancer	D001943
24980553	In breast phyllodes tumor xenografts , miR-21 accelerated tumor growth , induced myofibroblast differentiation , and promoted metastasis .	miR-21	metastasis	induce	positive	breast phyllodes tumor	D001943
24981590	The up-regulation of miR-215 or -192 was related with the clinical characteristics of gastric cancer , such as lymph node metastasis .	miR-215	metastasis	upregulate	positive	gastric cancer 	D061325
24988946	lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI .	miR-675	metastasis	repress	negative	prostate cancer	D001943
24992595	Paeonol suppresses chondrosarcoma metastasis through up-regulation of miR-141 by modulating PKC帤 and c-Src signaling pathway .	miR-141	metastasis	suppress	negative	chondrosarcoma	D009369
24994936	In conclusion , our results have revealed a new regulatory mechanism that involves C/EBP?] -LIP-mediated downregulation of miR-203 , which plays a key role in EMT and metastasis .	miR-203	metastasis	downregulate	negative	EMT	D009369
24997798	miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25 .	miRNA-200c	metastasis	inhibit	negative	non-small cell lung cancer	D009369
24997798	We demonstrated that over-expression of miR-200c inhibited NSCLC cells migration , invasion , epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .	miR-200c	metastasis	inhibit	negative	NSCLC|epithelial-mesenchymal transition ( EMT )|lung metastasis	D009369
25001183	In this study , we showed that the expression level of miR-128 was significantly downregulated in non-small cell lung cancer ( NSCLC ) tissues and cancer cells , and was significantly correlated with NSCLC differentiation , pathological stage and lymph node metastasis .	miR-128	metastasis	downregulate	negative	non-small cell lung cancer ( NSCLC ) 	D009369
25001613	We demonstrated that miR-17-5p inhibition in breast cancer cells enhanced expression of multiple pro-metastatic genes , rendered cells metastatic properties , and accelerated lung metastasis from orthotopic xenografts .	miR-17	metastasis	inhibit	negative	breast cancer cells|lung metastasis	D001943
25001613	These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .	miR-17|miR-200|miR-96	metastasis	activate	positive	EMT|IFN	D009369
25003330	CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d .	miR-519d	metastasis	promote	positive	human osteosarcoma	D009362
25003330	Taken together , data show CTGF elevating MMPs expression and subsequently promoting tumor metastasis in human osteosarcoma , down-regulating miR-519d via MEK and ERK pathways , making CTGF a new molecular therapeutic target in osteosarcoma metastasis .	miR-519d	metastasis	promote	positive	human osteosarcoma	D009362
25003638	miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1 .	miR-143	metastasis	inhibit	negative	NSCLC	D009369
25004126	Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance .	miR-203	metastasis	regulate	positive	prostate cancer|bone metastasis	D001943
25004126	Here we show that ectopic miR-203 expression displayed reduced bone metastasis and induced sensitivity to tyrosine kinase inhibitors ( TKIs ) treatment in a xenograft model .	miR-203	metastasis	induce	positive	bone metastasis	D001859
25004126	Our results demonstrate that the induction of bone metastasis and TKI resistance require miR-203 down regulation , activation of the EGFR pathway via altered expression of EGFR ligands ( EREG and TGFA ) and anti-apoptotic proteins ( API5 , BIRC2 , and TRIAP1 ) .	miR-203	metastasis	induction	positive	bone metastasis|EGFR	D001859
25004126	We propose that the loss of miR-203 is a molecular link in the progression of prostate cancer metastasis and TKIs resistance characterized by high EGFR ligands output and anti-apoptotic proteins activation .	miR-203	metastasis	activate	positive	prostate cancer|EGFR	D001943
25009651	miR-339-5p inhibits cell migration and invasion in vitro and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer .	miR-339	metastasis	inhibit	negative	tumor-node-metastasis |non-small cell lung cancer	D009369
25010867	Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein ( NOB1 ) .	miR-646	metastasis	downregulate	negative	renal carcinoma	D009369
25010867	Downregulated miR-646 in ccRCC was associated with tumour metastasis through MAPK pathway by targeting NOB1 .	miR-646	metastasis	downregulate	negative	ccRCC	D009369
25017439	In this study we explored whether FOXO1 3'UTR can function as a ceRNA in repressing epithelial-to-mesenchymal transition ( EMT ) and metastasis of breast cancer cells via regulating miR-9 activity .	miR-9	metastasis	repress	negative	epithelial-to-mesenchymal transition ( EMT )|breast cancer cells	D001943
25019203	MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1 .	MiR-20a	metastasis	inhibit	negative	cutaneous squamous cell carcinoma	D009369
25019299	Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer .	microRNA-145	metastasis	upregulate	positive	 colorectal cancer	D001943
25023326	MiR-151 is aberrantly overexpressed in HCC cells and promotes HCC metastasis yet its roles on HCC tumorigenicity are unknown .	MiR-151	metastasis	promote	positive	HCC	D009369
25030358	Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression .	microRNA-302a	metastasis	inhibit	negative	breast cancer metastasis	D001943
25030358	The purpose of this study is to investigate the role of miR-302a in the development of breast cancer metastasis mediated by CXCR4 , a critical regulator of metastasis , and to identify miR-302a as an effective therapeutic agent for therapy and prevention of breast cancer metastasis .	miR-302a	metastasis	mediate	neutral	breast cancer metastasis	D001943
25030358	More promisingly , miR-302a inhibited the invasion and metastasis of breast cancer cells in vitro and in vivo and reduced the expression of CXCR4 .	miR-302a	metastasis	inhibit	negative	breast cancer cells	D001943
25030358	Our findings demonstrated that the repression of miR-302a levels contributes to breast cancer metastasis and restoration of miR-302a baseline expression inhibits the invasion and metastasis of breast cancer cells .	miR-302a	metastasis	inhibit	negative	breast cancer metastasis|breast cancer cells	D001943
25032858	miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition .	miR-29b	metastasis	suppress	negative	colorectal cancer|epithelial-mesenchymal transition	D001943
25043055	miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 .	miR-34a	metastasis	block	negative	osteoporosis|bone metastasis	D001859
25043310	MiR-25 inhibition significantly decreased the metastasis , invasion and proliferation of GC cells in vitro , and reduced their capacity to develop distal pulmonary metastases and peritoneal dissemination in vivo .	MiR-25	metastasis	inhibit	negative	GC	D061325
25047463	Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-庥B signaling in cervical cancer .	miR-520h/PP	metastasis	inhibit	negative	cervical cancer	D009369
25049231	The overexpression of miR-941 suppressed in vitro cell proliferation , migration , and invasion and inhibited the metastasis of HCC cells in vivo .	miR-941	metastasis	suppress	negative	HCC	D009369
25052237	This study was to investigate the effect of miR-200c on regulation of ovarian cancer cell metastasis potential and explore the underlying molecular events .	miR-200c	metastasis	effect	neutral	ovarian cancer	D001943
25064732	In addition , miR-138 downregulation and PDK1 upregulation were both significantly associated with advanced tumor-node-metastasis ( TNM ) stage ( both P = 0.002 ) and positive lymph node metastasis ( both P = 0.01 ) of NSCLC patients .	miR-138	metastasis	downregulate	negative	tumor-node-metastasis ( TNM ) |NSCLC	D009369
25069832	MicroRNA-18a inhibits hypoxia-inducible factor 1帢 activity and lung metastasis in basal breast cancers .	MicroRNA-18a	metastasis	inhibit	negative	lung metastasis|basal breast cancers	D001943
25069832	In this study , we investigated the function of miR-18a in regulating breast cancer metastasis through the hypoxia-inducible factor 1帢 ( HIF1A ) -dependent hypoxic response .	miR-18a	metastasis	regulate	positive	breast cancer metastasis	D001943
25069832	miRNA-mRNA interactions ( AGO2 immunoprecipitation and 3 ' untranslated region Luciferase reporter assays ) , gene expression ( quantitative PCR and microarray ) , cell migration and invasion , and cell growth were assessed under normoxic or hypoxic conditions , complemented by orthotopic xenograft of tumor cells to the mammary fat pad to investigate the effect of modulating miR-18a expression on primary tumor growth and lung metastasis .	miR-18a	metastasis	effect	neutral	lung metastasis	D009362
25069832	Ectopic expression of miR-18a , a MIR17HG family member , in a metastatic variant of MDA-MB-231 cells reduced primary tumor growth and lung metastasis , whereas miR-18a inhibition in the parental cells promoted tumor growth and lung metastasis .	miR-18a	metastasis	inhibit	negative	lung metastasis	D009362
25069832	The results of this study reveal a novel role for miR-18a in targeting HIF1A and repressing metastasis of basal-like breast tumors .	miR-18a	metastasis	repress	negative	basal-like breast tumors	D001943
25070049	Here , we show that miR-7 , which was downregulated in breast CSCs ( BCSCs ) isolated from the human MCF-7 and MDA-MB-231 cell lines , inhibited cell invasion and metastasis , decreased the BCSC population and partially reversed EMT in MDA-MB-231 cells by directly targeting the oncogene , SETDB1 .	miR-7	metastasis	downregulate	negative	breast CSCs ( BCSCs )|EMT	D001943
25070049	MiR-7 inhibited the metastasis of BCSCs in lungs , kidneys , and adrenal glands of NOD/SCID mice .	MiR-7	metastasis	inhibit	negative	BCSCs	D001943
25073510	miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3 .	miR-144	metastasis	suppress	negative	hepatocellular carcinoma	D009369
25075255	Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis .	microRNA-10b	metastasis	upregulate	positive	breast cancer|brain metastasis	D001943
25080937	SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer .	miR-199a	metastasis	regulate	positive	gastric cancer	D061325
25080937	Specifically , our results showed that SRF promotes GC metastasis and the epithelial to mesenchymal transition ( EMT ) though miR-199a-5p-mediated downregulation of E-cadherin .	miR-199a	metastasis	promote	positive	GC|epithelial to mesenchymal transition ( EMT )	D061325
25080937	As increased activity of the SRF/miR-199a-5p/E-cadherin pathway appears to promote GC cell EMT and metastasis , these regulators may therefore be developed as therapeutic targets or biomarkers for GC progression .	miR-199a	metastasis	promote	positive	GC|EMT	D061325
25090005	MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer , and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1 .	MicroRNA-150	metastasis	inhibit	negative	epithelial ovarian cancer	D001943
25096247	microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R .	microRNA-194	metastasis	suppress	negative	osteosarcoma	D009362
25096247	We studied the effects of miR-194 in osteosarcoma and the possible mechanism by which miR-194 affected the survival , apoptosis and metastasis of osteosarcoma .	miR-194	metastasis	affect	neutral	osteosarcoma	D009362
25096247	Overexpression of miR-194 partially inhibited the proliferation , migration , and invasion of osteosarcoma cells in ? vitro , as well as tumor growth and pulmonary metastasis of osteosarcoma cells in ? vivo .	miR-194	metastasis	inhibit	negative	osteosarcoma|pulmonary metastasis	D009362
25096247	Overexpression of miR-194 inhibited tumor growth and metastasis of osteosarcoma probably by downregulating CDH2 and IGF1R .	miR-194	metastasis	inhibit	negative	osteosarcoma	D009362
25098939	MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma .	MiR-124	metastasis	suppress	negative	nasopharyngeal carcinoma	D009369
25105419	MicroRNA-493 suppresses tumor growth , invasion and metastasis of lung cancer by regulating E2F1 .	MicroRNA-493	metastasis	suppress	negative	lung cancer	D009369
25109390	Furthermore , we found that the downregulation of miR-100 was significantly correlated with the status of lymph node metastasis in the 34 ? ESCC patients .	miR-100	metastasis	downregulate	negative	 ESCC	D009369
25119590	Taken together , our data suggest that miR200 family inhibited ovarian cancer cell invasiveness and metastasis by downregulating MMP3 , possibly through ZEB1/pSMAD3 .	miR200	metastasis	inhibit	negative	ovarian cancer	D001943
25120799	Then , the downregulation of miR-133b and miR-206 both more frequently occurred in osteosarcoma patients with high tumor grade ( both P=0.01 ) , positive metastasis ( both P < 0.001 ) and recurrence ( both P < 0.001 ) .	miR-133b|miR-206	metastasis	downregulate	negative	osteosarcoma	D009362
25124610	In conclusiomn , miR-150-5p may suppress CRC metastasis through directly targeting MUC4 , highlighting its potential as a novel agent for the treatment of CRC metastasis .	miR-150	metastasis	suppress	negative	CRC	D001943
25128483	miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells .	miR-27a	metastasis	regulate	positive	lung adenocarcinoma	D001943
25135278	Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11?iRNA-541?ndrogen receptor ( AR ) ?MP9 signaling .	miRNA-541	metastasis	promote	positive	prostate cancer	D001943
25135278	Together , these results concluded that infiltrating CD4 ( + ) T cells could promote PCa metastasis via modulation of FGF11?iRNA-541?R?MP9 signaling .	miRNA-541	metastasis	promote	positive	prostate cancer	D001943
25136862	In this study , we found that the levels of miR-410 in gastric cancer and cell lines were much lower than that in the normal control , respectively , and the lower level of miR-410 was significantly associated with lymph-node metastasis .	miR-410	metastasis	control	neutral	gastric cancer|lymph-node metastasis	D061325
25142071	These results demonstrated that this type of arene ruthenium ( ii ) complex can block the invadopodia formation by regulating the PTEN/AKT signal pathway mediated by miR-21 to inhibit the invasion and metastasis of breast cancer cells .	miR-21	metastasis	block	negative	breast cancer cells	D001943
25142234	miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3 .	miR-141	metastasis	suppress	negative	HCC	D009369
25142234	Our results suggest a critical role of miR-141 in suppressing metastasis of HCC cells by targeting E2F3 .	miR-141	metastasis	suppress	negative	HCC	D009369
25149074	Functional analyses demonstrated that ectopic expression of miR-139-5p suppressed CRC cell migration and invasion in vitro and metastasis in vivo .	miR-139	metastasis	suppress	negative	CRC	D001943
25149074	Mechanistic investigations revealed that miR-139-5p suppress CRC cell invasion and metastasis by targeting AMFR and NOTCH1 .	miR-139	metastasis	suppress	negative	CRC	D001943
25149074	Knockdown of the two genes phenocopied the inhibitory effect of miR-139-5p on CRC metastasis .	miR-139	metastasis	effect	neutral	CRC	D001943
25149074	Together , our data indicate that miR-139-5p is a potential tumor suppressor and prognostic factor for CRC , and targeting miR-139-5p may repress the metastasis of CRC and improve survival .	miR-139	metastasis	repress	negative	CRC	D001943
25150396	MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells .	MiR-451	metastasis	suppress	negative	lung cancer	D009369
25150396	In order to explore the molecular mechanism of the occurrence and development of lung cancer , we investigated the effect of human miR-451 on the proliferation , invasion , and metastasis in lung cancer cell line A549 .	miR-451	metastasis	effect	neutral	lung cancer	D009369
25151965	This discovery suggests that a PAX4-miR-144/451-ADAMs axis regulates human epithelial cancer metastasis , thus opening up therapeutic possibilities and predicting prognosis for those cancer types .	miR-144/451	metastasis	regulate	positive	human epithelial cancer	D009369
25152390	We found that miR-183 was up-regulated in renal cancer tissues ; inhibition of endogenous miR-183 suppressed in vitro cell proliferation , colony formation , migration , and invasion and stimulated Caspase 3/7 activity ; up-regulated miR-183 increased cell growth and metastasis and suppressed Caspase 3/7 activity .	miR-183	metastasis	upregulate	positive	renal cancer	D009369
25154741	MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2 .	MiR-130b	metastasis	suppress	negative	prostate cancer	D001943
25154741	Ectopic expression of MMP2 rescued miR-130b-suppressed cell migration and invasion , and knock-down of MMP2 antagonized the effect of silencing miR-130b.Taken together , our data reveal for the first time that miR-130b exerts a suppressive effect in prostate cancer metastasis through down-regulation of MMP2 .	miR-130b	metastasis	antagonize	negative	prostate cancer	D001943
25164015	To better understand how the TGF?] inhibitors are suppressed in metastatic breast cancer cells , we compared miRNA expression profiles between breast cancers with or without metastasis and found that the miR424-503 cluster was markedly overexpressed in metastatic breast cancer .	miR424	metastasis	suppress	negative	breast cancer cells|breast cancer	D001943
25164015	Moreover , antagonizing miR424-503 in breast cancer cells suppressed metastasis in vivo and increased overall host survival .	miR424	metastasis	antagonize	negative	breast cancer cells	D001943
25164015	Overall , our findings demonstrate a novel mechanism , mediated by elevated expression of the miR424-503 cluster , underlying TGF?] activation and metastasis of human breast cancer .	miR424	metastasis	mediate	neutral	human breast cancer	D001943
25172416	Clinical information from a cohort of 54 PC patients demonstrated that down-regulated miR-217 was positively correlated with late tumor stage , lymphatic invasion , vascular infiltration and distant metastasis .	miR-217	metastasis	downregulate	negative	lymphatic invasion	D009362
25174450	MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8 .	MiR-198	metastasis	repress	negative	colorectal cancer	D001943
25187230	miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway .	miR-99a	metastasis	suppress	negative	non-small cell lung cancer	D009369
25187230	Herein , we found that miR-99a was downregulated in NSCLC tissues and suppressed tumor metastasis of NSCLC cells .	miR-99a	metastasis	downregulate	negative	NSCLC	D009369
25187230	Down-regulation of miR-99a is significantly associated with last-stage and tumor metastasis in NSCLC patients .	miR-99a	metastasis	downregulate	negative	NSCLC	D009369
25187230	Further functional experiments found that overexpression of miR-99a inhibit cell proliferation , migration , and invasion of NSCLC cells in vitro and tumor metastasis of NSCLC in vivo .	miR-99a	metastasis	inhibit	negative	NSCLC	D009369
25190211	MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression .	MicroRNA-101	metastasis	inhibit	negative	osteosarcoma	D009362
25190487	Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling .	microRNA-138	metastasis	upregulate	positive	ovarian cancer	D001943
25193015	Let-7d suppresses growth , metastasis , and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7 .	Let-7d	metastasis	suppress	negative	renal cell carcinoma	D001943
25193015	Functional studies indicated that ectopic expression of let-7d significantly inhibited RCC cell proliferation , migration , and peripheral blood monocyte ( PBMC ) recruitment in vitro , as well as tumor growth , metastasis , and tumor macrophage infiltration in vivo .	let-7d	metastasis	inhibit	negative	RCC	D001943
25193015	These results suggest that let-7d may suppress RCC growth , metastasis , and tumor macrophage infiltration at least partially through targeting COL3A1 and CCL7 .	let-7d	metastasis	suppress	negative	RCC	D001943
25193986	MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of ?] -catenin signaling .	MiR-29c	metastasis	mediate	neutral	colorectal carcinoma	D009369
25193986	miR-29c was markedly downregulated in PCs with distant metastasis and determined to be an independent predictor of shortened patient survival .	miR-29c	metastasis	downregulate	negative	PCs	D009369
25193986	In CRC cells , miR-29c dramatically suppressed cell migration and invasion abilities in vitro and cancer metastasis in vivo .	miR-29c	metastasis	suppress	negative	CRC	D001943
25202416	This study revealed that miR-101 is significantly downregulated in papillary thyroid carcinoma ( PTC ) tissue and thyroid cancer cell lines , and that the downregulated miR-101 is associated with lymph node metastasis .	miR-101	metastasis	downregulate	negative	papillary thyroid carcinoma ( PTC ) 	D009369
25204970	MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1 .	MiR-338	metastasis	suppress	negative	OSCC	D009369
25204970	Taken together , miR-338 might inhibit growth and metastasis of OSCC cells by targeting NRP1 .	miR-338	metastasis	inhibit	negative	OSCC	D009369
25205654	Moreover , in an orthotopic MDR colorectal cancer mouse model , we demonstrated that overexpression of miR200c effectively inhibited the tumor growth and metastasis .	miR200c	metastasis	inhibit	negative	colorectal cancer	D001943
25210796	Importantly , ectopic miR-101 expression was sufficient to trigger in vivo lung tumor regression and the blockage of metastasis .	miR-101	metastasis	trigger	positive	lung tumor	D009369
25211657	Upregulated expression of miR-183 was not correlated with tumour stage or lymphatic metastasis in ESCC patients .	miR-183	metastasis	upregulate	positive	lymphatic metastasis|ESCC	D009369
25215905	miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer .	miR-193b	metastasis	suppress	negative	pancreatic cancer	D001943
25215905	Therefore , miR-193b may constitute a promising therapeutic agent for the suppression of pancreatic cancer cell growth and metastasis .	miR-193b	metastasis	suppress	negative	pancreatic cancer cell	D001943
25216122	miR-200 genes have been studied intensively in relation to breast cancer progression and metastasis , where it has been shown that miR-200 members are down-regulated in basal-like breast cancer where the EMT phenotype is prominent .	miR-200	metastasis	downregulate	negative	breast cancer|EMT	D001943
25216122	There is growing evidence that the miR-200 family is up-regulated in distal breast metastasis indicating that these miRs are important for colonization of metastatic breast cancer cells through induction of mesenchymal to epithelial transition .	miR-200	metastasis	upregulate	positive	breast metastasis|breast cancer cells	D001943
25218344	In previous studies , miR-124 was found to repress proliferation and metastasis in different types of cancers , but whether it functions in cervical cancer remained unknown .	miR-124	metastasis	repress	negative	cervical cancer	D009369
25230372	Thus , miR-506 represents a new class of miRNA that regulates both E-cad and vimentin/N-cad in the suppression of EMT and metastasis .	miR-506	metastasis	regulate	positive	EMT	D009369
25231560	The downregulated miR-125a-5p was significantly associated with gastric cancer metastasis .	miR-125a	metastasis	downregulate	negative	gastric cancer	D061325
25232258	Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer .	miR-193a	metastasis	downregulate	negative	 colorectal cancer	D001943
25232258	Downregulation of miR-193a-5p correlates with lymph node metastasis and poor survival of CRC .	miR-193a	metastasis	downregulate	negative	 CRC	D001943
25238878	The potentials of proliferation , invasion , and metastasis in breast cancer MCF-7 cells were promoted by ectopic transfection of miR-93 .	miR-93	metastasis	promote	positive	breast cancer	D001943
25240815	MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2 .	MiR-126	metastasis	suppress	negative	hepatocellular carcinoma	D009369
25249556	miR21 expression promotes ccRCC cell proliferation , migration , invasion in vitro , and tumor growth and metastasis in vivo .	miR21	metastasis	promote	positive	ccRCC	D009369
25249556	Overexpression of PTENP1 in cells expressing miR21 reduces cell proliferation , invasion , tumor growth , and metastasis , recapitulating the phenotypes induced by PTEN expression .	miR21	metastasis	induce	positive	PTEN	D009369
25251503	Double-negative feedback loop between microRNA-422a and forkhead box ( FOX ) G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis .	microRNA-422a	metastasis	regulate	positive	hepatocellular carcinoma tumor	D009369
25251503	In this study , we report that microRNA-422a ( miR-422a ) is significantly down-regulated in HCC tumor samples and cell lines compared with normal controls , and its expression level is negatively correlated with pathological grading , recurrence , and metastasis .	microRNA-422a|miR-422a	metastasis	downregulate	negative	HCC|liver metastasis	D009369
25251503	At the same time , the overexpression of miR-422a in HCC tumor cells significantly inhibits tumor growth and liver metastasis in xenograft tumor models .	miR-422a	metastasis	inhibit	negative	HCC	D009369
25261234	Ectopic expression of miR23b inhibited invasion , anoikis , angiogenesis , and pulmonary metastasis .	miR23b	metastasis	inhibit	negative	pulmonary metastasis	D001943
25270723	Thus , for the first time , we provided convincing evidence that upregulation of miR-494 was associated with tumor aggressiveness and tumor metastasis and promoted cell migration and invasion by targeting PTEN gene in colorectal cancer , and miR-494 is an independent prognostic marker for colorectal cancer patients .	miR-494	metastasis	upregulate	positive	colorectal cancer	D001943
25277191	Osteoblast-derived WNT-induced secreted protein 1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126 .	miR-126	metastasis	enhance	positive	prostate cancer	D001943
25277211	miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6 .	miR-98	metastasis	suppress	negative	melanoma	D012878
25277211	These results suggest that miR-98 inhibits melanoma metastasis in part through a novel miR-98-IL-6-negative feedback loop .	miR-98	metastasis	inhibit	negative	melanoma	D012878
25284788	Rewiring of an epithelial differentiation factor , miR-203 , to inhibit human squamous cell carcinoma metastasis .	miR-203	metastasis	inhibit	negative	squamous cell carcinoma	D009369
25284788	We report that miR-203 , a miRNA that triggers differentiation in multilayered epithelia , inhibits multiple postextravasation events during HNSCC lung metastasis .	miR-203	metastasis	trigger	positive	HNSCC	D006258
25284788	In vivo genetic reconstitution experiments show that miR-203 inhibits lung metastasis by suppressing the prometastatic activities of three factors involved in cytoskeletal dynamics ( LASP1 ) , extracellular matrix remodeling ( SPARC ) , and cell metabolism ( NUAK1 ) .	miR-203	metastasis	inhibit	negative	lung metastasis	D009362
25286763	Our data showed that miR-720 level was significantly upregulated in CRC tissues than that in corresponding normal-appearing tissues ( NATs ) ( p ? < ? 0.05 ) , and high miR-720 correlated with the tumor size ( p ? = ? 0.014 ) , tumor-node-metastasis ( TNM ) stage ( p ? = ? 0.040 ) , lymphatic metastasis ( p ? = ? 0.008 ) , and distant metastasis ( p ? = ? 0.016 ) , which led to a poorer 5-year overall survival rate in CRC patients ( p ? < ? 0.05 ) .	miR-720	metastasis	upregulate	positive	CRC|tumor-node-metastasis ( TNM ) stage|lymphatic metastasis	D001943|D009369
25288334	let-7b/g was found down-regulated in gastric cancer and its downregulation was associated with poor survival and correlated with lymph node metastasis .	let-7b	metastasis	downregulate	negative	gastric cancer 	D061325
25289936	MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma .	MicroRNA-217	metastasis	regulate	positive	osteosarcoma	D009362
25292190	miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1 .	miR-382	metastasis	inhibit	negative	osteosarcoma	D009362
25292190	The overexpression of miR-382 suppressed epithelial-mesenchymal transition ( EMT ) and metastasis .	miR-382	metastasis	suppress	negative	epithelial-mesenchymal transition ( EMT )	D009369
25292190	In contrast , inhibition of miR-382 stimulated EMT and metastasis and increased CSC population in OS cells .	miR-382	metastasis	inhibit	negative	EMT|CSC|OS	D009369
25292190	Taken together , our findings suggest that miR-382 functions as a tumor suppressor function and that the overexpression of miR-382 is a novel strategy to inhibit tumor metastasis and prevent CSC-induced relapse in OS .	miR-382	metastasis	inhibit	negative	CSC	D009369
25296715	Thus , our findings demonstrate a double-negative feedback loop between ZEB2 and miR-145 and indicate that the ZEB2/miR-145 double-negative feedback loop plays a significant role in the control of EMT and stem cell properties during the bone metastasis of PCa cells .	miR-145	metastasis	control	neutral	PCa	D001943
25299640	Our results showed that the miR-545/374a cluster was upregulated in HBV-HCC tissue and significantly correlated with prognosis-related clinical features , including histological grade , metastasis and tumor capsule .	miR-545/374a	metastasis	upregulate	positive	HCC	D009369
25310895	MiR-451 was found to be significantly downregulated in docetaxel-resistant LAD cells , and re-expression of miR-451 could reverse EMT to mesenchymal-epithelial transition ( MET ) and inhibit invasion and metastasis of docetaxel-resistant LAD cells both in vitro and in vivo .	MiR-451|miR-451	metastasis	downregulate	negative	LAD|MET	D009369
25311085	Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis .	miR-568	metastasis	activate	positive	breast cancer metastasis	D001943
25319390	In this study , we found that miR-185 was strongly downregulated in TNBC tissues and cell lines and that its expression levels were associated with lymph node metastasis , clinical stage , overall survival , and relapse-free survival in TNBC .	miR-185	metastasis	downregulate	negative	TNBC 	D009369
25323629	The results showed that miR-22 was downregulated in the gastric cancer specimens and significantly correlated with the advanced clinical stage and lymph node metastasis .	miR-22	metastasis	downregulate	negative	gastric cancer 	D061325
25323629	miR-22 inhibited gastric cancer cell invasion and metastasis by directly targeting MTDH .	miR-22	metastasis	inhibit	negative	gastric cancer	D061325
25324143	miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer .	miR-154*|miR-379	metastasis	regulate	positive	prostate cancer	D001943
25326859	Our findings revealed that the level of circulating miR-182 in PCa patients was higher than that in CP patients and healthy controls ( both at P < 0.05 ) , which was significantly associated with clinical stages ( P < 0.001 ) and lymph node metastasis ( P = 0.018 ) .	miR-182	metastasis	control	neutral	Pca|CP 	D001943
25333261	miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma .	miR-145	metastasis	inhibit	negative	ovarian carcinoma	D061325
25333261	Overexpression of miR-145 in ovarian cancer cells significantly suppressed proliferation , migration and invasion in vitro and inhibited tumor growth and metastasis in vivo .	miR-145	metastasis	suppress	negative	ovarian cancer	D001943
25337200	In the present study , miR-183 expression was significantly decreased in gastric cancer tissues compared with its ' adjacent normal tissues , and down-regulation of miR-183 was significantly associated with lymph node metastasis and pathological TNM stage .	miR-183	metastasis	downregulate	negative	gastric cancer	D061325
25340791	Specifically , miR-30c , a FHIT-upregulated microRNA , contributes to FHIT function in suppression of EMT and metastasis by directly targeting metastasis genes Metadherin ( MTDH ) , High-mobility group AT-hook 2 ( HMGA2 ) , and the mesenchymal markers , Vimentin ( VIM ) and Fibronectin ( FN1 ) , in human lung cancer .	miR-30c	metastasis	suppress	negative	human lung cancer	D009369
25341426	We identify the metastasis suppressor TXNIP as new target of miR-224/miR-452 that induces feedback inhibition of E2F1 and show that miR-224/452-mediated downregulation of TXNIP is essential for E2F1-induced EMT and invasion .	miR-224/miR|miR-224/452	metastasis	induce	positive	EMT	D009369
25341915	mir-148a expression in cancer tissues of patients with lymph node metastasis , vascular invasion and TNM stage III ( -IIII ( was down-regulated more obviously ( P < 0.05 ) .	mir-148a	metastasis	downregulate	negative	TNM stage III ( -IIII	D009369
25345948	The down-regulation of miR-126/miR-126* may play an important role in HCC metastasis and contributes to poor survival of HCC patients .	miR-126/miR	metastasis	downregulate	negative	HCC	D009369
25348003	Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression .	microRNA-200/ZEB	Metastasis	regulate	positive	tumour cell PD-L1	D009369
25348003	Moreover , ZEB1 , an EMT activator and transcriptional repressor of miR-200 , relieves miR-200 repression of PD-L1 on tumour cells , leading to CD8 ( + ) T-cell immunosuppression and metastasis .	miR-200	metastasis	repress	negative	PD-L1	D009369
25356105	Up-regulation of miR-183 is associated with advanced clinical stage , positive lymph node , deep stromal invasion , and distant metastasis in gastric cancer patients .	miR-183	metastasis	upregulate	positive	gastric cancer	D061325
25356169	miR-219 inhibits the growth and metastasis of TSCC cells by targeting PRKCI .	miR-219	metastasis	inhibit	negative	TSCC	D009369
25356169	Taken together , miR-219 inhibited growth and metastasis by targeting PRKCI and might be used as a potential target for the treatment of TSCC .	miR-219	metastasis	inhibit	negative	TSCC	D009369
25361001	Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells .	microRNA-100	metastasis	downregulate	negative	hepatocellular carcinoma	D009369
25361001	Analyses using mouse orthotopic xenograft model further revealed that xenografts of miR-100-stable-expressing HCC cells displayed a significant reduction in pulmonary metastasis , compared with control group .	miR-100	metastasis	control	neutral	HCC	D009369
25361001	Taken together , miR-100 represses metastasis of HCC cells by abrogating the ICMT-Rac1 signaling .	miR-100	metastasis	repress	negative	HCC	D009369
25361001	Downregulation of miR-100 contributes to HCC metastasis and the restoration of miR-100 is a potential strategy for cancer therapy .	miR-100	metastasis	downregulate	negative	HCC	D009369
25362853	miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer .	miR-34a	metastasis	suppress	negative	colorectal cancer	D001943
25362853	Ectopic expression of miR-34a-5p in p53 wild-type colon cancer cell HCT116 significantly inhibited cell growth , migration , invasion and metastasis .	miR-34a	metastasis	inhibit	negative	colon cancer	D001943
25367851	MiR-29b was proved to inhibit metastasis through the targeting of TET1 , indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression .	MiR-29b|miR-29	metastasis	inhibit	negative	HCC	D009369
25373388	MCRS1 overexpression , which is specifically inhibited by miR-129* , promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer .	miR-129*	metastasis	inhibit	negative	non-small cell lung cancer	D009369
25373388	Furthermore , we found that MCRS1 binds to the miR-155 promoter and regulates its expression , as well as MCRS1 promotes epithelial-mesenchymal transition ( EMT ) , invasion , and metastasis through the up-regulation of miR-155 .	miR-155	metastasis	regulate	positive	epithelial-mesenchymal transition ( EMT )	D009369
25374067	miR-338-3p was shown to be downregulated in NSCLC tissues , and the expression levels of miR ? 338 ? 3p were significantly correlated with NSCLC cancer differentiation , pathological stage and lymph ? node metastasis .	miR-338	metastasis	downregulate	negative	NSCLC	D009369
25375090	MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma .	MicroRNA-9	metastasis	promote	positive	esophageal squamous cell carcinoma	D009369
25375090	This study aimed to investigate the effect of miR-9 in esophageal cancer metastasis .	miR-9	metastasis	effect	neutral	esophageal cancer	D009369
25375090	The up-regulation of miR-9 was frequently detected in primary ESCC tumor tissue , which was significantly associated with clinical progression ( P = 0.022 ) , lymph node metastasis ( P = 0.007 ) and poor overall survival ( P < 0.001 ) .	miR-9	metastasis	upregulate	positive	ESCC	D009369
25375090	In addition , miR-9 induced epithelial-mesenchymal transition ( EMT ) in ESCC , a key event in tumor metastasis .	miR-9	metastasis	induce	positive	epithelial-mesenchymal transition ( EMT )|ESCC	D009369
25375090	Taken together , our study demonstrates that miR-9 plays an important role in ESCC metastasis by activating ?] -catenin pathway and inducing EMT via targeting E-cadherin .	miR-9	metastasis	activate	positive	EMT	D009369
25396727	Diallyl disulfide suppresses SRC/Ras/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a .	miR-34a	metastasis	suppress	negative	ESCC	D009369
25400732	These findings suggest that decreased expression of miR-101 might promote metastasis of human ESCC by inducing accumulation of EZH2 protein .	miR-101	metastasis	promote	positive	human breast cancer	D001943
25400815	However , the exact molecular mechanisms by which miR-199a-5p influences melanoma invasion and metastasis remains unclear .	miR-199a	metastasis	influence	neutral	ESCC	D009369
25400827	It was found that the overexpression of miR-19a was significantly associated with metastasis of GC and inferior overall prognosis on clinical tissue level ; that promotes the proliferation , migration and invasion ; and that overexpression of miR-19a can promote the epithelial-mesenchymal transition through activating PI3K/AKT pathway .	miR-19a	metastasis	promote	positive	GC	D061325
25401471	miR-200-containing extracellular vesicles promote breast cancer cell metastasis .	miR-200	metastasis	promote	positive	breast cancer cell	D001943
25403884	miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 ( FGF2 ) .	miRNA-646	metastasis	suppress	negative	osteosarcoma	D009362
25404641	Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells .	miR-519d	metastasis	promote	positive	osteosarcoma	D009362
25404641	Additionally , AMP-activated protein kinase ( AMPK ) and p38 inhibitors or siRNAs reduced the resistin-increased cell migration and miR-519d suppression , and inhibition of resistin expression resulted in suppression of MMP-2 expression and lung metastasis in vivo .	miR-519d	metastasis	suppress	negative	lung metastasis	D009362
25404641	Taken together , our results indicate that resistin promotes chondrosarcoma metastasis and MMP-2 expression through activation of the AMPK/p38 signaling pathway and down-regulation of miR-519d expression .	miR-519d	metastasis	promote	positive	chondrosarcoma	D009369
25405368	Thus , the aim of the present study was to investigate the functional significance of the miR-23b/27b cluster and its regulated molecular targets , with an emphasis on its contributions to BC oncogenesis and metastasis .	miR-23b/27b	metastasis	regulate	positive	BC	D001943
25405368	Our data on RNA networks regulated by tumor-suppressive miR-23b/27b provide new insights into the potential mechanisms of BC oncogenesis and metastasis .	miR-23b/27b	metastasis	regulate	positive	BC	D001943
25405387	The results revealed that decreased expression of miR-429 was probably involved in negatively regulating bone metastasis of breast cancer cells .	miR-429	metastasis	regulate	positive	breast cancer cells	D001943
25411357	In addition , the microRNA ( miR ) -200 family plays a central role in the regulation of the epithelial-mesenchymal transition process during cancer metastasis , and aberrant DNA methylation is one of the key mechanisms underlying regulation of the miR-200 family .	miR-200	metastasis	regulate	positive	epithelial-mesenchymal transition	D009369
25412236	MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1 .	MiR-204	metastasis	inhibit	negative	NSCLC	D009369
25412959	Then , we found that miR-194 was significantly downregulated and RBX1 upregulated in GC tissues ; both of which showed significant association with tumor size , location , invasion , and tumor node metastasis .	miR-194	metastasis	downregulate	negative	GC	D061325
25422078	Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-?] 1/ZEB/miR-200 signaling network .	miR-200	metastasis	inhibit	negative	colorectal carcinoma	D009369
25422078	The processes of EMT and metastasis are highly regulated by a double-negative feedback loop consisting of TGF-?] 1/ZEB pathway and miR-200 family , which therefore has become a promising target for cancer chemotherapy .	miR-200	metastasis	regulate	positive	EMT	D009369
25422078	Collectively , our findings in this study suggest that PZH can inhibit metastasis of colorectal cancer cells via modulating TGF-?] 1/ZEB/miR-200 signaling network , which might be one of the mechanisms whereby PZH exerts its anticancer function .	miR-200	metastasis	inhibit	negative	colorectal cancer	D001943
25422913	miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop .	miR-1228	metastasis	promote	positive	hepatoma cells	D009369
25422913	miR-1228 promoted proliferation and metastasis , and facilitated the transition of cell cycle in hepatoma cells .	miR-1228	metastasis	promote	positive	hepatoma cells	D009369
25428378	MiR-145 was downregulated in the NSCLC specimens and significantly correlated with advanced clinical stage and lymph node metastasis .	MiR-145	metastasis	downregulate	negative	NSCLC	D009369
25428378	Ectopic expression of miR-145 suppressed cell invasion and metastasis in NSCLC cells .	miR-145	metastasis	suppress	negative	NSCLC	D009369
25429777	Chol-let-7a reached HCC orthotopic tumours , significantly inhibited tumour growth , and prevented local invasion and metastasis .	let-7a	metastasis	inhibit	negative	HCC	D009369
25434799	miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer .	miR-26a	metastasis	suppress	negative	triple negative breast cancer	D001943
25434799	In this study , we found that miR-26a was downregulated in triple-negative breast cancer ( TNBC ) , and its expression levels were associated with lymph node metastasis and overall survival in TNBC .	miR-26a	metastasis	downregulate	negative	triple-negative breast cancer ( TNBC )	D009369
25434799	We also found that the ectopic expression of miR-26a inhibited TNBC cell proliferation and metastasis in vitro and in vivo by downregulating MTDH ( a miR-26a ' target gene ) mRNA and protein and that the overexpression of MTDH could partially abrogate miR-26a-mediated suppression .	miR-26a	metastasis	inhibit	negative	TNBC	D009369
25435873	In addition , miR-15a and/or miR-16 downregulation were all significantly associated with advanced TNM stage ( all P < 0.05 ) , poorly histological grade ( all P < 0.05 ) , and positive lymph node metastasis ( all P < 0.05 ) .	miR-15a|miR-16	metastasis	downregulate	negative	TNM	D009369
25436097	In HCC , miR-221 was shown to be up-regulated in more than 70 % of the cases and was associated with higher tumor stage , metastasis and a shorter time to recurrence after surgery , suggesting an important pathogenic role .	miR-221	metastasis	upregulate	positive	HCC	D009369
25436421	MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7 .	MicroRNA-520g	metastasis	induce	positive	epithelial-mesenchymal transition|hepatocellular carcinoma	D009369
25436980	MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer .	MicroRNA-34a	metastasis	regulate	positive	bone metastasis|prostate cancer	D001943
25436980	Ectopic miR-34a expression inhibited bone metastasis and reduced cancer cell proliferation in a Ras-dependent xenograft model .	miR-34a	metastasis	inhibit	negative	bone metastasis	D001859
25436980	Our data show that the bone metastasis and anti-apoptotic effects found in Ras signaling-activated prostate cancer cells require miR-34a deficiency , which in turn aids in cell survival by activating the WNT and anti-apoptotic signaling pathways thereby inducing TCF7 and BIRC5 expressions .	miR-34a	metastasis	activate	positive	bone metastasis|prostate cancer	D001943
25439221	Additionally , statistical analysis showed that the combined miR 138 downregulation and CCND3 upregulation ( miR-138-low-CCND3-high ) was significantly associated with the advanced tumor-node-metastasis stage ( P = 0.008 ) and the presence of portal vein invasion ( P = 0.008 ) and lymph node metastasis ( P = 0.01 ) .	miR-138	metastasis	downregulate	negative	tumor-node-metastasis stage	D009369
25449782	MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma .	MicroRNA-362	metastasis	promote	positive	hepatocellular carcinoma	D009369
25449782	Inhibition of miR-362-5p in HCC cells dramatically decreased cell proliferation , clonogenicity , migration and invasion in vitro as well as tumor growth and metastasis in vivo .	miR-362	metastasis	inhibit	negative	HCC	D009369
25450365	Taken together , our data demonstrate a critical role of miR-132 in prohibiting cell proliferation , invasion , migration and metastasis in breast cancer through direct suppression of HN1 , supporting the potential utility of miR-132 as a novel therapeutic strategy against breast cancer .	miR-132	metastasis	suppress	negative	breast cancer	D001943
25460499	MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer .	MiR-373	metastasis	suppress	negative	ovarian cancer	D001943
25460499	Ectopic overexpression of miR-373 in human EOC cells suppressed cell invasion in vitro and metastasis in vivo , and the epithelial-mesenchymal transition process .	miR-373	metastasis	suppress	negative	EOC|epithelial-mesenchymal transition	D009369
25460499	Taken together , these results demonstrate that miR-373 suppresses EOC invasion and metastasis by directly targeting Rab22a gene , a new potential therapeutic target in EOC .	miR-373	metastasis	suppress	negative	EOC	D009369
25471786	In addition , miR-451 down-regulation more frequently occurred in osteosarcoma specimens with advanced clinical stage ( P ? < ? 0.001 ) , positive distant metastasis ( P ? = ? 0.015 ) , and poor response to neoadjuvant chemotherapy ( P ? < ? 0.001 ) .	miR-451	metastasis	downregulate	negative	osteosarcoma	D009362
25473903	The microRNA-218~Survivin axis regulates migration , invasion , and lymph node metastasis in cervical cancer .	microRNA-218	metastasis	regulate	positive	cervical cancer	D009369
25475727	In this study , we revealed a miR-203-BMI1 axis that regulated melanoma metastasis .	miR-203	metastasis	regulate	positive	melanoma	D012878
25475727	Taken together , our results demonstrated that miR-203 regulated melanoma invasive and proliferative abilities in part by targeting BMI1 , providing new insights into potential mechanisms of melanoma metastasis .	miR-203	metastasis	regulate	positive	melanoma	D012878
25475733	Moreover , we further found that the down-regulation of endogenous miR-495 expression plays a causative role in over expression of PRL-3 in GC peritoneal metastasis .	miR-495	metastasis	downregulate	negative	GC	D061325
25475733	However , the molecular regulation mechanisms by which endogenous miR-495 expression is down-regulated and PRL-3 promotes GC peritoneal metastasis remain to be clearly elucidated .	miR-495	metastasis	regulate	positive	GC	D061325
25477702	miR-127 was significantly downregulated in BC tissues , and low miR-127 expression was significantly correlated with lymph node metastasis and advanced clinical stage .	miR-127	metastasis	downregulate	negative	BC	D001943
25482402	miR-200a suppresses tumor development and progression ; however , its role in tumor growth and metastasis of hepatocellular carcinoma ( HCC ) and the underlying mechanism have not been elucidated .	miR-200a	metastasis	suppress	negative	hepatocellular carcinoma ( HCC )	D009369
25482402	In the present study , we identified that miR-200a was markedly downregulated in HCC and exerted suppressive effects on tumor cell growth and metastasis .	miR-200a	metastasis	downregulate	negative	HCC	D009369
25483152	miR-26b is downregulated in human tongue squamous cell carcinoma and regulates cell proliferation and metastasis through a COX-2-dependent mechanism .	miR-26b	metastasis	downregulate	negative	tongue squamous cell carcinoma	D009369
25483152	Ectopic expression of miR-26b suppressed the proliferation and metastasis of human tongue squamous cell carcinoma cells .	miR-26b	metastasis	suppress	negative	tongue squamous cell carcinoma	D009369
25483152	Specific inhibition of COX-2 activity by nimesulide further confirmed that miR-26b was able to regulate the cell proliferation and metastasis of the human tongue squamous cell carcinoma cells through a COX-2-dependent mechanism .	miR-26b	metastasis	inhibit	negative	tongue squamous cell carcinoma	D009369
25483817	MicroRNA-145 inhibits lung cancer cell metastasis .	MicroRNA-145	metastasis	inhibit	negative	lung cancer	D009369
25484183	It is shown that the epithelial-mesenchymal transition was associated with the down-regulation of miR-30a , up-regulation of AEG-1 and mesenchymal markers ( Snail and Vimentin ) ; miR-30a inhibited the metastasis of lung tumor A549 cells in vitro , whereas AEG-1 promoted it .	miR-30a	metastasis	downregulate	negative	lung tumor	D009369
25489984	The microRNA-367 inhibits the invasion and metastasis of gastric cancer by directly repressing Rab23 .	microRNA-367	metastasis	inhibit	negative	gastric cancer	D061325
25489984	Our study shows that miR-367 is a key negative regulator of the invasion and metastasis of gastric cancer and establishes a strong rationale for developing miR-367 as a novel therapeutic agent against gastric cancer .	miR-367	metastasis	regulate	positive	gastric cancer	D061325
25492484	A previous study has shown that miR-335 is downregulated in breast cancer and can suppress tumor invasion and metastasis .	miR-335	metastasis	downregulate	negative	breast cancer	D001943
25510669	Let-7b was found downregulated remarkably in gastric cancer tissues and was correlated with Helicobacter pylori infection , tumor stage , and lymphatic metastasis .	Let-7b	metastasis	downregulate	negative	gastric cancer	D061325
25515201	MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway .	MiR-92a	Metastasis	promote	positive	Colorectal Cancer	D001943
25516656	MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis .	MiR-374b	metastasis	suppress	negative	gastric cancer	D061325
25516656	To profile expression of microRNAs ( miRNAs ) in gastric cancer cells and investigate the effect of miR-374b-5p on gastric cancer cell invasion and metastasis .	miR-374b	metastasis	effect	neutral	gastric cancer	D061325
25516656	Compared with the control groups , the restoration of miR-374b-5p expression with anti-miR-374b-5p significantly suppressed the metastasis , invasion and proliferation of MGC-803 cells .	miR-374b	metastasis	control	neutral	MGC-803 cells	D009369
25516656	These findings indicate that upregulation of miR-374b-5p contributes to gastric cancer cell metastasis and invasion through inhibition of RECK expression .	miR-374b	metastasis	upregulate	positive	gastric cancer	D061325
25520857	MicroRNAs ( miRNAs ) are small non-coding RNAs that function as endogenous silencers of target genes , previous studies have shown that miR-335 play an important role in suppressing metastasis and migration in human cancer including gastric cancer ( GC ) .	miR-335	metastasis	suppress	negative	gastric cancer ( GC )	D061325
25520857	In addition , we found that the lower miR-335 expression induced by abnormal methylation may be mainly involved in gastric cell invasion and metastasis in GC tissues .	miR-335	metastasis	induce	positive	GC	D061325
25520864	The downregulation of miR-199a-3p expression is significantly correlated with the recurrence and lung metastasis of patients with osteosarcoma .	miR-199a	metastasis	downregulate	negative	osteosarcoma	D009362
25531317	Here , we demonstrate that TGF?] regulates the level of microRNA-96 ( miR-96 ) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer .	microRNA-96|miR-96|miR-96	metastasis	regulate	positive	prostate cancer	D001943
25531324	STIM1 , a direct target of microRNA-185 , promotes tumor metastasis and is associated with poor prognosis in colorectal cancer .	microRNA-185	metastasis	promote	positive	colorectal cancer	D001943
25531324	This novel miR-185-STIM1 axis promotes CRC metastasis and may be a candidate biomarker for prognosis and a target for new therapies .	miR-185	metastasis	promote	positive	CRC	D001943
25532941	Moreover , miR-224 down-regulation was significantly associated with advanced clinical stage ( P = .027 ) and metastasis ( P = .001 ) , whereas APLN up-regulation more frequently occurred in PCa tissues with advanced pathologic stage ( P = .003 ) , metastasis ( P < .001 ) , and prostate-specific antigen failure ( P = .001 ) .	miR-224	metastasis	downregulate	negative	PCa	D001943
25536052	These results indicated that miR-518c-5p regulates the growth and metastasis of oral cancer as a downstream target of the SDF-1/CXCR4 system .	miR-518c	metastasis	regulate	positive	oral cancer	D009369
25536365	As ANXA1 constitutively activates NF-庥B activity to modulate breast cancer metastasis , we found that miR26b* and miR562 directly targeted the canonical NF-庥B pathway by targeting the 3 ' UTR and inhibiting expression of Rel A ( p65 ) and NF-庥B1 ( p105 ) respectively .	miR26b*|miR562	metastasis	activate	positive	breast cancer metastasis	D001943
25537516	MicroRNA-135b , a HSF1 target , promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma .	MicroRNA-135b	metastasis	promote	positive	hepatocellular carcinoma	D009369
25537516	In addition , miR-135b promoted HCC cell migration and invasion in vitro and metastasis in vivo .	miR-135b	metastasis	promote	positive	HCC	D009369
25537895	miR-92b promotes the migration , adhesion and invasion of human gastric cancer cell line SGC7901 by mediating epithelial-mesenchymal transition , and may accelerate tumor cell metastasis via signaling pathways other than PI3K/Akt pathway .	miR-92b	metastasis	promote	positive	gastric cancer	D061325
25547151	MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3 .	MiR-146b	metastasis	promote	positive	epithelial-mesenchymal transition|thyroid cancer	D009369
25547151	In the present study , we showed that miR-146b-5p is upregulated in PTC with lymph node metastasis .	miR-146b	metastasis	upregulate	positive	EMT|PTC	D009369
25547151	These results indicate that miR-146b-5p induces EMT and may promote PTC metastasis through the regulation of Wnt/?] -catenin signaling , and suggest novel potential therapeutic targets for the treatment of PTC .	miR-146b	metastasis	induce	positive	PTC	D009369
25551284	In vivo metastasis , assays also demonstrated that overexpression of mir34a markedly inhibited bladder cancer metastasis .	mir34a	metastasis	inhibit	negative	bladder cancer	D061325
25551284	Our study defines a major metastasis and angiogenesis suppressive role for mir-34a , a microRNA functions as a tumor suppressor in bladder cancer by directly targeting CD44 , which would be helpful as a therapeutic approach to block bladder cancer metastasis .	mir-34a	metastasis	block	negative	bladder cancer	D061325
25551563	Although more work is required to understand how miR-145 conveys these effects , expression of miR-145 appears to promote EAC progression by enhancing invasion and protection against anoikis , which could in turn facilitate distant metastasis .	miR-145	metastasis	promote	positive	EAC	D009369
25562172	Typical metastatic lesions were found in the livers of mice injected with miR-378-transfected cells , and high levels of the CMV promoter were detected in the nodules , indicating that miR-378 promoted the metastasis of the tumor cells to the liver .	miR-378	metastasis	promote	positive	CMV	D009369
25563770	Inhibition of NADPH oxidase protects against metastasis of human lung cancer by decreasing microRNA-21 .	microRNA-21	metastasis	inhibit	negative	lung cancer	D009369
25563770	Increased expression of miR-21 abrogated the effect of NOX inhibitor on metastasis of human lung cancer in vitro and in vivo .	miR-21	metastasis	effect	neutral	lung cancer	D009369
25563770	Decreased expression of miR-21 facilitated the effect of NOX inhibitor on metastasis of human lung cancer in vitro and in vivo .	miR-21	metastasis	effect	neutral	lung cancer	D009369
25563770	Inhibition of NADPH oxidase protected against metastasis of human lung cancer cells by decreasing miR-21 expression , which could facilitate the understanding of lung cancer pathogenesis and provided clues for the development of novel therapeutics for lung cancer patients .	miR-21	metastasis	inhibit	negative	lung cancer	D009369
25569036	Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B .	microRNA-708	metastasis	mediate	neutral	ovarian cancer	D001943
25569036	Glucocorticoid treatments induce the expression of miR-708 , leading to the suppression of Rap1B , which result in the reduction of integrin-mediated focal adhesion formation , inhibition of ovarian cancer cell migration/invasion and impaired abdominal metastasis in an orthotopic xenograft mouse model .	miR-708	metastasis	induce	positive	ovarian cancer	D001943
25569036	Restoring Rap1B expression reverts glucocorticoid-miR-708 cascade-mediated suppression of ovarian cancer cell invasion and metastasis .	miR-708	metastasis	suppress	negative	ovarian cancer	D001943
25578496	miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer .	miR-145	metastasis	inhibit	negative	nasopharyngeal cancer	D009369
25578496	In this study , we proved that miR-145 was significantly downregulated in NPC and associated with NPC cell metastasis .	miR-145	metastasis	downregulate	negative	NPC	D010181
25592039	IFN-帠-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1 .	miR-29b	metastasis	suppress	negative	colorectal cancer	D001943
25592039	Targeting miR-29b may provide a strategy for blocking CRC growth and metastasis .	miR-29b	metastasis	block	negative	CRC	D001943
25597412	miR-197 is downregulated in platinum-resistant NSCLC specimens , resulting in the promotion of chemoresistance , tumorigenicity , and pulmonary metastasis in vitro and in vivo .	miR-197	metastasis	downregulate	negative	NSCLC|pulmonary metastasis	D009369
25601461	Combinatorial therapeutic viral delivery of miR-551a and miR-483-5p through single-dose adeno-associated viral ( AAV ) delivery significantly suppressed colon cancer metastasis , as did CKB inhibition with a small-molecule inhibitor .	miR-551a|miR-483	metastasis	suppress	negative	colon cancer	D001943
25608619	microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma .	microRNA-146a	metastasis	inhibit	negative	hepatocellular carcinoma	D009369
25608619	The restoration of miR-146a dramatically suppressed HCC cell invasion and metastasis by repressing VEGF expression through upregulating APC , which inhibits ?] -catenin accumulation in nucleus , and downregulating NF-庥B p65 by targeting HAb18G .	miR-146a	metastasis	suppress	negative	HCC	D009369
25608619	This study identified a novel target of miR-146a and defined miR-146a as a crucial tumor suppressor in human HCC that acts through multiple pathways and mechanisms to suppress HCC invasion or metastasis .	miR-146a	metastasis	suppress	negative	HCC	D009369
25608840	MiR-511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3 .	MiR-511	metastasis	inhibit	negative	hepatocellular carcinoma	D009369
25611392	MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET .	MiR-34c	metastasis	suppress	negative	nasopharyngeal carcinoma|MET	D009369
25611392	Ectopic expression of miR-34c suppressed NPC cell viability , colony formation , anchorage-independent growth , cell migration and invasion in vitro , and inhibited xenograft tumor growth and lung metastasis in vivo .	miR-34c	metastasis	suppress	negative	NPC|lung metastasis	D010181
25611392	In conclusion , miR-34c suppresses tumor growth and metastasis in NPC by targeting MET .	miR-34c	metastasis	suppress	negative	NPC|MET	D010181
25613480	In this study , we investigate whether let-7b acts as a tumor suppressor to inhibit invasion and metastasis in gastric cancers .	let-7b	metastasis	inhibit	negative	gastric cancers	D061325
25613480	Nude mice with xenograft models of gastric cancer confirmed that let-7b could inhibit gastric cancer metastasis in vivo after transfection by the lentivirus pGCsil-GFP- let-7b .	let-7b	metastasis	inhibit	negative	gastric cancers	D061325
25613903	miR-149 was significantly downregulated in CRC tissues , and low miR-149 expression was observed to be significantly correlated with lymph node or distant metastasis and advanced TNM stage of CRC patients .	miR-149	metastasis	downregulate	negative	TNM stage|CRC	D001943
25616722	miR-29b was proved to inhibit metastasis through the targeting of TET1 , indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression .	miR-29b|miR-29	metastasis	inhibit	negative	HCC	D009369
25621950	Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis .	miR-122	metastasis	promote	positive	Breast-cancer	D001943
25630658	We studied the effect of miR-204 modulation on master transcription factors important for lineage development , cell differentiation and prostate cancer bone marrow metastasis .	miR-204	metastasis	effect	neutral	prostate cancer	D001943
25630658	In this regulatory circuitry among miR-204 , c-MYB , RUNX2 and ETS1 , the c-MYB was found to induce all three other members , but its expression was differentially affected by the methylation status in lymph node vs. bone metastasis .	miR-204	metastasis	induce	positive	bone metastasis	D001859
25633292	MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif , TAZ .	MicroRNA-141	metastasis	inhibit	negative	gastric cancer	D061325
25633292	Finally , overexpression of miR-141 suppressed tumor growth and pulmonary metastasis in nude mice .	miR-141	metastasis	suppress	negative	pulmonary metastasis	D001943
25634213	Chemotherapy-Induced miRNA-29c/Catenin-帤 Signaling Suppresses Metastasis in Gastric Cancer .	miRNA-29c/Catenin	Metastasis	suppress	negative	Gastric Cancer	D061325
25636908	These findings provide further evidence that a crucial role for miR-203 in inhibiting metastasis of PCa through the suppression of Rap1A expression .	miR-203	metastasis	inhibit	negative	PCa	D001943
25639539	Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis , metastasis , and chemotherapy resistance in pancreatic cancer .	microRNA-21|microRNA-221	metastasis	inhibit	negative	pancreatic cancer	D001943
25639539	Combination of ASOs therapy against miRNA-21 and miRNA-221 significantly inhibited primary tumor growth and metastasis compared to single antagomir treatment , especially , in L3.6plGres-SP-induced pancreatic tumor growth in vivo .	miRNA-21|miRNA-221	metastasis	inhibit	negative	pancreatic tumor	D001943
25644077	We detected the expression level of miR-29b-2 , 155 , 197 and 205 in the serum of female breast cancer patients and healthy controls to detect whether serum level of this chosen micro-RNAs could detect patients with breast cancer and also to detect difference in level of micro-RNAs between non-metastatic cases and metastatic cases , also we tried to detect any relation between level of micro-RNAs and the stage of the tumor , the size of tumor , nodal affection , the presence of metastasis and also the site of metastasis .	miR-29b	metastasis	control	neutral	breast cancer	D001943
25646927	[ Corrigendum ] MicroRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer .	MicroRNA-320a	metastasis	inhibit	negative	colorectal cancer	D001943
25650662	miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy .	miR-638	metastasis	promote	positive	melanoma	D012878
25652012	The current study shows the therapeutic outcome achieved in triple negative breast cancer ( TNBC ) by simultaneously antagonizing miR-21-induced antiapoptosis and miR-10b-induced metastasis , using antisense-miR-21-PS and antisense-miR-10b-PS delivered by polymer nanoparticles ( NPs ) .	miR-21|miR-10b|miR-21|miR-10b	metastasis	antagonize	negative	triple negative breast cancer ( TNBC )	D009369
25653235	Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis .	miR-206	metastasis	activate	positive	gastric cancer	D061325
25653235	Here , we describe the function and regulation network of miR-206 in gastric cancer ( GC ) metastasis .	miR-206	metastasis	regulate	positive	gastric cancer ( GC )	D061325
25653235	Both gain- and loss-of-function studies confirmed that miR-206 significantly suppressed GC cell invasion and metastasis both in vitro and in vivo .	miR-206	metastasis	suppress	negative	GC	D061325
25653235	MiR-206 inhibited GC metastasis by negatively regulating expression of PAX3 .	MiR-206	metastasis	inhibit	negative	GC	D061325
25655186	miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON .	miR-486	metastasis	regulate	positive	hepatocellular carcinoma	D009369
25659578	miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-帢 .	miR-509	metastasis	suppress	negative	breast cancer cells	D001943
25667613	In addition , miR-124 downregulation more frequently occurred in osteosarcoma specimens with advanced clinical stage ( P < 0.001 ) , positive distant metastasis ( P=0.005 ) and poor response to neoadjuvant chemotherapy ( P=0.013 ) .	miR-124	metastasis	downregulate	negative	osteosarcoma	D009362
25668004	Our data describing pathways regulated by tumour-suppressive miR-26a/b provide new insights into the potential mechanisms of OSCC oncogenesis and metastasis .	miR-26a/b	metastasis	regulate	positive	OSCC	D009369
25670861	MicroRNA-873 ( miRNA-873 ) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1 .	MicroRNA-873|miRNA-873	metastasis	inhibit	negative	glioblastoma	D009369
25670861	Our further investigations of the inhibition mechanism indicated that miR-873 negatively affected the carcinogenesis and metastasis of GBM by down-regulating the expression of IGF2BP1 , which stabilizes the mRNA transcripts of its target genes .	miR-873	metastasis	inhibit	negative	GBM	D009369
25674252	Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .	miR-23a|miR-23b|miR-23a	metastasis	coexpress	neutral	GC|TNM stage	D061325
25677173	Inhibition of miR-382 in a weakly tumorigenic melanoma cell line increased tumor progression and metastasis in vivo .	miR-382	metastasis	inhibit	negative	melanoma	D012878
25686251	Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis .	miR-455	metastasis	promote	positive	melanoma	D012878
25686251	Indeed , wild-type miR-455-5p promotes melanoma metastasis through inhibition of the tumour suppressor gene CPEB1 .	miR-455	metastasis	promote	positive	melanoma	D012878
25686251	Moreover , wild-type miR-455 enhances melanoma growth and metastasis in ? vivo , whereas the edited form inhibits these features .	miR-455	metastasis	enhance	positive	melanoma	D012878
25687035	Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer .	miR-512	metastasis	inhibit	negative	non-small cell lung cancer	D009369
25693145	In the current study , we first observed that plasma levels of miR-101 were significantly lower in distant metastatic HCC patients than in HCCs without distant metastasis , and down-regulation of plasma miR-101 predicted a worse disease-free survival ( DFS , P < 0.05 ) .	miR-101	metastasis	downregulate	negative	HCC|HCCs	D009369
25693145	In an animal model of HCC , we demonstrated that systemic delivery of lentivirus-mediated miR-101 abrogated HCC growth in the liver , intrahepatic metastasis and distant metastasis to the lung and to the mediastinum , resulting in a dramatic suppression of HCC development and metastasis in mice without toxicity and extending life expectancy .	miR-101	metastasis	suppress	negative	HCC	D009369
25694126	The results demonstrated that expression of miR-218 was downregulated in gastric cancer tissues , which had a positive correlation with tumor invasion and metastasis .	miR-218	metastasis	downregulate	negative	gastric cancer	D061325
25695396	We found that miRNA-1207-5p ( miR ? 1207-5p ) was markedly downregulated in esophageal carcinoma ( EC ) tissues , and was correlated with EC differentiation , pathological stage and lymph node metastasis .	miRNA-1207	metastasis	downregulate	negative	esophageal carcinoma ( EC )	D009369
25706394	MicroRNA-181a inhibits tumor proliferation , invasiveness , and metastasis and is downregulated in gastric cancer .	MicroRNA-181a	metastasis	inhibit	negative	gastric cancer	D061325
25712342	Although FOXP3 significantly inhibited breast tumor growth and migration in vitro and metastasis in vivo , FOXP3-induced miR-146a/b contributed only to the inhibition of breast tumor growth .	miR-146a/b	metastasis	inhibit	negative	breast tumor	D001943
25714010	Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway .	microRNA-23a	metastasis	downregulate	negative	prostate cancer	D001943
25714029	miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression .	miR-188	metastasis	inhibit	negative	prostate cancer	D001943
25714029	Restoration of miR-188-5p in PCa cells ( PC-3 and LNCaP ) significantly suppresses proliferation , migration and invasion in vitro and inhibits tumour growth and metastasis in vivo .	miR-188	metastasis	suppress	negative	PCa	D001943
25716201	MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer .	MiR-129	metastasis	regulate	positive	non-small cell lung cancer	D009369
25716682	These findings suggest miR-424 plays distinct roles in tumor progression , potentially facilitating earlier , but repressing later , stages of metastasis by regulating an EMT-MET axis .	miR-424	metastasis	repress	negative	EMT|MET	D009369
25721211	miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells .	miR-15b	metastasis	regulate	positive	lung adenocarcinoma	D001943
25725129	Thus , the results suggest that EF24 suppresses melanoma metastasis via upregulating miR-33b and concomitantly reducing HMGA2 expression .	miR-33b	metastasis	suppress	negative	melanoma	D012878
25729853	Corrigendum. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis .	miR-34a	metastasis	promote	positive	EMT|colorectal cancer	D001943
25731730	Both gain- and loss-of-function studies showed that miR-221/222 regulate cell proliferation , the cell cycle and apoptosis , in addition to , invasion , metastasis , and angiogenesis in glioma cell lines .	miR-221/222	metastasis	regulate	positive	glioma cell	D009369
25742499	miR-186 was over-expressed in PDAC patients compared with controls , especially in patients with large tumors ( > 2 cm ) , lymph node metastasis , or short-term survival ( < 24 months ) .	miR-186	metastasis	control	neutral	PDAC	D009369
25749519	NF-庥B-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10 .	miR-124	metastasis	suppress	negative	non-small-cell lung cancer	D009369
25749519	These results suggest that NF-庥B-regulated miR-124 targets MYO10 , inhibits cell invasion and metastasis , and is down-regulated in node-positive NSCLC .	miR-124	metastasis	inhibit	negative	node-positive NSCLC	D009369
25760058	Thus , for the first time , we provide convincing evidence that downregulation of miR-326 inhibited tumor proliferation and tumor metastasis by directly targeting NOB1 in CRC .	miR-326	metastasis	downregulate	negative	CRC	D001943
25760077	In addition , UCA1 could reverse the inhibitory effect of miR-216b on the growth and metastasis of HCC cells , which might be involved in the derepression of fibroblast growth factor receptor 1 ( FGFR1 ) expression , a target gene of miR-216b , and the activation of ERK signaling pathway .	miR-216b	metastasis	effect	neutral	HCC	D009369
25761878	MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1 .	MicroRNA-26b	metastasis	inhibit	negative	osteosarcoma	D009362
25761878	Furthermore , miR-26b inhibited lung metastasis of osteosarcoma in vivo .	miR-26b	metastasis	inhibit	negative	lung metastasis|osteosarcoma	D009362
25761878	Our data indicated that downregulation of miR-26b in osteosarcoma elevated the levels of CTGF and Smad1 , facilitating osteosarcoma metastasis .	miR-26b	metastasis	downregulate	negative	osteosarcoma	D009362
25762634	HNSCC metastasis was found to be strongly suppressed in vitro and in vivo by over-expressing miR-34a .	miR-34a	metastasis	suppress	negative	HNSCC	D006258
25762634	Taken together , these findings indicate that miR-34a targets AREG , and is essential in inhibition of HNSCC metastasis .	miR-34a	metastasis	inhibit	negative	HNSCC	D006258
25769454	Recently , miR-21 is found to be aberrantly expressed in CRC and miR-21 has been recognized to perform significantly in CRC , where miR-21 can regulate several different target genes and pathways involving tumor proliferation , invasion and metastasis .	miR-21	metastasis	recognize	neutral	CRC	D001943
25773825	Overexpression of mir-196a-5p is associated with lymph node metastasis and clinical stage , and enriched KEGG pathway analyses showed that targeted genes regulated by mir-196a-5p may contribute to tumorgenesis , suggesting roles as an oncogenic miRNA biomarker in gastric cancer .	mir-196a	metastasis	regulate	positive	gastric cancer	D061325
25785020	MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer .	MicroRNA-7	metastasis	inhibit	negative	cervical cancer	D009369
25785020	Ectopic expression of miR-7 significantly inhibited metastasis and invasion in Hela and C33A cells .	miR-7	metastasis	inhibit	negative	C33A cells	D009369
25785020	In conclusion , miR-7 inhibited the metastasis and invasion of cervical cancer at least partially through targeting FAK .	miR-7	metastasis	inhibit	negative	cervical cancer	D009369
25788864	Serum miR-205 was significantly upregulated in cervical cancer patients compared with healthy donors ( p ? < ? 0.01 ) , and a high level of miR-205 expression was correlated with poor tumor differentiation ( p ? = ? 0.009 ) , lymph node metastasis ( p ? = ? 0.015 ) and increased tumor stage ( p ? = ? 0.001 ) .	miR-205	metastasis	upregulate	positive	cervical cancer	D009369
25792283	Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition .	microRNA-205	metastasis	inhibit	negative	triple-negative breast cancer	D009369
25792283	Importantly , pterostilbene suppressed tumor growth and metastasis in MDA-MB-231-bearing NOD/SCID mice by reducing Src/Fak signaling ; this observation was consistent with the negative correlations between miR-205 and Src expression in both normal and malignant breast tissues .	miR-205	metastasis	suppress	negative	malignant breast	D001943
25793370	MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1 .	MiR-506	metastasis	downregulate	negative	renal cell carcinoma	D001943
25793370	Over-expression of miR-506 in renal cancer cells decreased cell growth and metastasis , In contrast , down-regulation of miR-506 expression promoted renal cancer cell growth and metastasis .	miR-506	metastasis	downregulate	negative	renal cancer	D009369
25797260	We found that miR-200a was downregulated in HCC/SP and this was associated metastasis .	miR-200a	metastasis	downregulate	negative	HCC|SP	D009369
25797260	MiR-200a suppressed metastasis of SP cells .	MiR-200a	metastasis	suppress	negative	SP	D009369
25797260	These findings reveal that miR-200a suppresses metastasis of SP cells by downregulating ZEB2 .	miR-200a	metastasis	suppress	negative	SP	D009369
25798833	The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers .	miR-200|miR-183	metastasis	inhibit	negative	lung cancers	D009369
25798833	We , therefore , identified a novel mechanism whereby the miR-200 family and the miR-183~96~182 cluster inhibit lung cancer invasion and metastasis by targeting Foxf2 .	miR-200|miR-183	metastasis	inhibit	negative	lung cancer	D009369
25798837	Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis .	miR-193b	metastasis	downregulate	negative	ovarian cancer	D001943
25798837	Using a three-dimensional culture model that mimics the human omentum , one of the principal sites of OvCa metastasis , we identified and characterized the microenvironment-induced downregulation of a tumor suppressor miRNA , miR-193b , in metastasizing OvCa cells .	miR-193b	metastasis	downregulate	negative	OVCA	D009369
25799050	Consistently , stable over-expression of miR-30c inhibited the growth and lung metastasis of colon cancer cell xenografts in vivo .	miR-30c	metastasis	inhibit	negative	lung metastasis|colon cancer	D001943
25802280	Ectopic miR-1 expression inhibited extracellular signal-regulated kinase ( ERK ) signaling and bone metastasis in a xenograft model .	miR-1	metastasis	inhibit	negative	bone metastasis	D001859
25803820	MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo .	MiR-20a	metastasis	promote	positive	cervical cancer	D009369
25803820	In this study , we detected the relationship between miR-20a and the development of cervical cancer by qRT-PCR , we found that the expression level of miR-20a was significantly higher in cervical cancer patients than in normal controls , the aberrant expression of miR-20a was correlated with lymph node metastasis , histological grade and tumor diameter .	miR-20a	metastasis	control	neutral	cervical cancer	D009369
25804630	MiR-224 expression increases consistently with tumour burden and microsatellite stable status , and miR-224 enhances CRC metastasis in vitro and in vivo .	MiR-224|miR-224	metastasis	enhance	positive	CRC	D001943
25804630	MiR-224 promotes CRC metastasis , at least in part , through the regulation of SMAD4 .	MiR-224	metastasis	promote	positive	CRC	D001943
25805931	MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis .	MicroRNA-1290	metastasis	promote	positive	esophageal squamous cell carcinoma cell	D009369
25811077	Western blot was used to identify the potential signaling pathways that had an impact on RCC cell growth and alterations of markers for epithelial-mesenchymal transition ( EMT ) , which affected metastasis by miR-134 .	miR-134	metastasis	affect	neutral	epithelial-mesenchymal transition ( EMT )	D009369
25812647	The serum expression of miR-218 is downregulated in esophageal cancer patients and is correlated with tumor differentiation , stage , and lymph node metastasis .	miR-218	metastasis	downregulate	negative	esophageal cancer	D009369
25812680	The downregulation of miR-518a-3p was associated with tumor size , distant metastasis and TNM stage in the patients with CRC .	miR-518a	metastasis	downregulate	negative	CRC	D001943
25816323	MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma .	MiR-145	metastasis	inhibit	negative	nasopharyngeal carcinoma	D009369
25818666	These results suggest that miR-709 may positively regulate invasion and metastasis of HCC through targeting GPC5 .	miR-709	metastasis	regulate	positive	HCC	D009369
25818799	miR-200a plays a role in regulating the invasiveness and metastasis of CRC , and overexpression of miR-200a causes a significant reduction of cell proliferation and migration and promotes apoptosis and cell-cell adhesion in LoVo cells .	miR-200a	metastasis	regulate	positive	CRC	D001943
25823925	MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1 .	MiR-195	metastasis	suppress	negative	osteosarcoma	D009362
25823925	It was showed that over-expression of miR-195 substantially inhibits migration and invasion of osteosarcoma cells in vitro and pulmonary metastasis formation in vivo .	miR-195	metastasis	inhibit	negative	osteosarcoma	D009362
25823925	In summary , our study suggests miR-195 functions as a tumor metastasis suppressor gene by down-regulating CCND1 and can be used as a potential target in the treatment of osteosarcoma .	miR-195	metastasis	downregulate	negative	osteosarcoma	D009362
25825239	Downregulation of Sprouty homolog ? 2 by microRNA-21 inhibits proliferation , metastasis and invasion , however promotes the apoptosis of multiple myeloma cells .	microRNA-21	metastasis	downregulate	negative	multiple myeloma	D012878
25825239	The aim of the present study was to assess the effects of sprouty homolog 2 ( SPRY2 ) gene regulation by miR-21 on the occurrence , development and tumor metastasis in multiple myeloma ( MM ) .	miR-21	metastasis	regulate	positive	multiple myeloma ( MM )	D012878
25827073	Here we showed that abnormal activation of miR-21/CDK5 axis was associated with breast cancer lymph node metastasis , which was also contribute to high dose taxol-induced invasion and epithelial mesenchymal transition ( EMT ) in both breast cancer cell line MDA-MB-231 and glioblastoma cell line U87VIII .	miR-21/CDK	metastasis	activate	positive	breast cancer|epithelial mesenchymal transition ( EMT )|glioblastoma	D001943
25833338	To explore the molecular mechanisms by which miR-193a-3p inhibited NSCLC metastasis , we investigated the changes in the protein profile of SPC-A-1sci ( highly metastatic ) cells in response to the up-regulation of miR-193a-3p expression using a proteomics approach ( iTRAQ combined with NanoLC-MS/MS ) .	miR-193a	metastasis	inhibit	negative	NSCLC	D009369
25833338	miR-193a-3p inhibited the metastasis of lung cancer cells by deregulating the expression of tumor-related proteins .	miR-193a	metastasis	inhibit	negative	lung cancer	D009369
25844955	miR-126 is important for endothelial cell signaling and promotes angiogenesis , protects against atherosclerosis , and reduces breast cancer cell growth and metastasis .	miR-126	metastasis	promote	positive	breast cancer cell	D001943
25846246	miR-154 expression levels were significantly downregulated in the NSCLC compared to the corresponding non-cancerous lung tissues ( P < 0.05 ) , and decreased miR-154 expression was significantly associated with metastasis ( P < 0.001 ) , larger tumor size ( P < 0.001 ) and advanced TNM stage ( P < 0.001 ) .	miR-154	metastasis	downregulate	negative	NSCLC|TNM stage	D009369
25846734	In our study , we firstly found that the expression level of miR-335 was significantly downregulated in ccRCC tissues versus corresponding non-tumor tissues and the low expression of miR-335 was significantly associated with lymph node metastasis , larger tumor size , and poor T stage .	miR-335	metastasis	downregulate	negative	ccRCC	D009369
25854173	Our study supports the view that the miR-144 may regulate Ezrin protein expression by inhibiting the invasion and metastasis of osteosarcoma cells .	miR-144	metastasis	regulate	positive	osteosarcoma	D009362
25856297	miR-615-5p overexpression inhibited pancreatic cancer cell proliferation , migration , and invasion in vitro , and tumor growth and metastasis in vivo .	miR-615	metastasis	inhibit	negative	pancreatic cancer	D001943
25858144	Functional studies revealed that overexpression of miR-25 in prostate cancer cell lines and selected subpopulation of highly metastatic and tumorigenic cells ( ALDH ( high ) ) strongly affected the invasive cytoskeleton , causing reduced migration in vitro and metastasis via attenuation of extravasation in vivo .	miR-25	metastasis	affect	neutral	prostate cancer	D001943
25862551	Our results suggest microRNA involvement in malignant pituitary progression , whereby increased miR-20a , miR-106b and miR-17-5p promote metastasis by attenuating PTEN and TIMP2 in pituitary carcinoma .	miR-20a|miR-106b|miR-17	metastasis	promote	positive	PTEN	D009369
25863127	miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients .	miR-29c	metastasis	suppress	negative	pancreatic cancer	D001943
25863127	Overexpression of miR-29c suppresses pancreatic cancer liver metastasis in a nude mouse orthotopic implantation model .	miR-29c	metastasis	suppress	negative	pancreatic cancer	D001943
25863127	miR-29c plays an important role in mediating pancreatic cancer metastasis to the liver by targeting MMP2 .	miR-29c	metastasis	mediate	neutral	pancreatic cancer	D001943
25867271	Functional studies showed that miR-367 promoted pancreatic cancer invasion in vitro and metastasis in vivo through downregulating Smad7 .	miR-367	metastasis	promote	positive	pancreatic cancer	D001943
25868853	Cordycepin ( 3'-deoxyadenosine ) suppressed HMGA2 , Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b .	miR-33b	metastasis	suppress	negative	melanoma	D012878
25868853	We showed for the first time that targeting miRNA by cordycepin indicates a new mechanism of cordycepin-induced suppression of tumor metastasis and miR-33b/HMGA2/Twist1/ZEB1 axis plays critical roles in regulating melanoma dissemination .	miR-33b/HMGA	metastasis	suppress	negative	melanoma	D012878
25868860	The SOX17/miR-371-5p/SOX2 axis inhibits EMT , stem cell properties and metastasis in colorectal cancer .	miR-371	metastasis	inhibit	negative	colorectal cancer	D001943
25869101	microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer .	microRNA-217	metastasis	inhibit	negative	gastric cancer	D061325
25872451	Here we show that miR-1269a promotes colorectal cancer ( CRC ) metastasis and forms a positive feedback loop with TGF-?] signalling .	miR-1269a	metastasis	promote	positive	colorectal cancer ( CRC )	D001943
25872451	miR-1269a is upregulated in late-stage CRCs , and long-term monitoring of 100 stage II CRC patients revealed that miR-1269a expression in their surgically removed primary tumours is strongly associated with risk of CRC relapse and metastasis .	miR-1269a	metastasis	upregulate	positive	CRCs|CRC	D001943
25873390	Moreover , we observed that miR-96-182-183 promoted EMT and invasion by directly and simultaneously suppressing BRMS1L ( breast cancer metastasis suppressor 1-like ) gene expression .	miR-96	metastasis	promote	positive	EMT|breast cancer metastasis	D001943
25874488	MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer .	MicroRNA-15a	metastasis	induce	positive	non-small cell lung cancer	D009369
25874772	First , wound healing and Transwell assays revealed that miR-29b/c suppresses tumor metastasis in GC .	miR-29b/c	metastasis	suppress	negative	GC	D061325
25877755	MiRNA-494 inhibits metastasis of cervical cancer through Pttg1 .	MiRNA-494	metastasis	inhibit	negative	cervical cancer	D009369
25877755	Together , our data suggest that Pttg1 may increase CC cell metastasis , which is negatively regulated by miR-494 .	miR-494	metastasis	regulate	positive	CC	D009369
25879117	Retraction Notice to : A Pleiotropically Acting MicroRNA , miR-31 , Inhibits Breast Cancer Metastasis .	miR-31	Metastasis	inhibit	negative	Breast Cancer Metastasis	D001943
25880458	miR-372 was expressed at lower levels in HCC tissues compared with controls and was related to tumor metastasis and poor prognosis .	miR-372	metastasis	control	neutral	HCC	D009369
25884389	We aimed to investigate the function and mechanism of let-7a in nasopharyngeal carcinoma metastasis and clarified the regulation of high mobility group A2 ( HMGA2 ) by let-7a .	let-7a	metastasis	regulate	positive	nasopharyngeal carcinoma	D009369
25887170	The up-regulation of miRNA-1307 was not associated with menopause , tumor differentiation state , clinical stage , and lymph node metastasis of ovarian cancer .	miRNA-1307	metastasis	upregulate	positive	ovarian cancer	D001943
25889078	Wound healing and Transwell assays revealed that miR-29a-3p suppressed tumor metastasis in GC .	miR-29a	metastasis	suppress	negative	GC	D061325
25890121	Transient forced expression of miR-203 inhibited renal cancer cell growth and metastasis ( P ? < ? 0.05 ) .	miR-203	metastasis	inhibit	negative	renal cancer	D009369
25890121	In contrast , down-regulation of miR-203 expression promoted renal cancer cell growth and metastasis ( P ? < ? 0.05 ) .	miR-203	metastasis	downregulate	negative	renal cancer	D009369
25906011	Mechanistically , CARMA3 promoted cell motility by reducing the level of NME2 through the NF-庥B/miR-182 pathway and by increasing cancer stem cell properties and metastasis in lung cancer .	miR-182	metastasis	promote	positive	lung cancer	D009369
25906011	We identified a novel mechanism of CARMA3 in lung cancer stemness and metastasis through the negative regulation of NME2 by NF-庥B-dependent induction of miR-182 .	miR-182	metastasis	regulate	positive	lung cancer	D009369
25909223	MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis .	MiR-200b/200c	metastasis	regulate	positive	hepatocellular carcinoma	D009369
25909223	Re-expression of miR-200b significantly suppressed lung metastasis of HCC cells in an orthotopic liver implantation model in vivo .	miR-200b	metastasis	suppress	negative	HCC	D009369
25912304	MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2 .	MicroRNA-144	metastasis	suppress	negative	osteosarcoma	D009362
25912876	MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1 .	MicroRNA-129	metastasis	inhibit	negative	hepatocellular carcinoma	D009369
25919570	MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2 , SALL4 and Twist1 .	MicroRNA-33b	Metastasis	inhibit	negative	Breast Cancer Metastasis	D001943
25919570	Here , we report the identification of miR-33b as a negative regulator of cell stemness and metastasis in breast cancer .	miR-33b	metastasis	regulate	positive	breast cancer	D001943
25919570	Ectopic overexpression of miR-33b in highly metastatic breast cancer cells suppresses cell self-renewal , migration and invasion in vitro and inhibits lung metastasis in vivo .	miR-33b	metastasis	suppress	negative	breast cancer cells|lung metastasis	D001943
25919570	These data indicate that miR-33b acts as an onco-suppressive microRNA in breast cancer progression by inhibiting the stemness and metastasis of breast cancer cells .	miR-33b	metastasis	inhibit	negative	breast cancer|breast cancer cells	D001943
25924850	MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3 .	MiR-320a	metastasis	inhibit	negative	adenoid cystic carcinoma	D009369
25924850	MiR-320a inhibits metastasis in SACCs by targeting ITGB3 and may serve as a therapeutic target and prognostic marker in salivary cancers .	MiR-320a	metastasis	inhibit	negative	salivary cancers	D009369
25926384	MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition .	MiR-497	metastasis	promote	positive	colorectal cancer	D001943
25927670	MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression .	MicroRNA-144	metastasis	inhibit	negative	gastric cancer	D061325
25927670	Reintroduction of miR-144 expression in GC cells presents an attractive therapeutic approach to block the metastasis of gastric cancer .	miR-144	metastasis	block	negative	GC|gastric cancer	D061325
25931210	However , whether miR-429 plays a role in regulating metastasis of hepatocellular carcinoma is still unclear .	miR-429	metastasis	regulate	positive	hepatocellular carcinoma	D009369
25931210	In summary , our results here defined miR-429 as a key inducer for HCC pathogenesis and metastasis with potential utility for tumor intervention .	miR-429	metastasis	induce	positive	HCC	D009369
25932114	MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6 .	MicroRNA-506	metastasis	suppress	negative	oral squamous cell carcinoma	D009369
25933027	Studies have demonstrated that microRNA 106b ( miR-106b ) may be a promising therapeutic target for inhibiting breast cancer bone metastasis , but the role of miR-106b in EOC is largely unknown .	miR-106b	metastasis	inhibit	negative	breast cancer|bone metastasis	D001943
25934693	miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer .	miR-19	Metastasis	inhibit	negative	Colorectal Cancer	D001943
25934693	Chromosome-13 amplification in advanced colorectal cancer contributes to invasion and metastasis by upregulating miR-19 , which targets TG2 .	miR-19	metastasis	amplify	positive	colorectal cancer	D001943
25935837	Recent studies have indicated that miR-330-3p expression is up-regulated in NSCLC samples and in tissues of NSCLC brain metastasis .	miR-330	metastasis	upregulate	positive	NSCLC|brain metastasis	D009369
25952770	In vivo data further revealed that cisplatin induced miR-638 upregulation in the serum derived from mice xenograft models , and in NSCLC patient sera , miR-638 expression patterns after chemotherapy significantly correlated with lymph node metastasis .	miR-638	metastasis	induce	positive	NSCLC	D009369
25953723	MicroRNA-429 suppresses cell proliferation , epithelial-mesenchymal transition , and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma .	MicroRNA-429	metastasis	suppress	negative	epithelial-mesenchymal transition|renal cell carcinoma	D001943
25953723	The aim of this study was to investigate the potential role of miR-429 in regulating growth and metastasis of renal cell carcinoma .	miR-429	metastasis	regulate	positive	renal cell carcinoma	D001943
25953723	miR-429 expression was stably up-regulated or down-regulated in the renal cell carcinoma ACHN and A498 cell lines , and cell proliferation and metastasis were assessed .	miR-429	metastasis	upregulate	positive	renal cell carcinoma	D001943
25953743	Most important , the therapeutic delivery of synthetic miR-125b mimics decreased the target molecule of CSC and inhibited metastasis in the mice model .	miR-125b	metastasis	inhibit	negative	CSC	D009369
25955685	Thus , we concluded that miR-206 inhibited invasion and metastasis by degrading MRTF-A in anaplastic thyroid cancer .	miR-206	metastasis	inhibit	negative	anaplastic thyroid cancer	D009369
25955794	MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B .	MicroRNA-216a	metastasis	inhibit	negative	oral squamous cell carcinoma	D009369
25961434	MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5 .	MiR-744	metastasis	control	neutral	nasopharyngeal carcinoma	D009369
25961434	In this study , we found that miR-744 expression was upregulated in NPC specimens compared to nasopharyngeal epithelium ( NPE ) tissue , and miR- 744 upregulation was significantly associated with TNM stage , tumorigenesis and metastasis .	miR-744	metastasis	upregulate	positive	NPC|TNM stage	D009369
25961913	Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis .	miR550a	metastasis	regulate	positive	colorectal cancer	D001943
25961913	Here we demonstrated that decreased Brg-1 regulates a novel miR-550a-5p/RNF43/Wnt/?] -catenin signaling pathway , to promote CRC metastasis in vitro and in vivo .	miR-550a	metastasis	regulate	positive	CRC	D001943
25962395	The upregulation of urinary miR-30a-5p was closely associated with early stage of ovarian serous adenocarcinoma as well as lymphatic metastasis .	miR-30a	metastasis	upregulate	positive	ovarian serous adenocarcinoma	D009369
25962939	miR-433 inhibits oral squamous cell carcinoma ( OSCC ) cell growth and metastasis by targeting HDAC6 .	miR-433	metastasis	inhibit	negative	oral squamous cell carcinoma ( OSCC )	D009369
25964059	It was concluded that hsa-miR-665 and hsa-miR-95 were downregulated in GSRCC but upregulated in intestinal gastric adenocarcinoma , and the relatively differential expression of the miRNAs negatively controlling their target genes could be closely related to the high invasive metastasis and chemoresistance of GSRCC .	miR-665|miR-95	metastasis	downregulate	negative	gastric adenocarcinoma	D009369
25965817	MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1 .	MiR-361	metastasis	inhibit	negative	colorectal|gastric cancer	D061325
25965817	Most interestingly , in vivo studies showed that restoration of miR-361-5p significantly inhibited tumor growth and especially the lung metastasis in nude mice .	miR-361	metastasis	inhibit	negative	lung metastasis	D009362
25972084	Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73 .	mir-200a/b	metastasis	suppress	negative	epithelial-mesenchymal transition|breast cancer cells	D001943
25972084	Taken together , our results suggest that Restin inhibits EMT and tumor metastasis by controlling the expression of the tumor metastasis suppressor mir-200a/b via association with p73 .	mir-200a/b	metastasis	inhibit	negative	EMT	D009369
25973020	Next , it was showed that miR-34a overexpression in oral cancer cells could inhibit cell proliferation , G1 phase arrest , metastasis and epithelial mesenchymal transition .	miR-34a	metastasis	inhibit	negative	oral cancer	D009369
25973090	Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer .	microRNA-124	metastasis	downregulate	negative	lung cancer	D009369
25973137	miR-27a promotes cell proliferation and metastasis in renal cell carcinoma .	miR-27a	metastasis	promote	positive	renal cell carcinoma	D001943
25973317	The microRNA-520a-3p inhibits proliferation , apoptosis and metastasis by targeting MAP3K2 in non-small cell lung cancer .	microRNA-520a	metastasis	inhibit	negative	non-small cell lung cancer	D009369
25973317	Inhibition of expression of miR-520a-3p can reduce in vitro NSCLC cell migration and invasion as well as in vivo metastasis .	miR-520a	metastasis	inhibit	negative	NSCLC	D009369
25973317	Together , our data demonstrated that miR-520a-3p inhibits proliferation , apoptosis and metastasis in NSCLC by targeting MAP3K2 , and miR-520a-3p may be used as a prognosis marker for NSCLC in clinical research .	miR-520a	metastasis	inhibit	negative	NSCLC	D009369
25973950	MiR-182 might act as a tumor suppressor gene whose down-regulation contributes to the progression and metastasis of osteosarcoma , providing a potential therapy target for osteosarcoma patients .	MiR-182	metastasis	downregulate	negative	osteosarcoma	D009362
25980442	Together , these data suggest that TR4 may increase PCa metastasis via a newly identified signal and targeting these TR4/miR-473-3p/TGF?] R2/p-Smad3 signals using TR4 antagonist or TR4-siRNA or miR-373-3p may allow us to develop a new potential therapeutic approach to better suppress PCa metastasis .	miR-473|miR-373	metastasis	antagonize	negative	PCa	D001943
25986864	LncRNA-ATB plays an important role in EMT to promote invasion and metastasis through the TGF-?] /miR-200s/ZEB axis , resulting in a poor prognosis in GC .	miR-200s/ZEB	metastasis	promote	positive	GC	D061325
25987019	PU.1 Is Identified as a Novel Metastasis Suppressor in Hepatocellular Carcinoma Regulating the miR-615-5p/IGF2 Axis .	miR-615	Metastasis	regulate	positive	Hepatocellular Carcinoma	D009369
25991553	The induction of the miR-302/367 cluster in U87MG glioblastoma cells suppresses the expression of multiple transformation related genes , abolishes the tumor and metastasis formation potential of these cells and can potentially become a new approach for cancer therapy .	miR-302/367	metastasis	induction	positive	glioblastoma	D009369
25991585	MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression .	MicroRNA-409	metastasis	suppress	negative	colorectal cancer	D001943
25991585	MiR-409-3p expression was significantly downregulated in CRC tissue compared to adjacent non-tumor tissue , and reduced miR-409-3p expression was correlated with CRC metastasis .	MiR-409|miR-409	metastasis	downregulate	negative	CRC	D001943
25991585	In vitro and in vivo studies revealed that miR-409-3p negatively regulated CRC metastatic capacities , including suppressing cancer cell migration , invasion and metastasis .	miR-409	metastasis	regulate	positive	CRC	D001943
25997961	miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK .	miR-1271	metastasis	inhibit	negative	OSCC	D009369
25998163	MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma .	MicroRNA-188	metastasis	suppress	negative	hepatocellular carcinoma	D009369
25998163	Ectopic expression of miR-188-5p suppressed HCC cell proliferation and metastasis in vitro and in vivo .	miR-188	metastasis	suppress	negative	HCC	D009369
25998163	Enforced expression of miR-188-5p inhibited the expression of FGF5 significantly and the restoration of FGF5 expression reversed the inhibitory effects of miR-188-5p on HCC cell proliferation and metastasis .	miR-188	metastasis	inhibit	negative	HCC	D009369
25999024	MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1 .	MicroRNA-218	metastasis	inhibit	negative	esophageal squamous cell carcinoma	D009369
25999024	Furthermore , the decreased expression of miR-218 was found to be associated with an enhanced ESCC cell proliferation and metastasis .	miR-218	metastasis	enhance	positive	ESCC	D009369
26010911	Correction : MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1 .	MiR-506	Metastasis	inhibit	negative	Clear Cell Renal Cell Carcinoma	D001943
26013170	miR-181a Targets RGS16 to Promote Chondrosarcoma Growth , Angiogenesis , and Metastasis .	miR-181a	Metastasis	promote	positive	Chondrosarcoma	D009369
26013170	Therapeutic inhibition of miR-181a decreased expression of VEGF and MMP1 in vitro , and angiogenesis , MMP1 activity , tumor growth , and lung metastasis , all by more than 50 % , in a xenograft mouse model .	miR-181a	metastasis	inhibit	negative	lung metastasis	D009362
26013170	Targeting miR-181a can inhibit tumor angiogenesis , growth , and metastasis , thus suggesting the possibility of antagomir-based therapy in chondrosarcoma .	miR-181a	metastasis	inhibit	negative	chondrosarcoma	D009369
26019213	The influence of miR-218 on its putative target genes ( POU2F2 , ROBO1 and IKK-?] ) and GC metastasis was further explored via in vitro and in vivo approaches .	miR-218	metastasis	influence	neutral	GC	D061325
26019213	Finally , miR-218 was found to suppress GC metastasis by simultaneously mediating multiple molecules in the POU2F2-oriented network .	miR-218	metastasis	suppress	negative	GC	D061325
26019213	Blocking the activation of the POU2F2-oriented metastasis network using miR-218 precursors exemplified a promising approach that sheds light on new strategies for GC treatment .	miR-218	metastasis	block	negative	GC	D061325
26022123	The purpose of this study was to determine the role of miR-139-5p in regulation of epithelial-mesenchymal transition ( EMT ) and metastasis of HCC cells .	miR-139	metastasis	regulate	positive	epithelial-mesenchymal transition ( EMT )|HCC	D009369
26028030	Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer .	miRNA-181a	metastasis	induction	positive	breast cance	D001943
26028030	Here we show that genotoxic treatments significantly increased the expression of miR-181a in TNBC cells , which enhanced TNBC cell survival and metastasis upon Doxorubicin treatment .	miR-181a	metastasis	enhance	positive	TNBC	D009369
26028030	These results were further confirmed by evidence that suppression of miR-181a significantly enhanced therapeutic response and reduced lung metastasis in a TNBC orthotopic model .	miR-181a	metastasis	suppress	negative	TNBC	D009369
26028030	Antagonizing miR-181a may serve as a promising strategy to sensitize TNBC cells to chemotherapy and mitigate metastasis .	miR-181a	metastasis	antagonize	negative	TNBC	D009369
26029740	Thus , miR-506 possesses a multitasking property in the suppression of EMT and metastasis and thus may represent a promising tool in cancer therapeutics .	miR-506	metastasis	suppress	negative	EMT	D009369
26032086	miR-21 is already known as an oncogenic miRNA to promote metastasis , however , the exact functions of other three miRNAs in EMT are unclear .	miR-21	metastasis	promote	positive	EMT	D009369
26032086	To our surprise , we found that miR-148a , miR-505 , and miR-1207-5p can suppress EMT and metastasis phenotypes in HK-1 cells both in vitro and in vivo , which may relate to their inhibition on EMT and Wnt signaling molecules .	miR-148a|miR-505|miR-1207	metastasis	suppress	negative	EMT	D009369
26034994	The results showed that miR-491-5p expression was significantly downregulated in cervical cancer tissues when compared with the corresponding adjacent normal tissues ( P < 0.001 ) , and the value was negatively associated with advanced International Federation of Gynecology and Obstetrics ( FIGO ) stage , high histological grading and lymph node metastasis ( P < 0.01 ) .	miR-491	metastasis	downregulate	negative	cervical cancer	D009369
26036633	MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis .	MiR-1	metastasis	downregulate	negative	clear cell renal cell carcinoma	D001943
26036633	Functional study demonstrated that enforced overexpression of miR-1 in renal cancer cells inhibited proliferation and metastasis in vitro and in vivo .	miR-1	metastasis	inhibit	negative	renal cancer	D009369
26036633	Conversely , miR-1 inhibitor silencing miR-1 expression promoted cell proliferation and metastasis in ccRCC .	miR-1	metastasis	promote	positive	ccRCC	D009369
26047679	Gain- and loss-of-function studies demonstrated that miR-584-5p suppressed the growth , invasion , metastasis , and angiogenesis of NB cells in vitro and in vivo .	miR-584	metastasis	suppress	negative	NB	D009369
26054676	We found that miR-485-5p was significantly downregulated in HCC tissues and that its expression was inversely correlated with the TNM stage and metastasis in HCC samples .	miR-485	metastasis	downregulate	negative	HCC|TNM stage	D009369
26054676	Results of cellular functions in HCC showed that miR-485-5p could inhibit cell proliferation and metastasis .	miR-485	metastasis	inhibit	negative	HCC	D009369
26059417	Our data describing pathways regulated by tumor-suppressive microRNA-205 provide new insights into the potential mechanisms of prostate cancer oncogenesis and metastasis .	microRNA-205	metastasis	regulate	positive	prostate cancer	D001943
26059632	MiR-506 Over-Expression Inhibits Proliferation and Metastasis of Breast Cancer Cells .	MiR-506	Metastasis	inhibit	negative	Breast Cancer Cells	D001943
26063204	Taken together , our results demonstrate that miR-29b serves as a tumor metastasis suppressor , which suppresses NSCLC cell metastasis by directly inhibiting MMP2 expression .	miR-29b	metastasis	suppress	negative	NSCLC	D009369
26064276	In colorectal cancer , has-miR-195 can promote cell apoptosis and inhibit the invasion and metastasis by inhibiting the expression of Bcl-2 .	miR-195	metastasis	promote	positive	colorectal cancer	D001943
26065676	In this study , we found that miR-199a down-regulation was associated with the CRC and metastasis incidence .	miR-199a	metastasis	downregulate	negative	CRC	D001943
26068592	The upregulation of fibronectin and lysyl oxidase directly by miR-200 or indirectly through Fli-1 or TCF12 contributed to ECM remodeling , triggering the invasion and metastasis of breast cancer cells both in vitro and vivo .	miR-200	metastasis	upregulate	positive	breast cancer cells	D001943
26070602	Orthotopic xenografts of breast cancer cells were used to assess the effect of miR-184 on tumourigenesis as well as distant metastasis .	miR-184	metastasis	effect	neutral	breast cancer cells	D001943
26071255	EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1 .	miR-1	Metastasis	promote	positive	Prostate Cancer|Bone Metastasis	D001943
26071255	Our findings support a model in which nuclear EGFR acts as a transcriptional repressor to constrain the tumor-suppressive role of miR-1 and sustain oncogenic activation of TWIST1 , thereby leading to accelerated bone metastasis .	miR-1	metastasis	repress	negative	EGFR	D009369
26074491	Our data showed that the expression of miR-1246 was dramatically decreased in cervical cancer tissue , compared with normal control group ( p=0.0012 ) , and miR-1246 was negatively correlated with clinical stage and HPV16E6 infected status ( p=0.0410 ) , but no correlation was observed with age , tumor diameter , cervical invasion depth , lymph node metastasis , or vascular invasion ( p > 0.05 ) .	miR-1246	metastasis	control	neutral	cervical cancer	D009369
26075299	Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis .	miR-206	metastasis	inhibit	negative	MET|lung cancer	D009369
26075299	Furthermore , MET gene silence showed a similar anti-migration and anti-invasion effect with miR-206 mimics in 95D cells and could partially attenuate the migration- and invasion-promoting effect of miR-206 inhibitors in 95C cells , suggesting that miR-206 targets MET in lung cancer metastasis .	miR-206	metastasis	effect	neutral	MET|lung cancer	D009369
26075299	Finally , we also demonstrated that miR-206 can significantly inhibit lung cancer proliferation and metastasis in mouse models .	miR-206	metastasis	inhibit	negative	lung cancer	D009369
26075299	In conclusion , our study provided a miRNA-gene regulatory network in lung cancer metastasis and further demonstrated the roles of miR-206 and MET in this process , which enhances the understanding of the regulatory mechanism in lung cancer metastasis .	miR-206	metastasis	enhance	positive	lung cancer	D009369
26080838	miR-195 downregulation in prostate cancer tissues was significantly associated with high Gleason score ( P = 0.001 ) , positive metastasis failure ( P < 0.001 ) , and biochemical recurrence ( BCR , P < 0.001 ) .	miR-195	metastasis	downregulate	negative	prostate cancer	D001943
26084278	Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer : an indication for personalized medicine .	microRNA-409	metastasis	downregulate	negative	colorectal cancer	D001943
26084278	Ectopic expression of miRNA mimics suggested that miR-409-3p could inhibits the abilities of proliferation , wound healing , metastasis and invasion in CRC cells .	miR-409	metastasis	inhibit	negative	CRC	D001943
26084278	Our results suggest that miR-409-3p functions as a tumor suppressor by inhibiting the development and metastasis of CRC , suggesting that miR-409-3p is expected to become a new diagnostic marker and a new target of the treatment of CRC .	miR-409	metastasis	inhibit	negative	CRC	D001943
26084291	Gain- and loss-of-function studies demonstrated that miR-337-3p suppressed the growth , invasion , metastasis , and angiogenesis of NB cells in vitro and in vivo .	miR-337	metastasis	suppress	negative	NB	D009369
26091352	We previously reported that IL-6R , STAT3 and miR-34a form a positive feedback-loop , which promotes epithelial to mesenchymal transition ( EMT ) , invasion , and metastasis of colorectal cancer ( CRC ) [ 1 ] .	miR-34a	metastasis	promote	positive	epithelial to mesenchymal transition ( EMT )|colorectal cancer ( CRC )	D001943
26097565	miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN .	miR-106a	metastasis	promote	positive	non-small cell lung cancer	D009369
26097565	Overall , this study suggested that miR-106a inhibited the growth and metastasis of NSCLC cells by decreasing PTEN expression .	miR-106a	metastasis	inhibit	negative	NSCLC	D009369
26098771	The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer .	miR-21	metastasis	regulate	positive	breast cancer	D001943
26101708	miR-30c has been reported to act as a tumor suppressor and negatively regulate cancer metastasis by directly targeting metastasis associated genes ; however , miR-30c has also been shown to promote the invasion of metastatic breast cancer cells , suggesting that miR-30c might be involved in cancer cell metastasis in different ways via targeting different genes .	miR-30c	metastasis	regulate	positive	breast cancer cells	D001943
26101709	SP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1 .	microRNA-520d	metastasis	suppress	negative	colorectal cancer	D001943
26101709	In conclusion , our findings indicate that miR-520d-5p is significantly down-expressed and involved in CRC progression and metastasis by targeting CTHRC1 and regulated by SP1 , which provide new support for miR-520d-5p maybe as a novel anti-onco molecular target for the treatment of CRC in the future .	miR-520d	metastasis	regulate	positive	CRC	D001943
26102366	In conclusion , the miR-137 which is frequently down-regulated in gastric cancer is potentially involved in gastric cancer tumorigenesis and metastasis by regulating AKT2 related signal pathways .	miR-137	metastasis	downregulate	negative	gastric cancer	D061325
26103003	Moreover , ectopic miR-34a suppressed tumor growth and metastasis of CRC cells in vivo .	miR-34a	metastasis	suppress	negative	CRC	D001943
26103953	miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12 .	miR-448	metastasis	regulate	positive	ovarian cancer	D001943
26116372	MiR-21 is an oncomiR that affects critical target genes of malignant melanoma , resulting in sustained proliferation ( PTEN , PI3K , Sprouty , PDCD4 , FOXO1 , TIPE2 , p53 , cyclin D1 ) , evasion from apoptosis ( FOXO1 , FBXO11 , APAF1 , TIMP3 , TIPE2 ) , genetic instability ( MSH2 , FBXO11 , hTERT ) , increased oxidative stress ( FOXO1 ) , angiogenesis ( PTEN , HIF1帢 , TIMP3 ) , invasion and metastasis ( APAF1 , PTEN , PDCD4 , TIMP3 ) .	MiR-21	metastasis	affect	neutral	malignant melanoma	D012878
26134491	We found that the expression level of miR ? 133a was significantly downregulated in cervical cancer tissues and cervical cancer cell lines , and the aberrant expression of miR-133a was correlated with lymph node metastasis , histological grade and FIGO ? stage .	miR-133a	metastasis	downregulate	negative	cervical cancer	D009369
26134825	The effects of miR-204-5p on glioma cell growth and metastasis were examined by overexpressing or inhibiting miR-204-5p .	miR-204	metastasis	inhibit	negative	glioma cell	D009369
26134929	miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin ? 11 expression and may serve as a prognostic marker .	miR-99b	metastasis	promote	positive	hepatocellular carcinoma	D009369
26134929	Overexpression or knockdown of miR-99b expression increased or inhibited , respectively , the metastasis of HCC cells in ? vitro .	miR-99b	metastasis	inhibit	negative	HCC	D009369
26136868	microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo .	microRNA-425	metastasis	upregulate	positive	gastric cancer	D061325
26136868	In the in vivo studies , downregulation of miR-425-5p expression suppressed pulmonary metastasis in the nude mice .	miR-425	metastasis	downregulate	negative	pulmonary metastasis	D001943
26152520	Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas .	miR-372	metastasis	upregulate	positive	oral carcinomas	D009369
26156803	We find that miR-133a was downregulated in HCC tissues and cell lines and that miR-133a expression negatively correlated with tumor differentiation ( P ? < ? 0.01 ) , TNM stage ( P ? < ? 0.01 ) , and lymph node metastasis ( P ? < ? 0.01 ) .	miR-133a	metastasis	downregulate	negative	HCC|TNM stage	D009369
26158514	miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2 .	miR-612	metastasis	regulate	positive	colorectal cancer	D001943
26159827	Restoration of miR-146a in SCC25 and UMSCC1 cells decreased in vitro invasive activity , suppressed tumor growth in vivo , and decreased the incidence of UMSCC1 lung metastasis .	miR-146a	metastasis	suppress	negative	lung metastasis	D009362
26163260	miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1 .	miR-503	metastasis	suppress	negative	hepatocellular carcinoma	D009369
26163260	In the present study , we report that miR-503 suppresses cell metastasis in HCC through targeting the protein arginine methyl transferase 1 ( PRMT1 ) mRNA .	miR-503	metastasis	suppress	negative	HCC	D009369
26164082	Importantly , miR-451 could inhibit the migration and invasion in vitro , as well as in vivo metastasis of HCC cells through regulating EMT process .	miR-451	metastasis	inhibit	negative	HCC|EMT	D009369
26164082	Collectively , these data demonstrated that miR-451 is a novel prognostic biomarker for HCC patients and that function as a potential metastasis inhibitor in HCC cells through activation of the Erk1/2 signaling , at least partially by targeting c-Myc .	miR-451	metastasis	activate	positive	HCC	D009369
26166821	Finally , transfection of a miR-324-5p mimic inhibited the suppression of invasion and metastasis of MDA-MB-231 and 4T1 cell by sinomenine , providing evidence that sinomenine treatment suppressed breast cancer cell invasion and metastasis via regulation of the IL4/miR-324-5p/CUEDC2 axis .	miR-324	metastasis	inhibit	negative	breast cancer cell	D001943
26171025	It was identified that the expression levels of miR-551b-3p , miR-133b , miR-100-5p and miR-363-3p were significantly downregulated in the gastric cancer tissues , and this downregulation was closely correlated with the degree of differentiation ( i.e. , tumor grade ) , TNM stage and lymph-node metastasis ( P < 0.05 ) .	miR-551b|miR-133b|miR-100|miR-363	metastasis	downregulate	negative	TNM stage	D009369
26171025	By contrast , the expression of miR-215 was significantly upregulated in the gastric cancer tissues , and its expression level was correlated with tumor differentiation , TNM stage and lymph-node metastasis ( P < 0.05 ) .	miR-215	metastasis	upregulate	positive	gastric cancer|TNM stage	D061325
26179263	miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC .	miR-203	metastasis	suppress	negative	hepatocellular carcinoma	D009369
26182868	[ MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells ] .	MiR-373	Metastasis	promote	positive	Lung Adenocarcinoma	D001943
26182868	Our results demonstrated that miR-373-3p participated in the invasion and metastasis of lung adenocarcinoma cells , partly by upregulation of MMP-9 and MMP-14 .	miR-373	metastasis	upregulate	positive	lung adenocarcinoma	D001943
26182877	Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism .	microRNA-3178	metastasis	regulate	positive	hepatocellular carcinoma	D009369
26187928	Here , we identify microRNA-224 ( miR-224 ) to be significantly up-regulated in NSCLC tissues , particularly in resected NSCLC metastasis .	microRNA-224|miR-224	metastasis	upregulate	positive	NSCLC	D009369
26191158	In conclusion , microRNA-21 is crucial for CCA carcinogenesis and metastasis , which could induce EMT process , thereby promote the invasion and migration of CCA cells .	microRNA-21	metastasis	induce	positive	CCA|EMT	D009369
26191184	MicroRNA-365 inhibits growth , invasion and metastasis of malignant melanoma by targeting NRP1 expression .	MicroRNA-365	metastasis	inhibit	negative	malignant melanoma	D012878
26191184	MiR-365 was strongly down-regulated in malignant melanoma ( MM ) tissues and cell lines , and its expression levels were associated with lymph node metastasis and clinical stage , as well as overall survival and replase-free survival of MM .	MiR-365	metastasis	downregulate	negative	malignant melanoma ( MM )	D012878
26191184	We also found that ectopic expression of miR-365 inhibited MM cell proliferation and MM metastasis in vitro and in vivo .	miR-365	metastasis	inhibit	negative	MM	D012878
26191184	We further identified a novel mechanism of miR-365 to suppress MM growth and metastasis .	miR-365	metastasis	suppress	negative	MM	D012878
26194864	miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis .	miR-203	metastasis	suppress	negative	gastric carcinoma	D001943
26196741	MiR-373 suppresses TXNIP by binding to the 3'UTR of TXNIP , which in turn , induces cancer cell EMT and metastasis .	MiR-373	metastasis	suppress	negative	EMT	D009369
26196741	TXNIP co-expression , but not the TXNIP-3'UTR , reverses the enhancement of EMT , migration , invasion and metastasis induced by miR-373 .	miR-373	metastasis	coexpress	neutral	EMT	D009369
26199092	Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop .	miR-302c/IL	Metastasis	promote	positive	Gastric Cancer	D061325
26199650	Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .	miR-9|miR-10b|miR-17|miR-148a|miR-335|miR-30c|miR-187|miR-339	metastasis	control	neutral	BC	D001943
26201446	Furthermore , serum from NPC patients showed that miR-504 was up-regulated during different weeks of radiotherapy and correlated with tumor , lymph nodes and metastasis ( TNM ) stages and total tumor volume .	miR-504	metastasis	upregulate	positive	NPC|lymph nodes and metastasis ( TNM )	D009369
26204489	MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4 .	MiR-26b/KPNA	metastasis	inhibit	negative	epithelial ovarian carcinoma	D061325
26204489	miR-26b/KPNA2 axis suppresses tumor proliferation and metastasis through decreasing OCT4 expression , which is indicative of the important role of miR-26b/KPNA2/OCT4 axis in EOC carcinogenesis and progression .	miR-26b/KPNA	metastasis	suppress	negative	EOC	D009369
26208390	We investigated the expression patterns of miRNAs , including miR-10b , 21 , 200c , 373 and 520c , which regulate epithelial-to-mesenchymal transition ( EMT ) and metastasis in isolated cancer stem cells ( CSCs ) and non- CSCs .	miR-10b	metastasis	regulate	positive	epithelial-to-mesenchymal transition ( EMT )|cancer stem cells ( CSCs )	D009369
26212010	Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression , PDCD4 downregulation and breast cancer metastasis .	miR-21	metastasis	regulate	positive	breast cancer metastasis	D001943
26219893	In conclusion , in vivo and vitro findings provided evidence that miR-140 could inhibit the growth , migration , and metastasis of OS cells .	miR-140	metastasis	inhibit	negative	OS	D009369
26221053	Thus , we identified a pathway in which TNF帢-NF-庥B signaling switches off negative regulation by suppressing HNF-1帢-mediated expression of miR-194 , revealing insight into the mechanisms linking inflammatory pathways , miRNA , and HCC metastasis .	miR-194	metastasis	regulate	positive	HCC	D009369
26223867	miR-106b was significantly up-regulated in metastatic CRC tissues and cell lines , and high miR-106b expression was associated with lymph node metastasis and advanced clinical stage .	miR-106b	metastasis	upregulate	positive	CRC	D001943
26224480	Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression , metastasis , and unfavorable prognosis of human osteosarcoma .	microRNA-217|microRNA-646	metastasis	downregulate	negative	osteosarcoma	D009362
26231042	Registered report : the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 .	miR-34a	metastasis	inhibit	negative	prostate cancer	D001943
26231042	This Registered report describes the proposed replication plan of key experiments from 'The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 ' by Liu and colleagues published in Nature Medicine in 2011 ( Liu et al. , 2011 ) .	miR-34a	metastasis	inhibit	negative	prostate cancer	D001943
26231797	miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer .	miR-503	metastasis	suppress	negative	prostate cancer	D001943
26231797	Enforced expression of miR-503 inhibited the expression of RNF31 significantly and the restoration of RNF31 expression reversed the inhibitory effects of miR-503 on PCa cell proliferation and metastasis .	miR-503	metastasis	inhibit	negative	PCa	D001943
26234681	Furthermore , mechanistic studies revealed that Pax7 can promote sarcoma metastasis in vivo through MyoD-dependent regulation of pro-metastatic miR-182 .	miR-182	metastasis	promote	positive	sarcoma	D009362
26234681	Taken together , these results suggest that sarcoma metastasis can be partially controlled through Pax7/MyoD-dependent activation of miR-182 and provide insight into the role that myogenic transcription factors have in sarcoma progression .	miR-182	metastasis	control	neutral	sarcoma	D009362
26236665	Herein , we evaluated the effect of SEB on the expression of two master microRNAs , mir-335 and mir-10b , involved in metastasis .	mir-335|mir-10b	metastasis	effect	neutral	SEB	D001943
26239517	We observed that the miR-126 expression level was significantly downregulated in PTC tissue and PTC cell lines , the aberrant expression of miR-126 was correlated with lymph node metastasis , tumor size and TNM stage .	miR-126	metastasis	downregulate	negative	PTC|TNM stage	D009369
26244871	CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis .	miR98|miR27b	metastasis	downregulate	negative	breast cancer metastasis	D001943
26244871	More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .	miR98|miR27b	metastasis	enhance	positive	epithelial-mesenchymal transition ( EMT )|breast cancer cells|breast cancer metastasis	D001943
26252200	MicroRNA-24 upregulation inhibits proliferation , metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3 .	MicroRNA-24	metastasis	upregulate	positive	bladder cancer	D061325
26253263	Importantly , we demonstrated that the overexpression of miR-148a significantly inhibited CSCC cell proliferation and metastasis via down-regulation of MAP3K9 and MAP3K4 expression .	miR-148a	metastasis	inhibit	negative	CSCC	D009369
26254095	miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells .	miR-302b	metastasis	suppress	negative	hepatocellular carcinoma	D009369
26254095	Overexpression of miR-302b suppressed HCC cell invasion and metastasis .	miR-302b	metastasis	suppress	negative	HCC	D009369
26254095	Taken together , our findings indicate that miR-302b inhibits SMMC-7721 cell invasion and metastasis by targeting AKT2 , suggesting that miR-302b might represent a potential therapeutic target for HCC intervention .	miR-302b	metastasis	inhibit	negative	HCC	D009369
26259252	miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR .	miRNA-99b	metastasis	suppress	negative	colorectal cancer	D001943
26259653	Based on these findings , we suggest that miR-124 may inhibit OS metastasis , partly at least , via targeting ROR2 and thus suppressing the activity of ROR2-mediated non-canonical Wnt signaling .	miR-124	metastasis	inhibit	negative	OS	D009369
26261546	MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein .	MiR-1228	metastasis	promote	positive	breast cancer cell	D001943
26261588	Up-regulated miR-155-5p promotes cell proliferation , invasion and metastasis in colorectal carcinoma .	miR-155	metastasis	upregulate	positive	colorectal carcinoma	D001943
26261588	The aim of the study is to investigate miR-155-5p effect on proliferation and invasion metastasis of CRC .	miR-155	metastasis	effect	neutral	CRC	D001943
26261588	miR-155-5p expression is up-regulated in most CRC and promotes proliferation , invasion and metastasis of CRC cells .	miR-155	metastasis	upregulate	positive	CRC	D001943
26261606	The expression of miR-21-3p and miR-21-5p in HPV positive cervical cancer samples was significantly upregulated compared to that in the paired normal samples ( P < 0.05 ) ; A multivariate analysis demonstrated that the expression of miR-21 was associated with clinicopathological parameters , including depth of invasion and lymph node metastasis .	miR-21	metastasis	upregulate	positive	cervical cancer	D009369
26275944	MiR-205 , acting as an oncogenic miRNA , may promote the clinical progression of EOC patients and enhance the cellular motility in vitro by directly and negatively regulating ZEB1 , providing a potential therapeutic strategy for suppression of EOC metastasis .	MiR-205	metastasis	promote	positive	EOC	D009369
26278219	MicroRNA-203 Regulates Growth and Metastasis of Breast Cancer .	MicroRNA-203	Metastasis	regulate	positive	Breast Cancer	D001943
26278569	MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2 .	MiR-761	Metastasis	promote	positive	Non-Small Cell Lung Cancer	D009369
26278569	The aim of this study was to investigate the role of microRNA miR-761 in the progression and metastasis of non-small cell lung cancer ( NSCLC ) , and the mechanisms by which miR-761 regulates cell proliferation and metastatic activity of NSCLC cell lines .	miR-761	metastasis	regulate	positive	non-small cell lung cancer ( NSCLC )	D009369
26278569	Finally , we investigated whether miR-761 promotes proliferation and metastasis in NSCLC cell lines by targeting ING4 ( inhibitor of growth family , member 4 ) and TIMP2 ( tissue inhibitor of metalloproteinase 2 ) .	miR-761	metastasis	promote	positive	NSCLC	D009369
26278569	miR-761 promotes progression and metastasis of NSCLC by targeting ING4 and TIMP2 .	miR-761	metastasis	promote	positive	NSCLC	D009369
26282502	From the miRNAs comprehensive regulatory network , we found that has-miR-203 regulated a large number of target genes and lncRNAs , including suppressor of cytokine signaling 3 ( SOCS3 ) and metastasis associated in lung adenocarcinoma transcript 1 ( MALAT1 ) .	miR-203	metastasis	regulate	positive	lung adenocarcinoma	D001943
26286725	Furthermore , downregulation of miR-101 correlated with T3-4 tumour grade , lymph node metastasis , and an advanced clinical stage in the LSCC patients examined ( P ? < ? 0.05 ) .	miR-101	metastasis	downregulate	negative	LSCC	D009369
26289847	Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node metastasis and poor prognosis .	miR-21|miR-494	metastasis	upregulate	positive	nasopharyngeal carcinoma	D009369
26290438	MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1 .	MiR-186	metastasis	suppress	negative	bladder cancer	D061325
26298722	We then demonstrated that miR-944 promotes cell proliferation and tumor metastasis in breast cancer cell lines .	miR-944	metastasis	promote	positive	breast cancer cell	D001943
26299922	MiR-139-5p expression in MCF-7 , MCF-7/Doc cells and in selected breast cancer tissue samples was confirmed by real-time PCR ; cell viability was analyzed by Cell Counting Kit-8 assay ; apoptosis and cell cycle were analyzed by flow cytometry ; control of metastasis and invasion of breast cancer cells was measured by transwell assay ; expression of Notch1 was measured by western blot ; a luciferase reporter vector was constructed to identify the miR-139-5p target gene .	MiR-139|miR-139	metastasis	control	neutral	breast cancer	D001943
26302825	Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-帢 induced epithelial-to-mesenchymal transition in colorectal cancer .	miR-19a	metastasis	mediate	neutral	colorectal cancer	D001943
26302825	We found that miR-19a was up-regulated in CRC tissues and high expression of miR-19a was significantly associated with lymph node metastasis .	miR-19a	metastasis	upregulate	positive	CRC	D001943
26302825	Furthermore , miR-19a was up-regulated by TNF-帢 and miR-19a was required for TNF-帢-induced EMT and metastasis in CRC cells .	miR-19a	metastasis	upregulate	positive	CRC	D001943
26307684	We recently reported that miR-224 was significantly up-regulated in non-small cell lung cancer ( NSCLC ) tissues , in particular in resected NSCLC metastasis .	miR-224	metastasis	upregulate	positive	NSCLC	D009369
26309359	To elucidate the potential biological role of miR-30b in gastric cancer and investigate the underlying molecular mechanisms of miR-30b to inhibit metastasis of gastric cancer cells .	miR-30b	metastasis	inhibit	negative	gastric cancer	D061325
26310391	Collectively , our study demonstrates that miR-124 can impair the proliferation or metastasis of human bladder cancer cells by down-regulation of UHRF1 .	miR-124	metastasis	downregulate	negative	bladder cancer	D061325
26311392	Further , miR-197 has been identified to affect uterine leiomyoma cell proliferation , apoptosis , and metastasis ability , though the responsible molecular mechanism has not been well elucidated .	miR-197	metastasis	affect	neutral	uterine leiomyoma	D009362
26313360	Here , we report that chitosan nanoparticle-mediated delivery of miR-34a , a tumor suppressive microRNA that downregulates multiple gene products involved in PCa progression and metastasis , inhibited prostate tumor growth and preserved bone integrity in a xenograft model representative of established PCa bone metastasis .	miR-34a	metastasis	downregulate	negative	PCa	D001943
26314219	We have shown that miR-182 drives sarcoma metastasis in vivo by coordinated regulation of multiple genes .	miR-182	metastasis	regulate	positive	sarcoma	D009362
26316085	Up-Regulation of MiR-452 Inhibits Metastasis of Non-Small Cell Lung Cancer by Regulating BMI1 .	MiR-452	Metastasis	inhibit	negative	Non-Small Cell Lung Cancer	D009369
26317418	Overexpression of activin A in OSCCs , which is controlled by downregulation of miR-143/miR-145 cluster , regulates apoptosis , proliferation and invasiveness , and it is clinically correlated with lymph node metastasis and poor survival .	miR-143/miR	metastasis	control	neutral	OSCCs	D009369
26317898	MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer .	MicroRNA-940	metastasis	promote	positive	gastric cancer	D061325
26317898	Mechanistically , we found that miR-940 promoted GC cell migration , invasion , and metastasis in vivo by directly and functionally repressing the expression of Zinc Finger Transcription Factor 24 ( ZNF24 ) .	miR-940	metastasis	promote	positive	GC	D061325
26321759	The role of L1 in the differential expression of the let-7 family of miRNAs ( that regulate genes involved in the EMT and metastasis ) is also discussed .	let-7	metastasis	regulate	positive	EMT	D009369
26324236	MiR-34a inhibits colon cancer proliferation and metastasis by inhibiting platelet-derived growth factor receptor 帢 .	MiR-34a	metastasis	inhibit	negative	colon cancer	D001943
26328011	miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer .	miR-630	metastasis	regulate	positive	lung cancer	D009369
26330060	Additionally , Twist1 knockdown blocks EMT-related metastasis and forced expression of miR-33a inhibits lung cancer metastasis in a xenograft animal model .	miR-33a	metastasis	block	negative	EMT|lung cancer	D009369
26330060	These findings suggest that miR-33a targets Twist1 and inhibits invasion and metastasis in NSCLC .	miR-33a	metastasis	inhibit	negative	NSCLC	D009369
26330295	Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression , metastasis , and poor prognosis of osteosarcoma .	miR-300|miR-125b	metastasis	upregulate	positive	osteosarcoma	D009362
26330295	On the other hand , miR-300 expression was significantly upregulated in OS bone tissue than noncancerous bone tissues.Our findings suggested that a lower expression level of miR-125b was linked to advanced clinical stage ( P ? = ? 0.005 ) , metastasis ( P ? = ? 0.004 ) , and a large size of tumor ( P ? = ? 0.023 ) .	miR-300|miR-125b	metastasis	upregulate	positive	OS	D009369
26333174	MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras .	MiR-622	metastasis	inhibit	negative	colorectal cancer	D001943
26336827	MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1 .	MiR-497	metastasis	suppress	negative	hepatocellular carcinoma	D009369
26336827	MicroRNAs ( miRNAs ) have been shown to play important roles in regulating tumor properties in cancer , however , whether miR-497 contributes to HCC angiogenesis or metastasis remains unclear .	miR-497	metastasis	regulate	positive	HCC	D009369
26336827	Based on nude mouse models , we demonstrated that overexpression of miR-497 significantly repressed microvessel densities in xenograft tumors and reduced pulmonary metastasis .	miR-497	metastasis	repress	negative	pulmonary metastasis	D001943
26336827	In conclusion , our findings indicate that miR-497 downregulation contributes to angiogenesis and metastasis in HCC .	miR-497	metastasis	downregulate	negative	HCC	D009369
26338045	MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma .	MicroRNA-195	metastasis	suppress	negative	prostate carcinoma	D001943
26338045	Forced expression of miR-195 in PCa cells drastically inhibits proliferation , migration and invasion in vitro and inhibits tumor growth and metastasis in vivo .	miR-195	metastasis	inhibit	negative	PCa	D001943
26338045	Collectively , this is the first report unveils that loss of miR-195 expression and thus uncontrolled BCOX1 upregulation might drive PCa metastasis .	miR-195	metastasis	upregulate	positive	PCa	D001943
26349988	These findings provide new insights miR-101 down-regulation in CAFs could inhibit lung cancer proliferation and metastasis via targeting CXCL12 .	miR-101	metastasis	downregulate	negative	lung cancer	D009369
26352220	MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1 .	MicroRNA-128	metastasis	suppress	negative	colorectal carcinoma 	D009369
26352220	Taken together , these data suggested that miR-128 serves as a tumor suppressor and blocks CRC growth and metastasis by targeting IRS1 .	miR-128	metastasis	block	negative	CRC	D001943
26352279	Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42 .	miR-137	metastasis	inhibit	negative	hepatocellular carcinoma	D009369
26352279	In the HCC HuH7 and MHCC97L cell lines , miR-137 was upregulated to inhibit cell proliferation and metastasis in ? vitro and tumor growth in ? vivo .	miR-137	metastasis	upregulate	positive	HCC	D009369
26352279	Furthermore , co-overexpression of AKT2 in addition to CDC42 additively reduced the inhibition of miR-137 on HCC proliferation and metastasis , suggesting two independent pathways of CDC42 and AKT2 in miR-137-mediated HCC regulation .	miR-137	metastasis	inhibit	negative	HCC	D009369
26352673	MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4 .	MicroRNA-132	metastasis	inhibit	negative	osteosarcoma	D009362
26352673	miR-132 mimic , miR ? 132 inhibitor and negative control were transfected into osteosarcoma cells and the effects of miR ? 132 on the cell growth and metastasis were investigated .	miR-132	metastasis	control	neutral	osteosarcoma	D009362
26352673	In conclusion , miR ? 132 inhibited cell growth and metastasis in osteosarcoma cells by downregulation of Sox4 , and knockdown of Sox4 was essential for the miR-132-inhibited cell growth and metastasis in osteosarcoma cells .	miR-132	metastasis	inhibit	negative	osteosarcoma	D009362
26353930	H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b .	miR-675	metastasis	enhance	positive	breast cancer cells	D001943
26353930	We showed that overexpression of H19/miR-675 enhanced the aggressive phenotype of breast cancer cells including increased cell proliferation and migration in vitro , and increased tumor growth and metastasis in vivo .	miR-675	metastasis	enhance	positive	breast cancer cells	D001943
26356262	We found that miR-29a was up regulated in pancreatic tumor tissues and cell lines and positively correlated with metastasis .	miR-29a	metastasis	regulate	positive	pancreatic tumor	D001943
26359764	Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer .	miR-326	metastasis	downregulate	negative	gastric cancer	D061325
26360780	MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7 .	MiRNA-101	metastasis	inhibit	negative	breast cancer	D001943
26360780	Introduction of miR-101 inhibited breast cancer cell proliferation and invasion in vitro and suppressed tumor growth and lung metastasis of in vivo .	miR-101	metastasis	inhibit	negative	breast cancer cell|lung metastasis	D001943
26377202	Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4 .	microRNA-212/132	metastasis	suppress	negative	breast cancer	D001943
26377202	Also , current study suggest a new miRNA-based mechanism elucidating the anti-metastatic properties of Ahr agonists , suggesting possibility of using miR-212/132 to control metastasis in breast cancer patients .	miR-212/132	metastasis	control	neutral	breast cancer	D001943
26379863	In conclusion , matrine inhibited the invasion and metastasis of lung cancer cell by elevating expression of miR-133a which further suppressed activation of EGFR/Akt/MMP-9 pathway .	miR-133a	metastasis	inhibit	negative	lung cancer	D009369
26388699	MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer .	MicroRNA-125b	metastasis	promote	positive	non-small-cell lung cancer	D009369
26388699	These findings demonstrated that miR-125b promoted tumor metastasis via targeting TP53INP1 in human NSCLC cells , which uncovered a real clinical relevance of microRNAs in tumor biology , and provided novel potential candidates for NSCLC clinical practice .	miR-125b	metastasis	promote	positive	NSCLC	D009369
26388700	Up-regulation of miR-30b or down-regulation of Cthrc1 had potential significance in the invasion and metastasis of NSCLC .	miR-30b	metastasis	upregulate	positive	NSCLC	D009369
26389681	MiR-125a suppresses tumor growth , invasion and metastasis in cervical cancer by targeting STAT3 .	MiR-125a	metastasis	suppress	negative	cervical cancer	D009369
26389681	In this study , we found the expression of miR-125a was downregulated in cervical cancer patients , and negatively correlated with the tumor size , FIGO stage , and preoperative metastasis .	miR-125a	metastasis	downregulate	negative	cervical cancer	D009369
26395571	BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells .	miR-200	metastasis	inhibit	negative	lung adenocarcinoma	D001943
26398698	In NSCLC patients , the results showed that miR-130a downregulation exhibited clinical relevance as it was correlated with poor prognosis and increased tumor stage and metastasis .	miR-130a	metastasis	downregulate	negative	NSCLC	D009369
26398880	miR-506 regulates breast cancer cell metastasis by targeting IQGAP1 .	miR-506	metastasis	regulate	positive	breast cancer cell	D001943
26404322	Our results demonstrate the profound effect of fucoidan not only on the regulation of miR-29b-DNMT3B-MTSS1 axis but also on the inhibition of TGF-?] signaling in HCC cells , suggesting the potential of using fucoidan as integrative therapeutics against invasion and metastasis of HCC .	miR-29b	metastasis	effect	neutral	HCC	D009369
26404754	C/EBP帢-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer .	miR-100	metastasis	suppress	negative	gastric cancer	D061325
26404754	Overexpression of miR-100 suppressed tumor growth in vivo and inhibited gastric cancer invasion and metastasis in vitro and in vivo .	miR-100	metastasis	suppress	negative	gastric cancer	D061325
26406949	MicroRNA-365 inhibits growth , invasion and metastasis of malignant melanoma by targeting NRP1 expression .	MicroRNA-365	metastasis	inhibit	negative	malignant melanoma	D012878
26406949	MiR-365 was strongly down-regulated in malignant melanoma ( MM ) tissues and cell lines , and its expression levels were associated with lymph node metastasis and clinical stage , as well as overall survival and replase-free survival of MM .	MiR-365	metastasis	downregulate	negative	malignant melanoma ( MM )	D012878
26406949	We also found that ectopic expression of miR-365 inhibited MM cell proliferation and MM metastasis in vitro and in vivo .	miR-365	metastasis	inhibit	negative	MM	D012878
26406949	We further identified a novel mechanism of miR-365 to suppress MM growth and metastasis .	miR-365	metastasis	suppress	negative	MM	D012878
26414725	miR-1 suppresses cell proliferation , invasiveness , metastasis , and progression of ESCC by binding its targeted genes LASP1 and TAGLN2 .	miR-1	metastasis	suppress	negative	ESCC	D009369
26415857	Our data suggested that decreased expression of miR-124 has prognostic value in breast cancer and may serve as a prognostic marker for breast cancer , and also downregulation of miR-124 was inversely associated with the lymph node metastasis in breast cancer .	miR-124	metastasis	downregulate	negative	breast cancer	D001943
26429530	[ miR-135b promotes the invasion and metastasis of hepatocellular carcinoma cells ] .	miR-135b	metastasis	promote	positive	hepatocellular carcinoma	D009369
26429530	To explore the effect of miR-135b on the invasion and metastasis of hepatocellular carcinoma cells and the underlying molecular mechanism .	miR-135b	metastasis	effect	neutral	hepatocellular carcinoma	D009369
26429530	The invasive and metastasis abilities were detected by Transwell ( TM ) assay in hepatocellular carcinoma cells with over-expressed or down-regulated miR135b .	miR135b	metastasis	downregulate	negative	hepatocellular carcinoma	D009369
26432332	MicroRNA-92a promotes growth , metastasis , and chemoresistance in non-small cell lung cancer cells by targeting PTEN .	MicroRNA-92a	metastasis	promote	positive	non-small cell lung cancer	D009369
26432332	We found that miR-92a was significantly upregulated in NSCLC tissues compared to matched adjacent normal lung tissues , and its expression is significantly associated with clinical characteristics of patients , including tumor , node , and metastasis ( TNM ) stage ; tumor size ; and lymph node metastasis ( all P ? < ? 0.01 ) .	miR-92a	metastasis	upregulate	positive	NSCLC|TNM	D009369
26432332	Taken together , these findings suggested that miR-92a could promote growth , metastasis , and chemoresistance in NSCLC cells at least partially by targeting PTEN .	miR-92a	metastasis	promote	positive	 NSCLC	D009369
26441331	TGF-?] 1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4 .	miR-29a	Metastasis	promote	positive	Cholangiocarcinoma	D009369
26449831	miR-30a also suppressed tumor formation and pulmonary metastasis in vivo .	miR-30a	metastasis	suppress	negative	pulmonary metastasis	D001943
26451614	MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition .	MiR-573	metastasis	inhibit	negative	prostate cancer	D001943
26451614	Through gain- and loss-of function experiments , we demonstrated that miR-573 inhibits PCa cell migration , invasion and TGF-?] 1-induced epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis in vivo .	miR-573	metastasis	inhibit	negative	Pca|lung metastasis	D001943
26451614	Importantly , we showed that GATA3 directly increases miR-573 expression , and thus down-regulates FGFR1 expression , EMT and invasion of PCa cells in a miR-573-dependent manner , supporting the involvement of GATA3 , miR-573 and FGFR1 in controlling the EMT process during PCa metastasis .	miR-573	metastasis	downregulate	negative	PCa	D001943
26452129	MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2 .	MicroRNA-506	metastasis	suppress	negative	colon cancer	D001943
26452129	Here , we demonstrated that miR-506 was down-regulated in colon cancer tissue and cells and that miR-506 expression was inversely correlated with EZH2 expression , tumor size , lymph node invasion , TNM stage and metastasis .	miR-506	metastasis	downregulate	negative	colon cancer|TNM stage	D009369
26452129	In vitro and in vivo experiments confirmed that miR-506 inhibits the proliferation and metastasis of colon cancer , and a luciferase reporter assay confirmed that EZH2 is a direct and functional target of miR-506 via the 3'UTR of EZH2 .	miR-506	metastasis	inhibit	negative	colon cancer	D001943
26462018	microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein ( Sufu ) .	microRNA-214	metastasis	promote	positive	epithelial-mesenchymal transition|lung adenocarcinoma	D001943
26462018	In addition , we found that miR-214 enhanced the molecular program controlling the EMT of LAD cells and promoted LAD cell metastasis both in vitro and in vivo .	miR-214	metastasis	enhance	positive	EMT|LAD	D009369
26462018	Mechanistically , Sufu was identified as an important miR-214 functional target for the EMT and metastasis of LAD , ectopic expression of Sufu alleviated miR-214 promoted EMT and metastasis .	miR-214	metastasis	promote	positive	EMT|LAD	D009369
26462018	Collectively , this study uncovers a previously unappreciated miR-214-Sufu pathway in controlling EMT and metastasis of LAD and suggests that interfering with miR-214 and Sufu could be a viable approach to treat late stage metastatic LAD patients .	miR-214	metastasis	control	neutral	EMT|LAD	D009369
26463631	miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1 .	miR-425	metastasis	inhibit	negative	melanoma	D012878
26464633	MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2 .	MicroRNA-34a	metastasis	inhibit	negative	gastric cancer	D061325
26464633	To study how miR-34a acts as a tumor suppressor in inhibiting the invasion and metastasis of the gastric cancer cells .	miR-34a	metastasis	inhibit	negative	gastric cancer	D061325
26464633	Therefore , we concluded that miR-34a could inhibit tumor invasion and metastasis in gastric cancer by targeting Tgif2 and may be a novel therapeutic candidate for gastric cancer .	miR-34a	metastasis	inhibit	negative	gastric cancer	D061325
26464660	We found that miR-451 showed decreased expression in GC tissues and cell lines , and its down-regulation tended to be positively correlated with lymphatic metastasis , clinical staging and shorter overall survival of patients .	miR-451	metastasis	downregulate	negative	GC	D061325
26471185	MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets .	MiR-449a	metastasis	suppress	negative	hepatocellular carcinoma	D009369
26471185	In HCC cell lines , stable overexpression of miR-449a was sufficient to inhibit cell motility in vitro , and pulmonary metastasis in vivo .	miR-449a	metastasis	inhibit	negative	pulmonary metastasis	D001943
26473472	To investigate the influence of microRNA-378g ( miR-378g ) on radiosensitivity and metastasis of nasopharyngeal carcinoma cells and study how miR-378g regulated Src homology region 2 domain-containing phosphatase-1 ( SHP-1 ) expression .	microRNA-378g|miR-378g|miR-378g	metastasis	influence	neutral	nasopharyngeal carcinoma	D009369
26482618	miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3 .	miR-29a	metastasis	suppress	negative	papillary thyroid carcinoma	D009369
26482618	In the present study , we discovered that miR-29a was frequently downregulated in PTC tissues , and its expression was significantly associated with tumor size , TNM stage , and lymph node metastasis .	miR-29a	metastasis	downregulate	negative	PTC|TNM stage	D009369
26485753	We found that HIFU treatment decreased circulating B16F10 cells and pulmonary metastasis nodules while increased IFN-帠 and TNF-帢 in the peripheral blood and cumulative mouse survival , which was associated with inhibition of miR-134 expression and activation of CD86 expression in tumor tissues .	miR-134	metastasis	inhibit	negative	HIFU|pulmonary metastasis	D001943
26490990	Based on these results , we propose that miR-145 might carry crucial roles in LSCC tumorigenesis , prognosis , metastasis , chemoresistance , and recurrence through regulating stem cell properties of tumor cells .	miR-145	metastasis	regulate	positive	LSCC	D009369
26497851	Taken together , our results demonstrated that miR-139-5p plays a pivotal role in lung cancer through inhibiting cell proliferation , metastasis , and promoting apoptosis by targeting oncogenic c-Met .	miR-139	metastasis	inhibit	negative	lung cancer	D009369
26498692	miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F .	miR-149	metastasis	repress	negative	hepatocellular carcinoma	D009369
26498692	Here , we demonstrated that miR-149 was significantly down-regulated in HCC , which was correlated with distant metastasis and TNM stage with statistical significance .	miR-149	metastasis	downregulate	negative	HCC|TNM stage	D009369
26498692	In vivo studies confirm inhibition of HCC metastasis by miR-149 .	miR-149	metastasis	inhibit	negative	HCC	D009369
26499759	Results from qRT-PCR showed that miR-22 was significantly downregulated in RCC samples compared with corresponding non-cancerous tissues , which was significantly associated with tumor stage and lymph node metastasis .	miR-22	metastasis	downregulate	negative	RCC	D001943
26499759	These findings showed that miR-22 functioned as tumor suppressor in RCC and blocked RCC growth and metastasis by directly targeting SIRT1 in RCC , indicating a potential novel therapeutic role in RCC treatment .	miR-22	metastasis	block	negative	RCC	D001943
26499886	miR-16 is known to be abnormally expressed in hepatocellular carcinoma ( HCC ) cells , and the overexpression of miR-16 inhibits the proliferation , invasion and metastasis of various cancer cells .	miR-16	metastasis	inhibit	negative	hepatocellular carcinoma ( HCC )	D009369
26499912	The present study demonstrated for the first time that microRNA-616 ( miR-616 ) was markedly upregulated in HCC tissues , and was associated with the recurrence and metastasis of HCC .	microRNA-616|miR-616	metastasis	upregulate	positive	HCC	D009369
26499948	We found that rs9589207 in miR-92a was involved in the occurrence of GC by acting as a tumor protective factor and was highly associated with tumor size in GC patients instead of tumor number or metastasis in 554 GC patients and 531 cancer-free controls .	miR-92a	metastasis	control	neutral	GC	D061325
26501139	In the present study we demonstrated that miR-221 promoted EHCC invasion and metastasis through targeting PTEN and formed a positive feedback loop with ?] -catenin/c-Jun signaling pathway .	miR-221	metastasis	promote	positive	EHCC|PTEN	D009369
26503504	Ectopic expression of miR-24 inhibited the cell viability , proliferation , migration , and invasion in vitro ( all P ? < ? 0.05 ) , and suppressed the xenograft tumor growth and lung metastasis formation in vivo ( all P ? < ? 0.05 ) .	miR-24	metastasis	inhibit	negative	lung metastasis	D009362
26504803	We further found that upregulation of miR-125b inhibited the proliferation and metastasis of gastric cancer cells in vitro and in vivo .	miR-125b	metastasis	upregulate	positive	gastric cancer	D061325
26507842	MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1 .	MiR-33a	metastasis	suppress	negative	breast cancer cell	D001943
26507842	Here , we found that downregulated miR-33a in breast cancer tissues correlates with lymph node metastasis .	miR-33a	metastasis	downregulate	negative	breast cancer	D001943
26507842	Moreover , the overexpression of miR-33a in metastatic breast cancer cells remarkably decreases cell proliferation and invasion in vitro and significantly inhibits tumor growth and lung metastasis in vivo , whereas its knockdown in non-metastatic breast cancer cells significantly enhances cell proliferation and invasion in vitro and promotes tumor growth and lung metastasis in vivo .	miR-33a	metastasis	inhibit	negative	breast cancer cells	D001943
26507842	These findings identified miR-33a as a negative regulator of breast cancer cell proliferation and metastasis .	miR-33a	metastasis	regulate	positive	breast cancer cell	D001943
26508028	Here , we found that miRNA-146a expression is downregulated in both ESCC cell lines and tissues and obviously associated with pathological indicators , such as metastasis and stage of ESCC .	miRNA-146a	metastasis	downregulate	negative	ESCC	D009369
26515696	A series of loss-of-function and gain-of-function assays were performed to evaluate the effect of miR-206 on the proliferation , invasion and metastasis of CRC cells .	miR-206	metastasis	effect	neutral	CRC	D001943
26515696	miR-206 was significantly down-regulated in CRC tissues and correlated closely with differentiation , lymphatic metastasis and serosal invasion .	miR-206	metastasis	downregulate	negative	CRC	D001943
26515696	miR-206 also inhibited cell invasion and lung metastasis in CRC cells .	miR-206	metastasis	inhibit	negative	CRC	D001943
26517090	Moreover , miR-222 mimics and ABCG2 siRNA inhibited tumor growth and lung metastasis in vivo .	miR-222	metastasis	inhibit	negative	lung metastasis	D009362
26528854	Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1帢 in ERK-responsive lung cancer .	microRNA-622	metastasis	suppress	negative	lung cancer	D009369
26528854	These findings highlight the pivotal role of the FOXO3a/miR-622 axis in inhibiting HIF-1帢 to interfere with tumor metastasis , and this information may contribute to development of novel therapeutic strategies for treating aggressive lung cancer .	miR-622	metastasis	inhibit	negative	lung cancer	D009369
26530325	These results suggested that miR-148 may represent a novel molecular marker and a potential molecular therapeutic for inhibiting metastasis of HCC .	miR-148	metastasis	inhibit	negative	HCC	D009369
26535032	In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .	miR-185|miR-210|miR-423|let7e|miR-30c|miR-221	metastasis	upregulate	positive	endometrial cancer	D009369
26536104	Under hypoxia , methyl sulfone decreased expression of the master regulator of hypoxia , HIF-1帢 , and reduced levels of the glycolytic enzymes , PKM2 , LDHA , GLUT1 , the pro-angiogenic protein , VEGF , and the iron-sulfur metabolism molecules , miR-210 and transferrin , all of which promote metastasis .	miR-210	metastasis	regulate	positive	Lung Adenocarcinoma	D001943
26543233	Furthermore , using functional assays and The Cancer Genome Atlas ( TCGA ) Lung Adenocarcinoma ( LUAD ) dataset , we found that rs767649 variant allele could increase the transcriptional activity of miR-155 , which in turn facilitated tumor growth and metastasis by inhibiting HBP1 , TJP1 , SMAD5 and PRKAR1A expression .	miR-155	metastasis	inhibit	negative	Lung Adenocarcinoma	D001943
26543604	Furthermore , the up-regulation of serum miR-1290 more frequently occurred in NSCLC patients with high TNM stage , positive lymph node metastasis ( P=0.022 and P=0.024 , respectively ) .	miR-1290	metastasis	upregulate	positive	NSCLC|TNM stage	D009369
26546431	A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma .	miR-17	metastasis	regulate	positive	hepatocellular carcinoma	D009369
26546431	Taken together , our data indicated that there is a regulatory feedback loop between miR-17-5p and c-Myc , in which miR-17-5p could suppress some of the distinguishing features , invasion , and metastasis , of oncogenic c-Myc in HCC cells , and meanwhile , miR-17-5p is upregulated by c-Myc role as a transcription factor , although further studies are still needed .	miR-17	metastasis	suppress	negative	HCC	D009369
26546436	The exogenous introduction of miR-122 exhibits multiple antitumor effect in GBC cell proliferation , invasion , and metastasis .	miR-122	metastasis	effect	neutral	GBC	D001943
26549292	miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3 .	miR-146b	metastasis	promote	positive	osteosarcoma	D009362
26550456	Importantly , we demonstrate that the overexpression of miR-128 significantly inhibits HCC cell metastasis and stem-cell like properties via ITGA2 and ITGA5 .	miR-128	metastasis	inhibit	negative	HCC	D009369
26553452	ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis .	miR-218	metastasis	enhance	positive	lung tumor	D009369
26555172	Zhang and colleagues recently demonstrated that astrocyte-derived exosomal miR-19a reversibly downregulated PTEN expression in cancer cells , thereby increasing their CCL2 secretion and recruitment of myeloid cell to promote brain metastasis .	miR-19a	metastasis	downregulate	negative	PTEN|brain metastasis	D009369
26556542	The purpose of this study was to determine the role of miR-590-3p in regulation of epithelial mesenchymal transition ( EMT ) and metastasis of GBM cells .	miR-590	metastasis	regulate	positive	epithelial mesenchymal transition ( EMT )|GBM	D009369
26556718	Overexpression of miR-101 in ESCC inhibits proliferation and metastasis .	miR-101	metastasis	inhibit	negative	ESCC	D009369
26560033	Inhibiting EMT by overexpressing the microRNA miR-200 does not affect lung metastasis development .	miR-200	metastasis	inhibit	negative	EMT|lung metastasis	D009369
26561465	Here , we found that miR-150 expression was consistently downregulated in OS tissues and cell lines compared with the matched adjacent normal tissues and human normal osteoblast cells ( NHOst ) , and its expression was significantly correlated with lymph node metastasis and tumor-node-metastasis ( TNM ) stage .	miR-150	metastasis	downregulate	negative	OS|tumor-node-metastasis ( TNM ) stage	D009369
26568291	In the present study , we found that the expression level of miR-186 was downregulated in ESCC in comparison with the adjacent normal tissues and was significantly associated with differentiation level , TNM stage , and lymph node metastasis of ESCC .	miR-186	metastasis	downregulate	negative	ESCC|TNM stage	D009369
26572075	The results of in vitro 3H thymidine incorporation and Transwell migration assay indicated that miR-181b overexpression markedly promoted the proliferation and metastasis of breast cancer cells .	miR-181b	metastasis	promote	positive	breast cancer cells	D001943
26572149	miR-25 was identified as an essential oncogene by promoting the growth and metastasis through TOB1 in gastric cancer ( GC ) .	miR-25	metastasis	promote	positive	gastric cancer ( GC )	D061325
26573378	MicroRNA-1246 promotes growth and metastasis of colorectal cancer cells involving CCNG2 reduction .	MicroRNA-1246	metastasis	promote	positive	colorectal cancer	D001943
26574780	We observed that MEG3 was downregulated in cervical cancer tissues , compared to the adjacent normal tissues , and was negatively related with FIGO stages , tumor size , lymphatic metastasis , HR-HPV infection and the expression of homo sapiens microRNA-21 ( miR-21 ) .	microRNA-21|miR-21	metastasis	downregulate	negative	cervical cancer|FIGO stages	D009369
26577858	Downregulation and hypermethylation of miR-203a and miR-203b were associated with TNM stage , pathological differentiation , and lymph node metastasis .	miR-203a|miR-203b	metastasis	downregulate	negative	TNM stage	D009369
26578390	Furthermore , candidate biomarkers such as SOX11 and hsa-miR-204 which could cause cell proliferation but inhibit invasion or metastasis may be of importance in understanding the molecular mechanism of pancreatic oncogenesis and could be possible therapeutic targets for malignant pancreatic tumors .	miR-204	metastasis	inhibit	negative	pancreatic tumors	D001943
26580004	Downregulation of microRNA-586 Inhibits Proliferation , Invasion and Metastasis and Promotes Apoptosis in Human Osteosarcoma U2-OS Cell Line .	microRNA-586	Metastasis	downregulate	negative	Osteosarcoma	D009362
26580004	Downregulation of miR-586 expression in OS may inhibit cell proliferation , invasion and metastasis , and promote cell apoptosis .	miR-586	metastasis	downregulate	negative	OS	D009369
26580097	MicroRNA-192-5p Promote the Proliferation and Metastasis of Hepatocellular Carcinoma Cell by Targeting SEMA3A .	MicroRNA-192	Metastasis	promote	positive	Hepatocellular Carcinoma	D009369
26581116	In addition , serum miR-147 was markedly down-regulated in advanced NSCLC patients and the patients with lymph node metastasis ( LNM ) .	miR-147	metastasis	downregulate	negative	NSCLC	D009369
26581907	Considering that the most devastating aspect of lung cancer is metastasis , which can be promoted by transforming growth factor-?] ( TGF-?] ) -induced epithelial-to-mesenchymal transition ( EMT ) , we sought to determine whether miR-93 is involved in this process .	miR-93	metastasis	promote	positive	lung cancer|epithelial-to-mesenchymal transition ( EMT )	D009369
26584284	MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer .	MicroRNA-148a	Metastasis	suppress	negative	Non-Small-Cell Lung Cancer	D009369
26584284	Furthermore , functional assays showed that miR-148a expression suppressed NSCLC cell invasive and migratory abilities in vitro and suppressed cancer metastasis in vivo , while inhibition of miR-148a enhanced NSCLC cell invasion and lung metastasis formation in a mouse model .	miR-148a	metastasis	suppress	negative	NSCLC|lung metastasis	D009369
26587830	Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer .	microRNA-184|microRNA-574	metastasis	regulate	positive	lung cancer	D009369
26587830	We showed thatmiR-184 significantly attenuated the metastasis of SCLC , whereas miR-574-5p enhanced it .	miR-574	metastasis	enhance	positive	SCLC	D009369
26595523	Moreover , lentivirus delivered miR-630 bestows MDA-MB-231-luc cells with the ability to suppress cell colony formation in vitro and pulmonary metastasis in vivo .	miR-630	metastasis	suppress	negative	pulmonary metastasis	D001943
26604787	miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cells .	miR-122	metastasis	inhibit	negative	epithelial-mesenchymal transition|non-small-cell lung cancer cells	D009369
26604787	miR-122 attenuates the epithelial-mesenchymal transition process , which mediates cancer cells metastasis in NSCLC cells A549 and H460 .	miR-122	metastasis	mediate	neutral	epithelial-mesenchymal transition|non-small-cell lung cancer cells	D009369
26605780	MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16 .	MicroRNA-145	Metastasis	suppress	negative	Osteosarcoma	D009362
26605780	Conclcusion : Our results suggest that miR-145 functions as a tumor metastasis suppressor gene by down-regulating MMP16 and may be a potential target in osteosarcoma treatment .	miR-145	metastasis	downregulate	negative	osteosarcoma	D009362
26610210	MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail .	MicroRNA-22	metastasis	inhibit	negative	gastric cancer	D061325
26610210	Finally , overexpression of miR-22 suppressed tumor growth , peritoneal dissemination and pulmonary metastasis in vivo .	miR-22	metastasis	suppress	negative	pulmonary metastasis	D001943
26610210	MiR-22 downregulation promotes GC invasion and metastasis by upregulating MMP14 and Snail , and then inducing ECM remodeling and EMT .	MiR-22	metastasis	downregulate	negative	GC|ECM|EMT	D061325
26615424	Together , these findings indicate that miR-145 acts as a tumor suppressor and its downregulation in tumor tissues may contribute to the progression and metastasis of HCC through a mechanism involving ROCK1 , suggesting miR-145 as a potential new diagnostic and therapeutic target for the treatment of HCC .	miR-145	metastasis	downregulate	negative	HCC	D009369
26617733	MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells .	MicroRNA-370	metastasis	inhibit	negative	osteosarcoma	D009362
26617733	In conclusion , miR-370 inhibited cell growth and metastasis in osteosarcoma cells by down-regulation of FOXM1 .	miR-370	metastasis	inhibit	negative	osteosarcoma	D009362
26617763	MiR-106b has been confirmed to promote cancer cell proliferation ; however few studies are available on its functions in EMT and metastasis in colorectal cancer ( CRC ) .	MiR-106b	metastasis	promote	positive	colorectal cancer ( CRC )	D001943
26617846	MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition .	MiR-223	metastasis	inhibit	negative	epithelial-mesenchymal transition	D009369
26617846	In conclusion , miR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition .	miR-223	metastasis	inhibit	negative	cervical cancer|epithelial-mesenchymal transition	D009369
26620926	MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGF?] R1/Smad signaling pathway in NSCLC .	MiR-181b	metastasis	regulate	positive	NSCLC	D009369
26623562	Current evidence indicate that H19 lncRNA and the microRNA ( miRNA ) miR-675 , which is processed from it , play crucial roles in metastasis , through the regulation of critical events specifically the epithelial to mesenchymal ( EMT ) and the mesenchymal to epithelial transitions ( MET ) .	miR-675	metastasis	regulate	positive	epithelial to mesenchymal ( EMT )|mesenchymal to epithelial transitions ( MET )	D009369
26629004	MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression .	MiR181c	metastasis	inhibit	negative	ovarian cancer	D001943
26629004	In this study , we found that the expression of the miR-181c was significantly decreased in ovarian cancer tissue and in tissues with lymph node metastasis when compared with their control samples , respectively .	miR-181c	metastasis	control	neutral	ovarian cancer	D001943
26629004	In vitro , miR-181c significantly inhibited the proliferation , metastasis of A2780 cell line , and induced G1 phase arrest .	miR-181c	metastasis	inhibit	negative	A2780 cell	D009369
26629004	These results indicate that miR-181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression .	miR-181c	metastasis	inhibit	negative	ovarian cancer	D001943
26629033	MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line .	miR-96	metastasis	regulate	positive	tongue squamous cellular carcinoma|Tca8113 cell	D009369
26629033	MiR-96 is confirmed to be a direct target of MTSS1 gene and could regulate MTSS1 mediated Tca8113 cells proliferation and metastasis .	MiR-96	metastasis	regulate	positive	Tca8113 cells	D009369
26629033	MiR-96 targeting and promoting MTSS1 repression may precipitate in the TSCC tumorigenesis through bypassing cell proliferation and metastasis control .	MiR-96	metastasis	promote	positive	TSCC	D009369
26631042	miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3 .	miR-874	metastasis	suppress	negative	osteosarcoma	D009362
26631042	Here , we found that miR-874 expression was significantly decreased in OS cell lines and tissues by quantitative reverse transcriptase polymerase chain reaction ( qRT-PCR ) , and its expression was correlated with tumor-node-metastasis ( TNM ) stage , tumor size , and lymph node metastasis ( all P ? < ? 0.01 ) .	miR-874	metastasis	react	neutral	tumor-node-metastasis ( TNM ) stage	D009369
26631042	Taken together , these findings suggested that miR-874 might suppress the growth and metastasis of OS cells partially by targeting E2F3 .	miR-874	metastasis	suppress	negative	OS	D009369
26632252	MicroRNA-195 inhibits proliferation , invasion and metastasis in breast cancer cells by targeting FASN , HMGCR , ACACA and CYP27B1 .	MicroRNA-195	metastasis	inhibit	negative	breast cancer cells	D001943
26638007	Down-Regulation of miR-148a Promotes Metastasis by DNA Methylation and is Associated with Prognosis of Skin Cancer by Targeting TGIF2 .	miR-148a	Metastasis	promote	positive	Skin Cancer	D012878
26647850	MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase .	MicroRNA-335	metastasis	suppress	negative	bone metastasis|prostate cancer	D001943
26648487	MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2 .	MicroRNA-200b	metastasis	inhibit	negative	glioma cells	D009369
26650737	Overall , this study demonstrated that miR-195 suppressed PCa cell metastasis by downregulating FGF2 .	miR-195	metastasis	suppress	negative	PCa	D001943
26657507	MiR-145 also inhibited cell proliferation , migration , and metastasis , as well as controlled the cytoskeleton dynamics of esophageal cancer .	MiR-145	metastasis	inhibit	negative	esophageal cancer	D009369
26664144	Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b .	miR-148b	metastasis	inhibit	negative	lung cancer	D009369
26664144	Additionally , we suggested that miR-148b suppressed cell proliferation , metastasis , and EMT in lung cancer cells by directly binging to 3'-untranslated region of WNT1 , blocking the WNT1/?] -catenin signaling pathway .	miR-148b	metastasis	suppress	negative	lung cancer	D009369
26664144	BRG1 positively regulated the expression of miR-148b , leading to inhibition of cell proliferation , metastasis , restraint of EMT , and inactivation of the WNT/?] -catenin signaling pathway , which highlights potential therapeutic possibilities for the treatment of lung cancer .	miR-148b	metastasis	regulate	positive	EMT|lung cancer	D009369
26668606	In the present study , the expression levels of VEGF and miRNA-210 were upregulated in patients with MB and metastatic MB ; thus suggesting that miRNA-210 may promote the metastasis of MB primary tumors by regulating the expression of VEGF .	miRNA-210	metastasis	upregulate	positive	MB	D009369
26673620	Taken together , these results revealed that lower miR-497 levels in human CRC tissues induce KSR1 expression which is associated with CRC cancer occurrence , advanced stages , metastasis and chemoresistance .	miR-497	metastasis	induce	positive	CRC	D001943
26674378	We found that enhanced expression of miR-425 in ESCC cell lines not only promoted cell proliferation and colony formation , but also increased cellular metastasis .	miR-425	metastasis	enhance	positive	ESCC	D009369
26678891	These findings indicate that miR-34a inhibits breast cancer progression and metastasis through targeting TPD52 .	miR-34a	metastasis	inhibit	negative	breast cancer	D001943
26684241	Gain and loss of function studies revealed that miR-192 significantly suppressed metastasis of HCC cells in vitro and in vivo .	miR-192	metastasis	suppress	negative	HCC	D009369
26684358	MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of ?] -catenin signaling .	MicroRNA-1225	metastasis	inhibit	negative	gastric carcinoma	D001943
26693054	MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression .	MicroRNA-212	metastasis	downregulate	negative	gastric cancer	D061325
26693054	Restoring mir-212 expression by exogenous mirprecursor molecules transfection or reexpression of endogenous miR-212 treated by 5-aza-2'-deoxycytidine ( 5-aza ) can exert similar effect that reduce GC cells invasion and metastasis abilities in vitro by interacting PXN gene .	mir-212|miR-212	metastasis	effect	neutral	GC	D061325
26693054	Taken together , our results clearly show that overexpression of PXN induced by methylationsuppressed miR-212 promotes tumor metastasis and invasion , and regulation of miR-212 expression may be a novel therapeutic strategy for gastric cancer .	miR-212	metastasis	induce	positive	gastric cancer	D061325
26693056	In this study , down-regulated miR-101-3p expression was detected in ACC tissues and ACC cell lines with high potential for metastasis .	miR-101	metastasis	downregulate	negative	ACC	D009369
26707142	Taken together , our results suggest that miR-148a can suppress the migration and invasion of breast cancer cells by targeting WNT-1 and inhibiting Wnt/?] -catenin signaling pathway and this will provide new insights into the molecular mechanisms of breast cancer metastasis .	miR-148a	metastasis	suppress	negative	breast cancer cells|breast cancer metastasis	D001943
26707908	MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3 .	MicroRNA-124	metastasis	inhibit	negative	nasopharyngeal carcinoma	D009369
26708715	Here , we report that miR-217 expression was downregulated in EOC tissue and inversely correlated with advanced FIGO stage , high histological grading and lymph node metastasis ( P < 0.01 ) .	miR-217	metastasis	downregulate	negative	EOC|FIGO stage	D009369
26714817	MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGF?] R1 .	MicroRNA-490	metastasis	inhibit	negative	colorectal cancer	D001943
26714817	In this study we purposed to investigate the expression and biological functions of miR-490-3p in CRC metastasis , as well as to identify its downstream target genes and influenced pathway .	miR-490	metastasis	influence	neutral	CRC	D001943
26715270	Apart from that , over-expressed exogenous HMGA2 could reverse the inhibition of glioma cell metastasis and proliferation induced by let-7a .	let-7a	metastasis	inhibit	negative	glioma cell	D009369
26715809	MiR-203 may contribute to the metastasis and enhance apoptosis of HCC cells by regulating EZH2 and Bmi-1 .	MiR-203	metastasis	enhance	positive	HCC	D009369
26716895	Ectopic expression of miR-215 in GES-1 and HGC-27 cells ( low miR-215 expression ) promoted cell growth , migration , invasion , and metastasis , and these were reversed in NCI-N87 cells ( high miR-215 expression ) after miR-215 downregulation .	miR-215	metastasis	promote	positive	NCI-N87 cells	D009369
26718215	Expression of microRNA-452 via adenoviral vector inhibits non-small cell lung cancer cells proliferation and metastasis .	microRNA-452	metastasis	inhibit	negative	non-small cell lung cancer	D009369
26718215	This study aims to identify how miR-452 acts in regulating non-small cell lung cancer ( NSCLC ) proliferation and metastasis .	miR-452	metastasis	regulate	positive	non-small cell lung cancer ( NSCLC )	D009369
26718483	MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway .	MicroRNA-340	metastasis	inhibit	negative	prostate cancer	D001943
26722251	miR-339-3p inhibits proliferation and metastasis of colorectal cancer .	miR-339	metastasis	inhibit	negative	colorectal cancer	D001943
26722309	miR-128 downregulation promotes growth and metastasis of bladder cancer cells and involves VEGF-C upregulation .	miR-128	metastasis	downregulate	negative	bladder cancer	D061325
26722309	To investigate the regulation of miR-128 on VEGF-C expression and their effects on proliferation and metastasis of bladder cancer , T24 and 5637 BC cells were transfected with pre-miR-128 , anti-miR-128 and their respective negative control .	miR-128	metastasis	regulate	positive	bladder cancer	D061325
26722410	miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma .	miR-98	metastasis	suppress	negative	oral squamous cell carcinoma	D009369
26722410	These findings suggest that miR-98 inhibits cancer cell growth and metastasis by direct targeting IGF1R , implicating miR-98 as a novel potential therapeutic target for OSCC .	miR-98	metastasis	inhibit	negative	OSCC	D009369
26728244	Our findings highlight the critical ECM-tumor cell interactions regulated by miR-200/Zeb1-dependent EMT that activate intracellular signaling pathways responsible for tumor cell invasion and metastasis .	miR-200/Zeb	metastasis	regulate	positive	ECM	D009369
26729197	Upregulation of microRNA-31 targeting integrin 帢5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells .	microRNA-31	metastasis	upregulate	positive	gastric cancer	D061325
26729197	To verify the hypothesis that upregulation of microRNA-31 ( miR-31 ) targeting integrin 帢5 ( ITGA5 ) suppresses tumor cell invasion and metastasis by indirectly regulating phosphoinositide 3-kinase ( PI3K ) /protein kinase B ( AKT ) signaling pathway in human SGC7901 gastric cancer ( GC ) cells .	microRNA-31|miR-31	metastasis	upregulate	positive	gastric cancer ( GC )	D061325
26729197	Our study concluded that upregulation of miR-31 targeting ITGA5 may suppress tumor cell invasion and metastasis by indirectly regulating PI3K/AKT signaling pathway in human SGC7901 GC cells .	miR-31	metastasis	upregulate	positive	GC	D061325
26729198	The over-expression of miR-204 or downregulation of snai1 could significantly inhibit the metastasis and invasion of GC cells both in vitro and in vivo .	miR-204	metastasis	downregulate	negative	GC	D061325
26729198	Our study provided evidence that miR-204 may suppress the metastasis and invasion of GC cells through the regulation of the EMT process by targeting snai1 .	miR-204	metastasis	suppress	negative	GC|EMT	D061325
26730339	We further found that up-regulation of miR-493 inhibited the proliferation and metastasis of gastric cancer cells , in vitro and in vivo .	miR-493	metastasis	upregulate	positive	gastric cancer	D061325
26733151	Down-regulation of miR-26a in HCCLM3 and HepG2 cells resulted in an EMT-like cell morphology and high motility in vitro and increased in tumor growth and pulmonary metastasis in vivo .	miR-26a	metastasis	downregulate	negative	EMT|pulmonary metastasis	D009369
26743779	Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer .	miR-15b	metastasis	inhibit	negative	colorectal cancer	D001943
26743779	Plasma miR-15b levels were significantly higher in CRC patients than in healthy controls , in CRC patients with metastasis than in CRC patients without metastasis , and in CRC patients with recurrence than in CRC patients without recurrence in the 5-year follow-up .	miR-15b	metastasis	control	neutral	CRC	D001943
26743779	Inhibition of miR-15b activity by adenovirus carrying antimiR-15b sequence significantly increased MTSS1 and Klotho protein expression and subsequently decreased colony formation ability , invasion , and migration of HCT116 cells in vitro and liver metastasis of HCT116 tumors in vivo .	miR-15b	metastasis	inhibit	negative	liver metastasis|HCT116 tumors	D009362
26750490	In addition , miR-17-5p upregulation more frequently occurred in osteosarcoma specimens with advanced clinical stage , positive distant metastasis and poor response to neo-adjuvant chemotherapy .	miR-17	metastasis	upregulate	positive	osteosarcoma	D009362
26754294	Biofunctional investigations revealed that miR-28-5p deficiency promoted tumor growth and metastasis in nude mice without altering the in vitro biological characteristics of HCC cells .	miR-28	metastasis	promote	positive	HCC	D009369
26758430	MicroRNA-340 inhibits the migration , invasion , and metastasis of breast cancer cells by targeting Wnt pathway .	MicroRNA-340	metastasis	inhibit	negative	breast cancer cells 	D001943
26758430	By applying bioinformatic approaches for the prediction of miRNAs targeting 3'-UTRs of CTNNB1 , c-MYC , and ROCK1 , we found out that miR-340 could dramatically down-regulate metastasis by targeting Wnt signaling in breast cancer cells .	miR-340	metastasis	downregulate	negative	breast cancer cells 	D001943
26758430	We found that restoration of miR-340 in the invasive breast cancer cell line , MDA-MB-231 , suppresses the expression of the target genes ' messenger RNA ( mRNA ) and protein and , as a result , inhibits tumor cell invasion and metastasis .	miR-340	metastasis	suppress	negative	breast cancer cell	D001943
26758430	By bioinformatic analysis , we confirmed the important role of miR-340 as a pivotal regulator of breast cancer metastasis in targeting previously validated ( ROCK1 ) and potentially novel genes , i.e. , ( CTNNB1 and c-MYC ) .	miR-340	metastasis	regulate	positive	breast cancer metastasis	D001943
26769851	Moreover , miR-21 , a well-documented oncogenic miRNA for promoting tumor cell metastasis , was also found to be involved in inhibitory activity of SSA in breast tumor cell motility through the modulation of TGF?] pathway .	miR-21	metastasis	promote	positive	breast tumor	D001943
26769851	In conclusion , we demonstrate that a non-COX inhibitory derivative of sulindac can inhibit breast tumor metastasis by a mechanism involving the TGF?] /miR-21 signaling axis .	miR-21	metastasis	inhibit	negative	breast tumor	D001943
26781875	HPV 16 E7 inhibits OSCC cell proliferation , invasion , and metastasis by upregulating the expression of miR-20a .	miR-20a	metastasis	inhibit	negative	OSCC	D009369
26781875	The aim of this research was to study how HPV-16 E7 affects the proliferation , invasion , and metastasis of oral squamous cell carcinoma ( OSCC ) cells by upregulating the expression of miR-20a .	miR-20a	metastasis	affect	neutral	oral squamous cell carcinoma ( OSCC )	D009369
26783084	Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D .	miR-522	metastasis	downregulate	negative	non-small cell lung cancer cells	D009369
26783084	DENND2D was involved in miR-522 induced proliferation and metastasis of NSCLC cells by a miRNA-masking antisense oligonucleotides ( miR-mask ) technology .	miR-522	metastasis	induce	positive	NSCLC	D009369
26785733	We have thus identified panels of miRNAs , which include metastasis promoting miR-200 family and miR-203 , as well as oncogenic and tumor-suppressive miRNAs , that can serve as prognostic markers for MBC , and early detection markers of metastasis in BC .	miR-200|miR-203	metastasis	promote	positive	MBC|BC	D001943
26790956	Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway .	miR-141	metastasis	influence	neutral	hepatocellular carcinoma	D009369
26796277	miR-138 overexpression inhibited metastasis of breast cancer cells .	miR-138	metastasis	inhibit	negative	breast cancer cells	D001943
26807169	We also found that miR-485-5p suppressed gastric cancer cell metastasis and sphere formation .	miR-485	metastasis	suppress	negative	gastric cancer	D061325
26807173	Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC .	miR-532	metastasis	promote	positive	HCC	D009369
26807173	It was also verified that miR-532-5p inhibited cell proliferation and metastasis of HCC cells by inhibition CXCL2 .	miR-532	metastasis	inhibit	negative	HCC	D009369
26817521	PAI-1 , a target gene of miR-143 , regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma .	miR-143	metastasis	regulate	positive	osteosarcoma	D009362
26817521	We have previously reported that intravenous injection of miR-143 significantly suppresses lung metastasis of human osteosarcoma cells ( 143B ) in a mouse model .	miR-143	metastasis	suppress	negative	osteosarcoma	D009362
26817521	These results indicated that PAI-1 , a target gene of miR-143 , regulates invasion and lung metastasis via enhancement of MMP-13 expression and secretion in human osteosarcoma cells , suggesting that these molecules could be potential therapeutic target genes for preventing lung metastasis in osteosarcoma patients .	miR-143	metastasis	regulate	positive	osteosarcoma|lung metastasis	D009362
26818357	In vitro and in vivo experiments indicate that restoring miR-124 expression in NSCLC cells had a marked effect on reducing cell migration , invasion and metastasis .	miR-124	metastasis	effect	neutral	NSCLC	D009369
26818357	Notably , upon TGF-?] stimulation , phosphorylation of Smad2/3 was modulated by alteration of miR-124 or Smad4 expression , followed by inducing some special transcription of downstream genes including Snail , Slug and ZEB2 , all of which may trigger epithelial-mesenchymal transition and be associated with NSCLC metastasis .	miR-124	metastasis	stimulate	positive	NSCLC	D009369
26820102	In this study , we found that miR-655 was down-regulated in TNBC , and its expression levels were associated with molecular-based classification and lymph node metastasis in breast cancer .	miR-655	metastasis	downregulate	negative	TNBC|breast cancer	D001943
26820128	Our results proved that miR-152 expression was downregulated in CRC cell lines and tissue samples , and its expression was inversely correlated with advanced tumor-node-metastasis ( TNM ) stage ( P ? < ? 0.01 ) and lymph node metastasis ( P ? < ? 0.01 ) .	miR-152	metastasis	downregulate	negative	CRC|tumor-node-metastasis ( TNM ) stage	D001943|D009369
26820227	Together with the fact that high SOX4 or NT5E levels were associated with poor prognosis , we also demonstrated that downregulation of miR-187 was closely related to tumor metastasis and poor prognosis in CRC .	miR-187	metastasis	downregulate	negative	CRC	D001943
26823724	MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA .	MiR-195	metastasis	regulate	positive	hepatocellular carcinoma	D009369
26823724	Taken together , our results suggest that miR-195 , a tumor suppressor miRNA , contributes to the lung metastasis of HCC by negatively regulating FGF2 and VEGFA , providing key implications of miR-195 for the therapeutic intervention of HCC .	miR-195	metastasis	regulate	positive	HCC	D009369
26823738	Together , these findings indicated that miR-152 suppression in NSCLC cells might promote neuropilin-1 mediated cancer metastasis and suggested a new therapeutic application of miR-152 in the treatment of NSCLC .	miR-152	metastasis	suppress	negative	NSCLC	D009369
26823832	Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer .	microRNA-126|microRNA-133b	metastasis	downregulate	negative	non small cell lung cancer	D009369
26825606	Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122 .	miR-122	metastasis	inhibit	negative	cholangiocarcinoma	D009369
26827826	MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-庥B/MMP-9/VEGF pathways .	MicroRNA-26b	metastasis	suppress	negative	non-small cell lung cancer	D009369
26827826	In the present study , we report that miR-26b suppresses cell metastasis in NSCLC through targeting migration and invasion enhancer 1 ( MIEN1 ) .	miR-26b	metastasis	suppress	negative	NSCLC	D009369
26827826	In conclusion , this study revealed that miR-26b suppresses NSCLC metastasis by targeting MIEN1 via NF-庥B/MMP-9/VEGF pathways , implicating a potential prognostic biomarker and therapeutic target for NSCLC treatment .	miR-26b	metastasis	suppress	negative	NSCLC	D009369
26831666	MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis .	MicroRNA-7	metastasis	downregulate	negative	hepatocellular carcinoma	D009369
26835790	The expression levels of miR-23b were upregulated in plasma samples from GC patients ( P < 0.01 ) and were significantly associated with T stage , distant metastasis , and differentiation .	miR-23b	metastasis	upregulate	positive	GC	D061325
26840372	microRNA-497 inhibits invasion and metastasis of colorectal cancer cells by targeting vascular endothelial growth factor-A .	microRNA-497	metastasis	inhibit	negative	colorectal cancer	D001943
26845446	MiR-133a was lower expressed in human osteosarcoma cell lines than human normal osteoblastic cell line hFOB and its effect on inhibiting proliferation , invasion and metastasis is mediated by its direct interaction with the IGF-1R .	MiR-133a	metastasis	effect	neutral	osteosarcoma	D009362
26845446	MiR-133a suppresses osteosarcoma progression and metastasis by targeting IGF-1R in human osteosarcoma cells , providing a novel candidate prognostic factor and a potential anti-metastasis therapeutic target in osteosarcoma .	MiR-133a	metastasis	suppress	negative	osteosarcoma	D009362
26847706	Quantitative RT-PCR ( qRT-PCR ) assay showed that miR-137 expression was significantly downregulated in human PTC tissues , and its expression was significantly negatively correlated with tumor-node-metastasis ( TNM ) stage and lymph node metastasis .	miR-137	metastasis	downregulate	negative	PTC|tumor-node-metastasis ( TNM ) stage	D009369
26851540	miR-1290 promotes gastric tumor cells proliferation and metastasis through FOXA1 , which could be used as a marker for diagnosis and a target for therapeutic intervention .	miR-1290	metastasis	promote	positive	gastric tumor	D009369
26852690	miR-1 , regulated by LMP1 , suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma .	miR-1	metastasis	regulate	positive	nasopharyngeal carcinoma	D009369
26861561	MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1帢 signaling .	MicroRNA-130b	metastasis	promote	positive	EMT	D009369
26861561	Moreover , high levels of miR-130b predicted poor overall and disease-free survival of HCC patients , and in vitro and in vivo research revealed that knockdown or overexpression of miR-130b inhibited and promoted proliferation and metastasis of HCC cells , respectively .	miR-130b	metastasis	inhibit	negative	HCC	D009369
26861561	Next , using a gain and loss assay and epithelial-mesenchymal transition ( EMT ) relative assays , we show that miR-130b may promote proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1帢 signaling .	miR-130b	metastasis	promote	positive	epithelial-mesenchymal transition ( EMT )	D009369
26868958	MiR-132 was significantly down-regulated in primary CRC tissues with liver metastasis and liver metastatic lesions compared to primary lesions without liver metastasis .	MiR-132	metastasis	downregulate	negative	CRC	D001943
26870180	MicroRNA-183-5p promotes the proliferation , invasion and metastasis of human pancreatic adenocarcinoma cells .	MicroRNA-183	metastasis	promote	positive	pancreatic adenocarcinoma	D001943
26870188	The current results provided evidence that the T > C polymorphism in the miR-196a-2 precursor may influence tumorigenesis and metastasis in EOC , and suggested that the functional SNP rs11614913 in the promoter region of pri-miR-196a-2 may be a potential indicator of EOC susceptibility in the population analyzed .	miR-196a	metastasis	influence	neutral	EOC	D009369
26870245	miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6 .	miR-135b	metastasis	inhibit	negative	prostate cancer	D001943
26870245	A previous microarray study demonstrated that miR-135b is downregulated in prostate cancer ( PCa ) cells , but the role and molecular mechanism of miR-135b in the regulation of tumour metastasis remain to be elucidated .	miR-135b	metastasis	downregulate	negative	prostate cancer ( PCa )	D001943
26871477	MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis .	MicroRNA-150	metastasis	suppress	negative	hepatocellular carcinoma	D009369
26872369	In conclusion , our results suggest that miR-335-5p and miR-15b-5p down-regulation results in TRIM29 over-expression , which induces proliferation , EMT and metastasis of NPC through the PTEN/AKT/mTOR signaling pathway .	miR-335|miR-15b	metastasis	downregulate	negative	EMT|NPC	D010181
26872723	Here , we reported that high miR-21 expression was strongly associated with lymph node metastasis in breast cancer , and the activation of the miR-21/NF- ? B was required for the metastatic promoting effect of CAFs .	miR-21|miR-21/NF	metastasis	activate	positive	breast cancer	D001943
26872723	Taken together , our findings identified miR-21 as a critical mediator of metastasis in breast cancer through the tumor environment .	miR-21	metastasis	mediate	neutral	breast cancer	D001943
26873866	MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer .	MicroRNA-183	metastasis	inhibit	negative	cervical cancer	D009369
26873866	miR-183 was found to inhibit or promote the invasion and metastasis of multiple solid tumors .	miR-183	metastasis	inhibit	negative	solid tumors	D009369
26873866	In conclusion , our study revealed that miR-183 might be a tumor suppressor via inhibiting the invasion and metastasis of cervical cancer cells through targeting MMP-9 , indicating that miR-183 may be a novel potential therapeutic target for cervical cancer .	miR-183	metastasis	inhibit	negative	cervical cancer	D009369
26879016	Mechanism of Regulatory Effect of MicroRNA-206 on Connexin 43 in Distant Metastasis of Breast Cancer .	MicroRNA-206	Metastasis	effect	neutral	Breast Cancer	D001943
26879016	It remains unclear whether the regulatory effect of miR-206 on Cx43 is involved in metastasis of breast cancer .	miR-206	metastasis	effect	neutral	breast cancer	D001943
26879016	Using quantitative real-time polymerase chain reaction and Western blot , the expressions of miR-206 and Cx43 were determined in breast cancer tissues , hepatic and pulmonary metastasis ( PM ) , and cell lines ( MCF-10A , MCF-7 , and MDA-MB-231 ) .	miR-206	metastasis	react	neutral	breast cancer|pulmonary metastasis ( PM )	D001943
26879016	MiR-206 can regulate the expression of Cx43 , the cytobiological activity , and the metastasis of breast cancer through binding to the two binding sites in Cx43-3'UTR : position 478-484 and position 1609-1615 .	MiR-206	metastasis	regulate	positive	breast cancer	D001943
26883008	MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma .	MicroRNA-365a	metastasis	promote	positive	laryngeal squamous cell carcinoma	D009369
26883008	We then investigated the role of miR-365a-3p in LSCC in ? vivo and found that miR-365a-3p inhibitor suppressed LSCC xenograft tumor growth and metastasis in xenograft mouse models .	miR-365a	metastasis	suppress	negative	LSCC	D009369
26883008	The data suggest that miR-365a-3p may act as an oncomiR and may promote growth and metastasis in LSCC via the PI3K/AKT signaling pathway , and thus miR ? 365a-3p may be a potential therapeutic target for treatment of LSCC .	miR-365a	metastasis	promote	positive	LSCC	D009369
26885269	Together , our data suggest that miR-506 suppression in OS cells may promote Snail2-mediated cancer metastasis .	miR-506	metastasis	suppress	negative	OS	D009369
26891730	Targets of miR-21 ( TIMP3 , PDCD4 , PTEN , TPM1 and RECK ) are also primarily involved in BC promotion and progression , especially invasion , angiogenesis and metastasis .	miR-21	metastasis	promote	positive	BC	D001943
26893720	In conclusion , the current study demonstrated that miR-126 inhibited EC cell migration and invasion , at least partially through the direct targeting of IRS1 , suggesting that miR-126 may aid the treatment of EC metastasis .	miR-126	metastasis	inhibit	negative	EC	D009369
26893786	MicroRNA-26a induces osteosarcoma cell growth and metastasis via the Wnt/?] -catenin pathway .	MicroRNA-26a	metastasis	induce	positive	osteosarcoma	D009362
26893786	In the present study , the role of miR-26a in the progression and metastasis of OS was investigated using reverse transcription-quantitative polymerase chain reaction , a luciferase activity assay , cell viability assay , in vitro migration and invasion assays , transfection and western blot analysis .	miR-26a	metastasis	react	neutral	OS	D009369
26898455	Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway .	Let-7a	metastasis	induce	positive	breast cancer cell	D001943
26898757	The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related .	microRNA-23b/	metastasis	suppress	negative	prostate cancer	D001943
26898757	However , neither miR-23b/-27b expression or inhibition impacts prostate cancer cell proliferation suggesting that miR-23b/-27b selectively suppresses metastasis .	miR-23b/	metastasis	inhibit	negative	prostate cancer	D001943
26898757	To examine the effects of miR-23b/-27b on prostate cancer metastasis in vivo , orthotopic prostate xenografts were established using aggressive prostate cancer cells transduced with miR-23b/-27b or non-targeting control miRNA .	miR-23b/	metastasis	control	neutral	prostate cancer	D001943
26899325	miR-155 may promote the invasion and metastasis of lung adenocarcinoma through reducing the target PTEN gene expression .	miR-155	metastasis	promote	positive	lung adenocarcinoma	D001943
26903137	hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a .	microRNA-29a	metastasis	mediate	neutral	gastric cancer	D061325
26903137	Our study also found that the restoration of miR-29a suppressed the expression of ITGB1 and inhibited GC cell metastasis both in vitro and in vivo .	miR-29a	metastasis	suppress	negative	GC	D061325
26903137	Taken together , our results suggested that hTERT may promote GC metastasis through the hTERT-miR-29a-ITGB1 regulatory pathway .	miR-29a	metastasis	promote	positive	GC	D061325
26908446	MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3 .	MicroRNA-323	metastasis	inhibit	negative	pancreatic ductal adenocarcinoma	D001943
26909612	Both in vitro and in vivo experiments showed that ectopic stable expression miR-194 suppressed proliferation , migration , invasion and metastasis and induced apoptosis in NSCLC cells and that this suppression could be reversed by reintroducing forkhead box A1 ( FOXA1 ) , a functional target of miR-194 .	miR-194	metastasis	suppress	negative	NSCLC	D009369
26909612	These findings suggested that miR-194 inhibits proliferation and metastasis and reverses cisplatin-resistance of NSCLC cells and may be useful as a new potential therapeutic target for NSCLC .	miR-194	metastasis	inhibit	negative	NSCLC	D009369
26910912	An orthotopic xenograft nude mouse model further affirmed that miR-410 promoted NSCLC cell growth and metastasis in vivo .	miR-410	metastasis	promote	positive	NSCLC	D009369
26913720	MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR , respectively .	MiR-193a|miR-193a	metastasis	suppress	negative	osteosarcoma	D009362
26913720	MiR-193a-3p and miR-193a-5p play important roles in osteosarcoma metastasis through down-regulation of the Rab27B and SRR genes and therefore may serve as useful biomarkers for the diagnosis of osteosarcoma and as potential candidates for the treatment of metastatic osteosarcoma .	MiR-193a|miR-193a	metastasis	downregulate	negative	osteosarcoma	D009362
26917489	Our findings demonstrate the critical role of KDM5B and its negative regulator hsa-miR-448 in TNBC metastasis and progression .	miR-448	metastasis	regulate	positive	TNBC	D009369
26918943	MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer .	MicroRNA-30a	metastasis	suppress	negative	breast cancer	D001943
26933999	Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness , EMT traits , and lymph node metastasis .	miR-204	metastasis	suppress	negative	oral squamous cell carcinomas	D009369
26934001	Screening of the differentially expressed microRNAs identified that microRNA-92b-3p ( miR-92b ) could dramatically inhibit invasion and metastasis of ESCC cells in vitro and in vivo .	microRNA-92b|miR-92b	metastasis	inhibit	negative	ESCC	D009369
26934001	Together , these results for the first time describe how miR-92b suppresses the motility of ESCC cells and provide a promise for diagnosis or therapy of ESCC invasion and metastasis .	miR-92b	metastasis	suppress	negative	ESCC	D009369
26934648	MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1 .	MiR-652	metastasis	upregulate	positive	non-small cell lung cancer	D009369
26934648	In this study , we detected the expression of miR-652-3p in NSCLC tumor tissues and cell lines and investigated the effect of miR-652-3p on the proliferation and metastasis of NSCLC cells .	miR-652	metastasis	effect	neutral	NSCLC	D009369
26934648	Our results showed that the expression of miR-652-3p was significantly upregulated in tumor tissues of 50 patients with NSCLC , and it was significantly higher in patients with positive lymph node metastasis , advanced TNM stage and poor prognosis .	miR-652	metastasis	upregulate	positive	NSCLC|TNM stage	D009369
26935156	MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma .	MicroRNA-200b	metastasis	suppress	negative	epithelial-mesenchymal transition|cervical carcinoma	D001943
26935975	MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2 , an epithelial-mesenchymal transition regulator .	MicroRNA-200c	metastasis	inhibit	negative	non-small cell lung cancer|epithelial-mesenchymal transition	D009369
26936591	In this study , the expression of miR-1284 was reduced in gastric cancer ( GC ) tissue specimens with metastasis and in vincristine-resistant ( VCR ) GC ? SGC7901 cells ( SGC-7901/VCR ) compared to that in the controls .	miR-1284	metastasis	control	neutral	gastric cancer ( GC )	D061325
26940738	The purpose of this study was to determine the role of miR-1271 in regulation of epithelial mesenchymal transition ( EMT ) and metastasis of pancreatic cancer cells .	miR-1271	metastasis	regulate	positive	epithelial mesenchymal transition ( EMT )|pancreatic cancer	D009369
26944318	MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma .	MicroRNA-379	metastasis	inhibit	negative	hepatocellular carcinoma	D009369
26944318	Here , we report that miR-379-5p , which is down-regulated in HCC tissues and cell lines , is associated with advanced TNM stage and metastasis in HCC .	miR-379	metastasis	downregulate	negative	HCC|TNM stage	D009369
26944318	The ectopic overexpression of miR-379-5p inhibited HCC cell migration , invasion , epithelial-to-mesenchymal transition ( EMT ) and metastasis both in vitro and in vivo .	miR-379	metastasis	inhibit	negative	HCC|epithelial-to-mesenchymal transition ( EMT )	D009369
26944318	Taken together , our findings highlight the important role of miR-379-5p in regulating the EMT and metastasis of HCC by targeting FAK/AKT signaling , suggesting that miR-379-5p may represent a novel potential therapeutic target and prognostic marker for HCC .	miR-379	metastasis	regulate	positive	EMT|HCC	D009369
26947878	MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene .	MiR-200a	Metastasis	suppress	negative	Pancreatic Ductal Adenocarcinoma	D001943
26947878	MiR-200a has been reported to be able to suppress the epithelial-mesenchymal transition process in pancreatic cancer stem cells , suggesting that miR-200a could suppress the metastasis of pancreatic ductal adenocarcinoma ( PDAC ) .	MiR-200a|miR-200a	metastasis	suppress	negative	pancreatic ductal adenocarcinoma ( PDAC )	D001943
26947878	Our study demonstrated that miR-200a suppresses the metastasis in pancreatic PDAC through downregulation of DEK , suggesting that miR-200a may be used as a novel potential marker in prediction of metastasis of PDAC .	miR-200a	metastasis	suppress	negative	PDAC	D009369
26949125	Moreover , miR-548j was shown to stimulate breast cancer cell invasion and metastasis in ? vitro and in ? vivo , but had no effect on proliferation .	miR-548j	metastasis	stimulate	positive	breast cancer cell	D001943
26949125	Our findings demonstrate that miR-548j functions as a metastasis-promoting miRNA to regulate breast cancer cell invasion and metastasis by targeting Tensin1 and activating Cdc42 , suggesting a potential therapeutic application in breast cancer .	miR-548j	metastasis	regulate	positive	breast cancer	D001943
26959737	MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2 .	MiR-26a|miR-144	metastasis	inhibit	negative	esophageal squamous cell cancer	D009369
26959737	Co-expression of miR-26a and miR-144 in ESCC cells resulted in inhibition of proliferation and metastasis in vitro and in vivo , suggesting that targeting COX-2 may be the mechanism of these two miRNAs .	miR-26a|miR-144	metastasis	coexpress	neutral	ESCC	D009369
26961483	Collectively , these observations showed that miR-183 maybe function as an oncogene by regulating GC cell proliferation , apoptosis and metastasis and the oncogenic effect of miR-183 may relate the direct targeting PDCD4 .	miR-183	metastasis	regulate	positive	GC	D061325
26965144	It was determined that miR-146a coordinated melanoma cell growth by its direct targets lunatic fringe ( LFNG ) and NUMB which operate on the NOTCH/PTEN/Akt pathway ; while , inhibition of metastasis formation was linked to decreased expression of ITGAV and ROCK1 .	miR-146a	metastasis	inhibit	negative	melanoma	D012878
26967387	MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer .	MiR-148a	metastasis	suppress	negative	triple-negative breast cancer	D009369
26968810	MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS , MTA1 and HMGA2 .	MicroRNA-543	metastasis	suppress	negative	colorectal cancer	D001943
26968810	Moreover , ectopic expression of miR-543 inhibited the proliferation and metastasis of CRC cells in vitro and in vivo by targeting KRAS , MTA1 and HMGA2 .	miR-543	metastasis	inhibit	negative	CRC	D001943
26968810	Conversely , miR-543 knockdown promoted the proliferation , migration and invasion of CRC cells in vitro and augmented tumor growth and metastasis in vivo .	miR-543	metastasis	promote	positive	CRC	D001943
26968810	Collectively , these data show that miR-543 inhibits the proliferation and metastasis of CRC cells by targeting KRAS , MTA1 and HMGA2 .	miR-543	metastasis	inhibit	negative	CRC	D001943
26968810	Our study highlights a pivotal role for miR-543 as a suppressor in the regulation of CRC growth and metastasis and suggests that miR-543 may serve as a novel diagnostic and prognostic biomarker for CRC metastasis .	miR-543	metastasis	regulate	positive	CRC	D001943
26968949	miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and smad pathways in gallbladder carcinoma .	miR-101	metastasis	suppress	negative	gallbladder carcinoma	D009369
26969828	Taken together , we consider that down-regulation of TRPS1 by miR-373 , acting as a transcriptional activator , promotes EMT and metastasis by repressing FOXA1 transcription , expanding upon its previously reported role as a transcription repressor .	miR-373	metastasis	downregulate	negative	EMT	D009369
26972445	Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3 .	miR-499	metastasis	inhibit	negative	non-small cell lung cancer	D009369
26972445	Furthermore , miR-499-5p overexpression also inhibited NSCLC metastasis in vitro and in vivo .	miR-499	metastasis	inhibit	negative	NSCLC	D009369
26980408	miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT : an essential role for Twist-1 in HCC .	miR-27a	metastasis	suppress	negative	HCC	D009369
26980408	The miR-27a-3p-mediated down-regulation of VE-cadherin and inhibition of EMT may be essential for Twist-1 to induce tumor metastasis and VM .	miR-27a	metastasis	downregulate	negative	EMT	D009369
26983694	Thus , our data showed that two genes promoting metastasis , LOXL2 and PLOD2 , were epigenetically regulated by tumor-suppressive microRNAs , miR-26a and miR-26b , providing important insights into the molecular mechanisms of RCC metastasis .	miR-26a|miR-26b	metastasis	promote	positive	RCC	D001943
26983891	These results suggest that miR-9 functions as a tumor-suppressor in CRC , and that its suppressive effects mediate invasion and metastasis by inhibition of TM4SF1 expression .	miR-9	metastasis	mediate	neutral	CRC	D001943
26986073	Downregulation of miR-99a was significantly associated with advanced stage and tumor metastasis in lung adenocarcinoma patients , and it was found to be a poor prognostic factor in lung adenocarcinoma .	miR-99a	metastasis	downregulate	negative	lung adenocarcinoma	D001943
26990571	We examined the effect of miR-301a expression on biochemical recurrence and metastasis among 585 men treated with radical prostatectomy for prostate cancer .	miR-301a	metastasis	effect	neutral	prostate cancer	D001943
26992424	Moreover , exosomal miR-21 markedly enhanced snail and vimentin expression , while significantly decreasing E-cadherin levels in OSCC cells , in vitro and in vivo Finally , circulating exosomal miR-21 levels were closely associated with HIF-1帢/HIF-2帢 expression , T stage , and lymph node metastasis in patients with OSCC .	miR-21	metastasis	enhance	positive	OSCC	D009369
26992637	Altogether , these results indicated that miR-409-3p targets catenin-帤1 to repress osteosarcoma metastasis .	miR-409	metastasis	repress	negative	osteosarcoma	D009362
26993767	MicroRNA-630 suppresses tumor metastasis through the TGF-?] - miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma .	MicroRNA-630|miR-630	metastasis	suppress	negative	hepatocellular carcinoma	D009369
27000495	Autocrine TGF-?] /ZEB/microRNA-200 signal transduction drives epithelial-mesenchymal transition : Kinetic models predict minimal drug dose to inhibit metastasis .	microRNA-200	metastasis	inhibit	negative	epithelial-mesenchymal transition	D009369
27000664	By simulating the tumor microenvironment , the MV-delivered miR-29a/c significantly suppresses VEGF expression in GC cells , inhibiting vascular cell growth , metastasis , and tube formation .	miR-29a/c	metastasis	suppress	negative	GC	D061325
27002617	Moreover , TUSC7 inhibited cell metastasis , invasion , and epithelial-to-mesenchymal transformation ( EMT ) through competitively binding miR-10a .	miR-10a	metastasis	inhibit	negative	epithelial-to-mesenchymal transformation ( EMT )	D009369
27006642	Taken together , these findings implicated that miR-519d promoted the progression and metastasis of cervical cancer through targeting Smad7 .	miR-519d	metastasis	promote	positive	cervical cancer	D009369
27008415	H19 Functions as a ceRNA in Promoting Metastasis Through Decreasing miR-200s Activity in Osteosarcoma .	miR-200s	Metastasis	promote	positive	Osteosarcoma	D009362
27010860	MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1帢 expression .	MiR-485|miR-485	metastasis	suppress	negative	breast cancer cell	D001943
27010860	Overexpression of miR-485-3p and miR-485-5p suppressed mitochondrial respiration and potential for cell migration and invasion in vitro , and also inhibited spontaneous metastasis of breast cancer cells in vivo .	miR-485	metastasis	suppress	negative	breast cancer cells	D001943
27015119	MiR-371-5p expression ( measured using qRT-PCR ) was upregulated in GC tissues and correlated positively with TNM staging and lymph node ( LN ) metastasis .	MiR-371	metastasis	upregulate	positive	GC|TNM	D061325
27015119	These results indicate that miR-371-5p expression is strongly upregulated in GC tissues and negatively correlated with SOX2 expression , while miR-371-5p expression is inversely related to proliferation , TNM stage , and LN metastasis of GC cells .	miR-371	metastasis	upregulate	positive	TNM stage|LN metastasis|GC	D061325
27016414	MicroRNA-421 regulated by HIF-1帢 promotes metastasis , inhibits apoptosis , and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer .	MicroRNA-421	metastasis	regulate	positive	gastric cancer	D061325
27016414	Overexpression of miR-421 promoted metastasis , inhibited apoptosis , and induced cisplatin resistance in gastric cancer in vivo and in vitro .	miR-421	metastasis	promote	positive	gastric cancer	D061325
27018975	Downregulation of TIMP2 via HIF-1帢/miR-210/HIF-3帢 regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma .	miR-210/HIF	metastasis	downregulate	negative	hepatocellular carcinoma	D009369
27023472	This study aimed to explore the roles of microRNA-491-5p ( miR-491 ) and its target MMP9 in the control of metastasis of osteosarcoma ( OS ) as well as how the rs1056629 polymorphism in the 3 ' untranslated region ( 3'UTR ) of MMP9 compromises the interaction between miR-491 and MMP9 .	microRNA-491|miR-491|miR-491	metastasis	control	neutral	osteosarcoma ( OS )	D009362
27027434	miR-26b-5p suppresses Twist1-induced EMT , invasion , and metastasis of HCC cells by targeting SMAD1 and BMP4/Smad1 signaling .	miR-26b	metastasis	suppress	negative	HCC	D009369
27028860	Grapefruit-derived nanovectors deliver miR-18a for treatment of liver metastasis of colon cancer by induction of M1 macrophages .	miR-18a	metastasis	induction	positive	colon cancer	D001943
27028860	We found that miR-18a encapsulated in grapefruit-derived nanovector ( GNV ) mediated inhibition of liver metastasis that is dependent upon the induction of M1 ( F4/80+IFN帠+IL-12+ ) macrophages ; depletion of macrophages eliminated its anti-metastasis effect .	miR-18a	metastasis	mediate	neutral	liver metastasis	D009362
27028860	Taken together our results indicate that miR-18a can act as an inhibitor for liver metastasis through induction of M1 macrophages .	miR-18a	metastasis	induction	positive	liver metastasis	D009362
27028864	We suggest that the induction of SRC results in increased PCa metastasis that is linked to the dysregulation of the AR signaling pathway through the inactivation of miR-203 .	miR-203	metastasis	induction	positive	PCa	D001943
27033573	The expression level of miR-140-5p was significantly downregulated in hypopharyngeal carcinoma tissues compared with adjacent tissues ( t=-4.016 , P < 0.01 ) , which was significantly correlated with tumor classification and lymph node metastasis ( P < 0.05 ) .	miR-140	metastasis	downregulate	negative	hypopharyngeal carcinoma	D009369
27033573	The expression of miR-140-5p was significantly downregulated in hypopharyngeal carcinoma tissues and correlated with tumor classification and lymph node metastasis .	miR-140	metastasis	downregulate	negative	hypopharyngeal carcinoma	D009369
27035216	MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN .	MicroRNA-130a	metastasis	promote	positive	osteosarcoma	D009362
27035216	This study demonstrates for the first time that microRNA-130a ( miR-130a ) is significantly upregulated in osteosarcoma , and associated with the metastasis of osteosarcoma .	microRNA-130a|miR-130a	metastasis	upregulate	positive	osteosarcoma	D009362
27036018	Our data suggest that the miR-509-3p/YAP1 axis may be a new druggable target in cancers with high YAP1 , and we propose that therapeutically targeting the miR-509-3p/YAP1/ECM axis may disrupt early steps in multi-cellular spheroid formation , and so inhibit metastasis in epithelial ovarian cancer and potentially in other cancers .	miR-509	metastasis	inhibit	negative	epithelial ovarian cancer	D001943
27037000	Ectopic overexpression of miR-539 can drastically inhibit SPAG5 expression and the restoration of SPAG5 expression can reverse the inhibitory effects of miR-539 on PCa cell proliferation and metastasis .	miR-539	metastasis	inhibit	negative	PCa	D001943
27037061	Gain- and loss-of-function assays in vitro and in vivo reveal that miR-490-3p suppresses cancer cell proliferation by inducing apoptosis and inhibits cell invasiveness by repressing the initiation of epithelial-to-mesenchymal transition ( EMT ) , a key mechanism in cancer cell invasiveness and metastasis .	miR-490	metastasis	suppress	negative	epithelial-to-mesenchymal transition ( EMT )	D009369
27042117	miR-32 inhibits proliferation , epithelial-mesenchymal transition , and metastasis by targeting TWIST1 in non-small-cell lung cancer cells .	miR-32	metastasis	inhibit	negative	epithelial-mesenchymal transition	D009369
27042117	Here , we report the effect of miR-32 on NSCLC cell proliferation , epithelial-mesenchymal transition ( EMT ) , and metastasis .	miR-32	metastasis	effect	neutral	NSCLC|epithelial-to-mesenchymal transition ( EMT )	D009369
27042117	MTT , transwell chamber , and Western blot assays were used to assess the effect of miR-32 on proliferation , EMT , and metastasis of NSCLC cells , respectively .	miR-32	metastasis	effect	neutral	EMT|NSCLC	D009369
27042117	An inverse correlation existed between miR-32 expression level and NSCLC cell proliferation , EMT , and metastasis , and upregulation of miR-32 repressed NSCLC cell proliferation , EMT , and metastasis .	miR-32	metastasis	upregulate	positive	NSCLC|EMT	D009369
27042117	Moreover , we identified and validated that TWIST1 was a direct target of miR-32 , and miR-32 regulated NSCLC cell proliferation , EMT , and metastasis , at least in part via modulation of TWIST1 .	miR-32	metastasis	regulate	positive	NSCLC|EMT	D009369
27044835	Moreover , we found that down-regulation of miR-601 was closely associated with distant metastasis and poor distant metastasis-free survival in breast cancer .	miR-601	metastasis	downregulate	negative	breast cancer	D001943
27044840	MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1 .	MiR-200b	metastasis	promote	positive	cervical cancer	D009369
27049079	Part of the common nursing methods had a certain influence on miR-574-5p expression , HeLa reproduction and metastasis , and even cell cycle .	miR-574	metastasis	influence	neutral	HeLa	D009369
27060060	A vast number of miRNAs , including the well-studied miR-21 , miR-155 and miR-34 , has been shown to regulate PDAC growth , invasion and metastasis in vitro and in vivo by targeting members of key signaling pathways .	miR-21|miR-155|miR-34	metastasis	regulate	positive	PDAC	D009369
27063799	Overexpression of miR-1976 inhibited the growth and metastasis of NSCLC cells .	miR-1976	metastasis	inhibit	negative	NSCLC	D009369
27063799	The PLCE1 was a direct target of miR-1976 and promoted the growth and metastasis of NSCLC cells .	miR-1976	metastasis	promote	positive	NSCLC	D009369
27063799	Further study showed that PLCE1 could reverse the inhibitory effect of miR-1976 on growth and metastasis of NSCLC cells .	miR-1976	metastasis	effect	neutral	NSCLC	D009369
27065331	Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a .	miR-374a	metastasis	inhibit	negative	hepatocellular carcinoma	D009369
27069535	miR-144 suppresses the growth and metastasis of laryngeal squamous cell carcinoma by targeting IRS1 .	miR-144	metastasis	suppress	negative	laryngeal squamous cell carcinoma	D009369
27070574	In this article , I have focused on the role of HA interaction with CD44 and several important signaling molecules in the regulation of unique miRNAs ( e.g. , miR-21 , miR-302 and miR-10b ) and their downstream targets leading to multiple tumor cell-specific functions ( e.g. , tumor cell growth , drug resistance and metastasis ) and cancer progression .	miR-21|miR-302|miR-10b	metastasis	regulate	positive	HA	D009369
27070713	Regulation of the miR-452-WWP1 axis contributed to PCa cell migration and invasion , and elucidation of downstream signalling of this axis will provide new insights into the mechanisms of PCa oncogenesis and metastasis .	miR-452	metastasis	regulate	positive	PCa	D001943
27073718	Moreover , we found that TIMP3 , which was reported to suppress invasion and metastasis of ESCC , was a direct target of miR-373 .	miR-373	metastasis	suppress	negative	ESCC	D009369
27075851	miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer .	miR-141	Metastasis	regulate	positive	Breast Cancer	D001943
27075851	Our study suggests miR-141 is a regulator of brain metastasis from breast cancer and should be examined as a biomarker and potential target to prevent and treat brain metastases .	miR-141	metastasis	regulate	positive	brain metastasis|breast cancer	D001943
27078844	MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer .	MicroRNA-26b	metastasis	inhibit	negative	gastric cancer	D061325
27078844	Forced expression of miR-26b led to inhibition of GC cell migration and invasion in vitro and lung metastasis formation in vivo .	miR-26b	metastasis	inhibit	negative	GC|lung metastasis	D061325
27078844	Additionally , miR-26b affected GC cell behavior through negative regulation of the metastasis promoter , karyopherin alpha 2 ( KPNA2 ) .	miR-26b	metastasis	affect	neutral	GC	D061325
27078844	Based on the study findings , we propose that miR-26b overexpression or KPNA2/c-jun suppression may have therapeutic potential in inhibiting GC metastasis .	miR-26b	metastasis	suppress	negative	GC	D061325
27079864	MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer .	MicroRNA-409	metastasis	regulate	positive	breast cancer	D001943
27079864	These data demonstrate that miR-409-3p plays an important role in regulating the metastasis of BC , which is involved in the post-transcriptional repression of ZEB1 .	miR-409	metastasis	regulate	positive	BC	D001943
27079864	Our results indicate that miR-409-3p can regulate the invasion and metastasis process of BC by targeting ZEB1 and may serve as a new prognostic marker and therapeutic target for treating BC metastasis. c 2016 IUBMB Life , 68 ( 5 ) : 394-402 , 2016 .	miR-409	metastasis	regulate	positive	BC	D001943
27094913	In the present study , the miR-381 expression was assessed in a cohort of 113 CRC specimens using real-time quantitative polymerase chain reaction ( RTq-PCR ) , which demonstrated that miR-381 was significantly downregulated in CRC and correlated with distant metastasis and tumor , node , and metastasis ( TNM ) stage .	miR-381	metastasis	react	neutral	CRC|TNM	D001943
27098433	Here we show , in the BON1 cell line derived from lymphnode metastasis of a human carcinoid tumour of the pancreas , that menin binds specifically to the primary RNA sequence pri-miR-24-1 by promoting the miR-24-1 biogenesis .	miR-24	metastasis	promote	positive	carcinoid tumour of the pancreas	D009369
27100897	Functionally , miR-92b could promote cell proliferation and metastasis of HCC in vitro and in vivo .	miR-92b	metastasis	promote	positive	HCC	D009369
27100897	Furthermore , long non-coding RNA ( lncRNA ) X-inactive specific transcript ( XIST ) and miR-92b could directly interact with and repress each other , and XIST could inhibit HCC cell proliferation and metastasis by targeting miR-92b .	miR-92b	metastasis	repress	negative	HCC	D009369
27101583	Whole-blood samples from 89 patients who have been histopathologically confirmed as having cervical cancer and 20 control subjects were collected , and then the association between lymph node metastasis and the level of circulating miR-21 was compared .	miR-21	metastasis	control	neutral	cervical cancer	D009369
27101583	Circulating miR-21 in serum could be a promising biomarker in auxiliary diagnosis of lymph node metastasis in cervical cancer , and inhibition of miR-21/RASA1 axis could be a possible strategy to restrain migration of cervical cancer .	miR-21|miR-21/RASA	metastasis	inhibit	negative	cervical cancer	D009369
27102539	Taken together , our data suggest that miR-181b-3p functions as a metastasis activator by promoting Snail-induced EMT , and may therefore be a therapeutic target in metastatic cancers .	miR-181b	metastasis	promote	positive	EMT	D009369
27107415	miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1 .	miR-1207	metastasis	suppress	negative	lung cancer	D009369
27107415	miR-1207-5p also significantly inhibited A549 cells metastasis in a nude mouse xenograft model .	miR-1207	metastasis	inhibit	negative	A549 cells	D009369
27107696	miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase , PIM1 , in melanoma .	miR-542	metastasis	suppress	negative	melanoma	D012878
27107696	Exogenous expression of miR-542-3p resulted in marked inhibition of melanoma cell migration , invasion and epithelial-mesenchymal transition ( EMT ) in ? vitro and lung metastasis in ? vivo .	miR-542	metastasis	inhibit	negative	melanoma|epithelial-mesenchymal transition ( EMT )	D012878
27108693	MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma .	MicroRNA-126	metastasis	inhibit	negative	renal cell carcinoma	D001943
27108696	miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer .	miR-136	metastasis	suppress	negative	triple-negative breast cancer	D009369
27108696	Herein , we demonstrate that miR-136 is an anti-invasive microRNA in TNBC and suppresses mesenchymal invasion and metastasis .	miR-136	metastasis	suppress	negative	TNBC	D009369
27110773	Consistent with the effect of mmu-miR-1894-3p , knockdown of Trim46 inhibited the experimental lung metastasis of 4TO7 cells .	miR-1894	metastasis	effect	neutral	lung metastasis	D009362
27110773	These results suggested that the effect of knockdown of Trim46 alone was sufficient to recapitulate the effect of mmu-miR-1894 on the metastasis of the breast cancer cells in mouse and that Trim46 was involved in the proliferation and migration of mouse and human breast cancer cells .	miR-1894	metastasis	effect	neutral	breast cancer cells	D001943
27120794	miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2 .	miR-675	metastasis	enhance	positive	esophageal squamous cell carcinoma	D009369
27120794	We also showed here that down-regulation of miR-675-5p in ESCC cells dramatically induced cell G1 arrest and reduced cell proliferation , colony formation , migration and invasion in vitro as well as tumorigenesis and tumor metastasis in vivo .	miR-675	metastasis	downregulate	negative	ESCC	D009369